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Abstract  
 
The aim of this study was to develop new high strength dental composites with antimicrobial 
release,  using  primarily  high  molecular  weight  monomers  for  reduced  shrinkage  but 
additional  inclusion  of  components  that  might  promote  dentine  adhesion  and 
remineralisation.  
 
Urethane dimethacrylate :  poly(propylene glycol) dimethacryate (3:1) was mixed with 5 wt% 
adhesive  monomer  (2-hydroxyethyl  methacrylate  or  methacrylate  phosphate).  This  was 
combined with glass particles mixed with chlorhexidine diacetate (CHX, 5 or 10 wt%)  and 
mono and  tri calcium phosphate (CaP 10 or 40 wt%) in a powder to liquid ratio of 4:1  
 
Light activated monomer conversion was assessed by FITR. Biaxial flexural strength of set 
discs (10 mm diameter, 1 mm thick, n=8) was determined after 24 hours in distilled water 
and compared with a commercial control (Gradia).  CHX release (24 hours, 2 weeks, and 4 
weeks) was assessed using UV spectrometry. 
 
The monomer conversion of experimental formulations was 71% and 81% with 5 and 10 
wt% CHX respectively and not affected by other variables.  Gradia conversion was 50%.  
New material strengths ranged between 130 and 180 MPa being lower with higher CHX and 
CaP. Varying adhesive monomer type had negligible effect. Gradia strength was 70 MPa. 
Over 4 weeks, CHX release was 2.9 - 7.1 wt% and mass increase 1.2 - 3.9 wt%. 
 
In conclusion, experimental composites containing antibacterial, remineralising and adhesion 
promoting  components  have  been  produced  with  flexural  strengths  comparable  with 
commercial materials and higher monomer conversion.  
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1  Introduction 
 
1.1  Caries: an introduction 
 
Dental  caries  is  one  of  the  most  common  diseases  afflicting  mankind,  and  has  been 
estimated to affect up to 40% of UK adults. The UK government spends millions every year 
on the prevention and treatment of dental caries. Around 175 million pounds has been spent 
on the placement of direct restoration by the NHS in both England and Wales since the 90’s 
(Dental  Practice  Board,  1996).  Caries  adversely  affects  and  progressively  destroys  the 
tissues of the tooth, including the dental pulp, leaving teeth unsightly, weakened and with 
impaired function (Davies et al., 2011;Marya et al., 2010).  
1.1.1  The Epidemiology of Dental Caries 
 
Dental caries is probably one of the most common chronic diseases; it has affected humans 
since prehistoric times. The prevalence of this disease has increased due to the dietary 
changes that occurred in human life styles though there is now evidence that this trend has 
peaked and begun to decline in certain segments of the population of Western Europe, New 
Zealand, Unites State, and Australia. The main cause of the decrease is  the addition of 
fluoride to toothpastes,  and also the addition of trace amounts  of fluoride ions  to public 
drinking water. This decline in developed countries has been prominent in the upper classes 
and middle classes, while the lower socioeconomic and rural classes have retained a high 
prevalence of tooth decay (Kidd and Fejerskov 2004; Kidd et al., 2002). 
 20 
 
Dental caries has been studied extensively during the last 60 years in both Europe and 
North America.  Studies have been very useful in determination of the extent of the need for, 
and effectiveness of, dental treatment. The most common epidemiological measure of caries 
is the DMF; this is a measure of the number of teeth that are diseased, missing, or filled. 
Since 1973, national surveys of dental caries in children (one series directed decennially by 
the Office of Population Censuses and Surveys and another, using analogous methods, 
coordinated  regionally  on  a  regular  basis  by  the  British  Association  for  the  Study  of 
Community Dentistry) have produced a comprehensive record of trends in caries experience 
of children in England and Wales (Davies et al., 2011; Kidd et al., 2002). Between 1973 and 
1993 a decline in caries experience of 55% in primary teeth of 5-year-old children, 75 per 
cent  in  permanent  teeth  of  12-year-old,  and  74  per  cent  in  14-year-old  children,  was 
documented.  
 
Data from the NHS Dental Epidemiology Programme for England (British Association for the 
Study of Community Dentistry) indicates that the mean number of decayed, missing or filled 
primary  teeth  (dmft)  in  5-years-old  in  great  Britain  is  1.11  (2007-2008),  and  DMFT  of 
permanent teeth in 11 year old in England and Wales is 7.4 (2008 – 2009). In the UK, only 
14% of teeth with dentine decay in 5 years old are restored (NHS DEP) and if caries is not 
treated affected teeth are likely to become non-vital and may require extraction. The number 
of children who required hospital admissions for caries treatment rose by 66% between 1997 
and 2006 (Moles and Ashley 2009). A great part of this failure is due to the difficulties faced 
by dentists in treating young children. 
   21 
 
 
1.1.2  The Aetiology of Caries 
 
Dental caries is an infectious microbiological disease of the teeth that results in localized 
dissolution  and  destruction  of  the  calcified  tissues  (Kidd  and  Beighton  1996;  Kidd  and 
Fejerskov  2004).  The  evidence  for  the  role  of  bacteria  in  the  genesis  of  caries  is 
overwhelming. Animal and human models have been used in an extensive series of studies. 
The  presence  of  fermentable  carbohydrates  (Banerjee  et  al.,  2001)  such  as  sucrose, 
glucose, fructose and cooked starch, and the present of the biofilm on the teeth support the 
metabolism of acidogenic microorganisms (mutans streptococci and lactobacilli) (Banerjee et 
al.,  2004),  results  in  the  release  of  acidic  substances  which  lead  to  dissolution  of  the 
carbonated hydroxyapatite crystal lattice of enamel, cementum and dentine. The greater the 
demineralisation, the more cavitations occur on the tooth surface (Featherstone 2000; Kidd 
2004). It is now established that the aetiology of caries is no longer as simplistic; it involves 
the complex interaction of these various factors within the dental plaque biofilm.  
 
1.1.3  The pathogenesis of caries  
 
Demineralisation  and  remineralisation  are  dynamic  processes  affected  by  both  tooth 
structure  and  the  oral  environment.    The  mineral  composition  of  enamel  and  dentine, 
hydroxyapatite  (Ca10(PO4)6(OH)2,  is  at  equilibrium  at  neutral  pH  (6-7).    Hydroxyapatite, 
however, will start to dissolve when the pH of the local environment declines below a critical 
level  (for  hydroxyapatite  ~  pH  5.5)  (Dawes  2003).  This  phenomenon  is  known  as 
demineralisation and normally occurs every time sugary food is ingested with the presence 
of bacteria (Pecharki et al., 2005) 
 22 
 
The demineralisation process, however, is reversed by the buffering effect of hydroxyapatite 
dissolution  products  and  the  presence  of  sufficient  Ca
2+  and  PO4
3-  in  the  surrounding 
environment.  Environmental pH neutralisation above the critical level enhances precipitation 
of Ca
2+  and PO4
3-  within demineralized tooth structures.  This phenomenon is  known as 
remineralisation (Pecharki et al., 2005). 
 
The earliest visible sign of enamel caries is the “white spot lesion”. On a smooth surface 
lesion, it is classically triangular in shape. It follows the direction of the enamel prisms and 
can be thought of as multiple individual lesions each at different stages of progression. The 
central traverse, where the lesion is deepest, is the oldest and most advanced part of the 
lesion where the biofilm is thickest. The shape of the lesion and the activity of the lesion 
entirely reflect the specific environmental conditions of overlying biofilm. 
 
Occlusally, purely because of the sloping fissure walls and direction of enamel prisms, the 
lesion assumes an undermining character. This explains why in the advanced lesion, where 
there appears to be a small hole in the tooth, something apparently so small on the surface 
can  be  large  when  entered  with  the  bur.  Following  exposure  of  dentine  to  the  mass  of 
bacteria  in  the  cavity,  the  dentine  is  decomposed  by  the  action  of  acids  produced  by 
microorganisms  and  this  is  known  as  the  zone  of  destruction.  Underneath  this,  tubular 
invasion of bacteria is frequently seen which is called the zone of penetration because the 
tubules  have  become  penetrated  by  microorganisms.  Beyond  this  is  an  area  of 
demineralised  dentine  which  does  not  yet  contain  bacteria.  When  a  lesion  progresses 
rapidly, something called the dead tract may form when the odontoblast processes have 
been destroyed without producing tubular sclerosis (Kidd 1999). 
 
The  defence  reaction  of  tubular  sclerosis  and  tertiary  dentine  formation  continue  as  a 
response to these destructive processes.  Both processes reduce the permeability of the 23 
 
dentine, although tertiary dentine is less well mineralised than primary or secondary dentine, 
and contains irregular dentinal tubules (Kidd 1998). At this stage, removal of caries from the 
cavity  and  placing  a  filling  to  seal  the  area  arrests  the  progression  of  the  lesion  and 
encourages the two reparative processes. When dead tracts have formed and odontoblast 
have  been  destroyed,  new  odontoblasts  can  form  fibroblasts  in  the  pulp  and  lay  down 
dentine. If destruction continues, eventually the pulp will become inflamed.  
 
1.1.4   Management of caries    
 
A necessary first step in preventing dental caries in children is to understand the caries risk. 
Unfortunately dentists often see children when it is too late and caries is established.  In 
primary teeth, enamel cavities or lesions that have progressed into the superficial dentine 
layer  are  usually  treated  by  simple  restorations  involving  amalgam,  composites  or  glass 
ionomer cement. Because the enamel and dentine layers are thinner in primary teeth, the 
reality is that by the time caries is diagnosed, more invasive operative procedures are often 
necessary.  
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1.2  Current Restorations:  
 
1.2.1  Amalgam  
 
Despite the dental material revolutions in the last century, amalgam is still the most widely 
used dental material in many parts of the world (Berry et al., 1998). This material, which 
consists of mercury and alloy particles of different compositions and form, is cost effective in 
the management of dental caries, although lacking many of the features of an ideal dental 
filling material. (Downer et al., 1999; Mackert, Jr. and Wahl 2004). Amalgam has been used 
for over 150 years.  The continued use of amalgam, however, has become a controversial 
topic in recent years with concerns being raised about its safety, particularly in the relation of 
mercury release during removal, placement carving and, in the longer term, during chewing 
(Engel 2011; Merchant 2011). There are also concerns regarding the safety of disposing of 
amalgam capsules after use. There remains however, considerable evidence to support its 
safety as a dental material, and no apparent evidence to indicate an association with any 
systemic disease.  
 
Amalgam is an alloy of mercury with other metals. High copper alloys are most commonly 
used nowadays with 12-13% copper (by weight) in addition to silver, tin and zinc. The high 
amount of copper helps eliminate the weak gamma 2 phase, which was very corrodible. 
 
Amalgam has many advantages; it is cheap, strong, easy to handle, wear resistant, has low 
microleakage and good longevity. However, its major  limitations include poor  aesthetics, 
inability  to  bond  to  tooth  structure  and  mercury  hazard  to  operator,  associate  staff  and 
possibly to patients. 25 
 
 
1.2.2  Composite  
Dental composites were developed in the 1960s (Bowen 1963) and represented at the time 
a big revolution in clinical dentistry materials.  They contain filler particles which are usually a 
type of glass or silicon dioxide - the greater the filler, the better the physical properties, 
although  this  has  to  be  balanced  by  reduction  in  clinical  handling.  The  improved 
performances of resin composites have encouraged more clinicians to select resin-based 
composites for posterior restorations as an alternative to amalgam (Jordan and Suzuki 1991; 
Ottenga and Mjor 2007; Roulet and Noack 1991; Suzuki and Leinfelder 1993) because the 
adhesive  technology  allows  limited  removal  of  tooth  substance  beyond  that  required  to 
eliminate caries and undermined enamel. Lack of electrical conductivity and elimination of 
galvanism was a great advantage over amalgam fillings. Composites also incorporate an 
initiator to initiate polymerisation and this may be mediated by chemical or by light activation 
(460-480 nm).  
 
The physical, mechanical, and aesthetic properties and the clinical behaviour of composites 
depend on their structure. Three main components of dental composites are the organic 
matrix, inorganic fillers accelerator and initiator.  The latter two together allow curing to take 
place  in  the  presence  of  inhibitors  (eg.  hydroquinone  monomethyl  ether).  The  inhibitors 
maximise the product storage life and provide colour stability and eliminate the effect of UV 
light on the amine compounds in the initiator system that might cause discolouration in the 
medium long term (Del Nero and de la Macorra 1999; Peutzfeldt 1997). The predominant 
base monomer used in commercial dental composites has been bis-GMA, which due to its 
high viscosity is mixed with dimethacrylates, such as TEGDMA, UDMA or other monomers. 
In  attempts  to  have  a  clear  clinical  indication  for  the  existing  commercial  composites, 
classification criteria were developed, most of them based on filler system. These criteria are 
primarily based on the amount of inorganic filler fraction in volume per cent or the particular 26 
 
filler size.  Young’s modulus of elasticity and intrinsic surface roughness, however, has also 
been taken into consideration. Composites can be divided into traditional, hybrids containing 
a mixture of ground glass and microfill particles, and microfill composites. The microfills are 
further divided into subclasses including a characterization of the type of prepolymerzied 
resin fillers incorporated. The shape of fillers are taken to account also, since the spherical 
fillers can be incorporated in higher amount in composite than irregular fillers of the same 
size and result in higher wear rate (Venhoven et al., 1996).  It has been proved that microfill 
composites have the more ideal aesthetic qualities due to their excellent polishability and 
capacity to retain surface smoothness over time (Venhoven, de Gee, Werner, & Davidson 
1996).  However,  it’s  also  accepted  that,  due  to  their  poor  mechanical  properties,  these 
materials  are  contraindicated  for  stress-bearing  restorations,  such  as  incisal  edges  and 
moderate to large stress bearing restorations in occlusal contact with opposing (Ferracane 
and  Mitchem  1994;  Fujishima  et  al.,  1995).  Recently,  another  classification  system  was 
introduced based on the filler volume fracture and filler size, distinguishes between densified 
composites, microfine composite, miscellaneous composite, and fibre-reinforced composite. 
The  densified  composites  were  subdivided  into  classes,  midway-filled  (<60  vol  %)  and 
compact-filled (>60 vol %) with classification of ultrafine (<3µm) and fine (>3 µm) within each 
category  as  a  function  of  the  mean  particle  size  of  the  filler  (Ferracane  2011). 
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Monomers can be mixed with low level of peroxide initiators and amine activators such as 
benzoyl  peroxide  (BP)  and  dimethyl  paratoluidine  (DMPT).  The  methacrylate  based 
composites set via free radical initiated polymerization (Sideridou et al., 2008). Alternatively, 
camphorquinone (CQ) and an amine can be used (Ogunyinka et al., 2007;Sideridou et al. 
2004a).  Blue light (470 nm) exposure is used in this case to activate polymerization. New 
modern narrow wavelength light sources include blue lasers and light emitting diodes (LED). 
Levels and rates of polymerisation of methacrylate can be measured using spectroscopic 
methods such as Raman and Fourier Transform Infrared (FTIR). During light exposure low 
levels of free radicals are generated. Polymer chains then form which bind the monomers 
together.    For  monomethacrylates  chains  are  linear.  With  dimethacrylate  systems  all 
monomers molecules can potentially be bounded within polymer molecules with just 50% 
methacrylate conversion (Burdick et al., 2003).  Light curable composite are supplied as 
single component formulations.  This is considered as a major advantage as it eliminates 
any chance of irreproducibility that might occur during mixing. 
 
1.2.2.1  The organic matrix:    
The organic matrix constitutes the body of the composite and is produced by polymerization 
of  dimethacrylate  monomers,  via  a  free  radical  reaction.  Along  with  dimethacryalte 
monomers, Bis-GMA (BisphenolAdiglycidylmethacrylate), and Urethane dimethacrylate are 
widely used in formulation of the dental composite. In addition the organic matrix contains 
diluent monomers and polymerisation initiator and activator systems as it will be mentioned 
below. 
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1.2.2.2    Urethane dimethacrylate:                                   
Urethane dimethacrylate (UDMA) (Figure 1-1) is used either with, or as an alternative to, Bis-
GMA  monomer.    UDMA  is  an  aliphatic  high  molecular  weight  monomer  with  two  imine 
groups  (─NH─).    These,  through  intermolecular  hydrogen  bonds,  can  associate  with 
carbonyl groups (C=O). These types of intermolecular hydrogen bonds are responsible to 
some degree for the high viscosity and relatively high glass transition temperature (Tg) of the 
monomer.  This imine group however, produces weaker hydrogen bonds than the hydroxyl 
group  (─OH─)  of  Bis-GMA  (Hoszek  et  al.,  2005).  Therefore,  the  viscosity  and  glass 
transition temperature (Tg) of UDMA are much lower than Bis-GMA and hence on curing, 
exhibit higher degree of conversion (Frencken et al., 2007).  
 
However, the degree of conversion of UDMA is considerably higher due to the presence of 
flexible aliphatic chains.  The UDMA polymer shows lower water sorption and releases less 
untreated  species  compared  to  Bis-GMA  (Karanika-Kouma  et  al.  2001).  This  has  been 
explained by the lower water affinity of the urethane (─NHCOO─) group of UDMA than the 
hydroxyl group of Bis-GMA. In addition, UDMA has been proved as less cytotoxic than Bis-
GMA, in vitro (Vermeersch et al., 2005a).   
 
 
                        
  Figure 1-1 The chemical structure of UDMA (molecular weight 470 g mol-1). 
 
                
1.2.2.2.1        Bisphenol A diglycidyl methacrylate: 
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Bisphenol A diglycidyl methacrylate (Bis-GMA) was initially used by Bowen and named after 
him (Bowen’s Resin) (Weerheijm et al., 1993; Weerheijm et al., 1999) (Figure 1-2). It is a 
high molecular weight monomer, which has two aromatic rings with pendant hydroxyl groups 
(─OH─).  This double rigid aromatic group and hydrogen intermolecular bonding of hydroxyl 
groups  are  responsible  for  the  high  viscosity  of  the  monomer  (Takahashi  et  al.,  2006; 
Botelho  2003).  Consequently,  the  glass  transition  temperature  (Tg)  is  activated  and  the 
degree  of  monomer  conversion  will  be  reduced  (Takahashi  et  al.,  2006).  Moreover,  the 
presence of pendant hydroxyl groups account for some inevitable water sorption after curing 
(Palmer et al., 2004) 
 
 
Figure 1-2 The chemical structure of Bis-GMA (molecular weight 510.6 g mol-1)  
 
 
 
1.2.2.3  Diluent comonomers: 
In order to reduce the high viscosity of base monomers and enhance handling properties of 
composites, low molecular weight monomers are introduced to the resin phase.  The most 
commonly used diluent monomers are triethylene glycol dimethacrylate (TEGDMA) and 2-
hydroxyethylmethacryalte (HEMA)  
 
1.2.2.3.1  Triethylene glycol dimethacrylate (TEGDMA): 
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Triethylene glycol dimethacrylate (TEGDMA) is an aliphatic and hydrophilic monomer with 
less  viscosity  and  glass  transition  temperature  (Tg)  and  higher  degree  of  conversion 
compared to UDMA and Bis-GMA (Frencken et al., 2007)(Figure 1-3).  The water affinity of 
TEGDMA  is mainly attributed to the presence of ether linkages (C-O-C)  (Matalon  et  al., 
2006). 
 
Although the degree of conversion of resin composites increases upon addition of TEGDMA 
(Kielbassa  et  al.,  2003),  polymerisation  shrinkage  and  water  sorption  (Kielbassa  et  al.,  
2003)  are  adversely  affected.    TEGDMA  is  still  widely  used  within  most  current  dental 
composites regardless of its high polymerisation shrinkage.    
 
                      
     Figure 1-3 The chemical structure of TEGDMA (molecular weight 286.3 g mol-1).   
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1.2.2.3.2    2-Hydroxyethylmethacryalte (HEMA): 
 
2-Hydroxyethylmethacryalte (HEMA) is an aliphatic low molecular weight monomer, which is 
commonly  used  in  biomedical  applications  (Figure  1-4).  HEMA  is  widely  used  in  dental 
adhesive systems as a solvent and adhesion-promoting agent (Trachtenberg et al., 2009). 
The hydrophilic nature of HEMA makes it attractive for use in the formulation of bioactive 
dental  composites  that  release  remineralising  (Dawes  2003)  or  antibacterial  agents  to 
reduce bacterial microleakage.  After polymerisation however, poly (HEMA) has high water 
sorption  (Chen  et  al.,  2003).  This  affinity  for  water  is  attributed  to  the  presence  of  the 
hydroxyl group (─OH) on HEMA molecules.   
 
                                        
Figure 1-4 The chemical structure of HEMA (molecular weight 130.14 g mol-1). 
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1.2.2.4  Initiator/ activator system: 
In general, dental composite resins are cured through a free radical polymerization reaction 
where  free  radicals  are  generated  through  two  systems:  chemically  activated  and 
photoactivated. 
 
1.2.2.4.1    The chemically activated system  
 
This system uses benzoyl peroxide (BP) (Figure 1-5) which is activated by a tertiary amine, 
such  as  N,N-dimethyl-p-toludine  (DMPT)  (Figure  1-6).    Dental  composites  cured  by  this 
method are supplied as a two paste system, where one of the pastes contains the initiator 
and the other the activator.  When these two pastes are mixed together, free radicals will be 
formed  from  the  chemical  reaction  between  peroxide-amine  systems,  to  induce  the 
polymerization process (Aiuchi et al.,2008).  
 
1.2.2.4.2   Photo activated systems 
 
In the beginning, UV light was used to cure the dental composites, but this provided a limited 
depth of curing which compromised the composite structure.  In addition, UV light exposure 
can induce tissue damage.  It has therefore been replaced with high intensity visible (blue) 
light sources which are more compatible with living tissue.  These include halogen lights 
(tungsten-quartz) and more recently light emitting diodes (LED) and lasers.  Curing of dental 
composites  by  either  LED  or  halogen  light  sources  produces  comparable  degrees  of 
monomer  conversion.  The  emission  spectra  of  LED  light  units,  however  match  the 
absorption spectrum of Camphorquinone (CQ) (Goto et al., 2006), better than the broader 
spectrum of the halogen light.  Furthermore, LED light sources produce lower temperature 33 
 
rise within the composite upon polymerisation (Ginebra et al., 2006). This can decrease the 
possibility of thermal stress on pulpal tissues particularly within deeper restorations.  
 
This system works by visible light and Camphorquinone (CQ) (Figure 1-7) as a free radical 
photoinitiator with a tertiary amine, such as DMPT as co-initiator.  The Camphorquinone 
(CQ) absorbs light between 400-500 nm (maximum at 470 nm) to form an activated state 
complex with association of the tertiary amine.  This complex subsequently breaks down to 
produce free radicals, which will start the polymerisation reaction.  
 
 
Figure 1-5  BP (C14H10O4) (molecular weight 242.23 g mol-1) 
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Figure 1-6 DMPT (C9H13N) (molecular weight 135.21 g mol-1) 
 
 
 
 
Figure 1-7  CQ (C10H14O2) (molecular weight 166.22 g mo-1) 
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1.2.2.5  Inorganic filler: 
The  inorganic  filler  phase  of  composites  consists  of  silanated  glass,  fibres  and  quartz 
particles.  Ideally,  around  80  wt%  is  incorporated  in  the  resin  matrix  phase,  mainly  to 
enhance physical properties and decrease polymerisation shrinkage (Bohner 2000).  
 
The filler particles are categorised according to their size into macrofillers or microfillers.  
The macrofillers  are obtained through mechanical grinding and milling of larger glass or 
quartz particles to sizes ranging from 0.2 to 20 μm. The microfillers, such as pyrogenic silica 
particles are prepared through heat treatment of silicon chloride (SiCl4) and have an average 
particle size of 0.04 μm.   
1.2.2.6   Silane bonding:   
The silane coupling agent acts as a bond between the resin matrix and the inorganic filler 
phase of the composite.  This type of adhesion plays a major role and decisive effect on 
several properties of the dental composites for example; 
1.2.2.6.1   Silorane 
Silorane  is  a  ring-opening,  silicon  based  monomer  which  is  composed  of  siloxan  and 
oxirane.  The  ring  opening  character  of  the  monomer  reduces  polymerisation  shrinkage 
below 1% of the overall volume (Figure 1-8). 
Several studies have been performed on this monomer and its clinical properties. Palin et al 
(2005), Ilie and Hickel (2006) showed that microleakage was significantly lower for a silorane 
material than other composites (Z250, 3M ESPE). Al-Boni et al (2010) also showed that low 
shrinkage  silorane  system  had  lesser microleakage than  other methacrylate  resin  based 
composite (Amelogen, Filtek Z250). In another study, Krifka et al (2012) found that Filtek 36 
 
Silorane, a silorane-based composite resin, exhibited the best marginal seal in comparison 
with methacrylate based composite.  
 
Silanation  will  enhance  the  composite  resistance  to  hydrolytic  degradation  and  maintain 
good mechanical properties (Lee et al., 2007; Regnault et al., 2008). Besides that, it also 
improves filler wetting by hydrophobic monomers, which subsequently will enhance the level 
of filler that can be incorporated within the composite 
 
.    
Figure 1-8 the chemical structure of Silorane 
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1.2.3  Glass Ionomer cements 
 
Glass ionomer cements were first developed in the 1970s and have undergone significant 
modification since then. Their major advantage over other restorative materials is the fluoride 
release and the ability to adhere directly to dentine. Disadvantages are poor mechanical 
properties (Okuyama et al., 2006). They have traditionally contained fluoroaluminosilicate 
glass.  This contains aluminium and silica, in addition to fluoride. Other elements include 
calcium and strontium. The liquid component is polyacrylic acid. Setting occurs by the acid 
attacking the surface of the glass, forming a gel layer  with resultant cross-linking as the 
material sets (Ab-Ghani et al., 2007; Smith 1998). Although the reaction starts fast it can 
continue  at  a  slow  rate  for  several  days  (Young  et  al.,  2004).  It’s  believed  that  fluoride 
release inhibits caries formation. The average fluoride release rate from GIC samples at two 
days is approximately half that at one day and continues to decline thereafter (Okuyama et 
al., 2006). Glass ionomers also have the same coefficient of thermal expansion as tooth and 
minimal setting contraction. Therefore it has been reported that glass ionomers provide a 
good marginal seal and reduced microleakage.  
 
Water  is  a  crucial  component  of  glass  ionomer  cements.  It  provides  initial  fluidity  and 
enables  transport  of  ions  through  the  polymer  matrix  but  then  becomes  bound  in  the 
polyacrylate  salts  structures  upon  setting  of  the  material.  It  has  been  found  in  some 
formulations that a fixed number of molecules of water are required for each polyacid group 
reacting and the additional water sorption by set materials from the surroundings may drive 
the polyacid neutralisation process closer to completion (Young 2002; Young et al., 2004). 
 
Glass ionomer is supplied as a separate powder and liquid which the clinician needs to mix.  
This might lead to reduced mechanical properties (Fleming et al., 2003).  Alternatively, they 38 
 
are available in capsules which could improve the reproducibility of the mixing process (De 
Moor et al., 1996) 
 
It is well known that glass ionomer cements have poor mechanical properties compared with 
other composite and hybrid resin fillings. Their flexural strength is (10-30) MPa which makes 
them an unsuitable restoration for adult posterior teeth and limits  their use a permanent 
filling. Although recently improved GICs have high compressive strength (100-300) MPa they 
wear more than composites (Piwowarczyk et al., 2002a). According to ISO 9917 for water–
based dental cements, all materials should fall between 70 MPa if used as a liner / base or 
luting material and 130 MPa for restorative cement.  
 
The mechanism of glass ionomer adherence to the tooth surface is a combination of micro- 
mechanical attachment and chemical bonding (Van Meerbeek et al., 2003). The carboxyl 
group  interacts  with  the  calcium  ions  of  hydroxyapatite  in  both  enamel  and  dentine. 
Conditioner  use  enhances  the  adhesive  properties  of  the  GIC.    This  is  typically  10  % 
polyacrylic  acid  solution.  (Pereira  et  al.,  2002).  The  glass  ionomer  cement  bond  is 
considered more durable.  This could be due to the presence of ionic bonds and crosslinks 
between polyacrylate calcium ions which can break and reform, while covalent bonds in a 
polymerized methacrylate cannot reform once it breaks (Sidhu et al., 2004a; Sidhu et al., 
2004b; Sidhu 2011).   
 
Fluoride release from glass Ionomer is limited in its effect. There is an initial high burst of 
fluoride release due to the high concentration of fluoride that exists in the matrix immediately 
after  the  setting  reaction  is  complete.  During  the  initial  acid  dissololution  of  the  powder 
particle edges, a large amount of fluoride becomes part of the reaction product matrix. This 
fluoride diffuses quickly from the matrix exposed on the surface of the material and is only 
slowly replaced by fluoride diffusing from greater distances in the matrix below the surface or 39 
 
by fluoride diffusing from the particles into the matrix for the first time. Therefore, the long-
term fluoride release is at much lower rates. 
 
1.2.4  Resin adhesives  
 
Adhesive  materials  are  non-filler  monomers,  which  enhance  the  adhesion  procedure 
between the tooth surface and composite filling. However, the strength of adhesion varies 
from enamel to dentine due to the differences in their structures. The unit of structure in 
dental enamel is hydroxyapatite crystals which make the bonding between methacrylate and 
hydroxyapatite  easier,  more  straightforward  and  more  reproducible.  In  generally,  this 
involves acid etching with 37% of phosphoric acid gel for thirty seconds.  Rinsing and drying 
will leave a microscopic rough surface enhancing methacrylate monomers to penetrate into 
it. Upon polymerisation with the light cure,  a  micromechanical bond will be formed  (Van 
Landuyt et al., 2007).  
 
Dentine hydrophilicity is considered as a challenge in adhesion and bonding mechanisms 
due to dentine structure which consists of water (10%), collagen (20%) and hydroxyapatite 
(70%) (Perdigao et al. v n, 2013). During tooth preparation, cutting of the tooth structure with 
a rotary instrument, a smear layer will be formed and by etching with 37% of phosphoric acid 
for  10-20 seconds and rinsing this layer  will be removed. This etching process will also 
dissolve  the  surface  hydroxyapatite  from  dentine  inner  surface.  Methacrylate  primer  is 
therefore  often  applied  to  acid  etched  dentine  prior  to  a  low  viscosity  resin  adhesive. 
Lowering the viscosity of fluid will improve its ability to spread over and penetrate dentinal 
tubules (De et al., 2005a;Van et al., 2005). In general, the solvent may be water, ethanol 
and/or  acetone  and  it  must  be  eliminated  by  air-drying  before  monomer  polymerisation. 
Beside the solvent the primer also contain adhesion promoting monomers / polymers with 
acidic phosphate and / or carboxylate group.  40 
 
 
Adhesive resins systems have been divided into:  
1) three step technique etch and rinse as above.  This is the most commonly employed 
technique by clinicians because of formation of a hybrid layer of intertwined collagen and 
polymethacrylates  
2) two step etch and rinse,  
3) two steps without rinsing (self-etch)  
4) one step (self-etch) (Van Meerbeek et al., 2003). With self-etch resins phosphoric acid is 
not used. Instead the resin contains acidic monomers or polymers.  These types of adhesive 
are not rinsed after application but chelate with calcium in hydroxyapatite to form an ionic 
bond similar to that in GICs. 
 
The most commonly used methods for assessing dental adhesive bond strength include 
shear (Piwowarczyk et al., 2007) and micro tensile tests (De et al., 2005; Van Meerbeek et 
al., 2003).  Results produced, however, have been highly variable for  a wide number of 
reasons and are rarely comparable between groups. In general, bond strength to dentine 
has a significant reduction upon reducing the number of stages and steps (De et al., 2005)   41 
 
1.2.5  Hybrid restorative materials 
 
GICs have significant problems.  In order to overcome these, researchers developed hybrid 
materials.  These  were  a  combination  of  conventional  GICs  and  composites  and  can  be 
divided  into  compomers  (or  acid  modified  composite)  and  resin  modified  glass  ionomer 
cements (RMGICs)  
1.2.5.1  Resin modified glass ionomer cements 
RMGIC bond properties to enamel and dentine are higher than those of conventional GICs 
(Inoue et al., 2003; Palmer et al., 1999). This type of restoration has hydrophilic properties 
due  to  the  presence  of  water  in  its  composition  and  hydroxyl  ethyl  methacrylate  (Smith 
1998). Resin modified glass ionomer cements have the advantage of being able to set in 
moist environments but improper mixing of the liquid and powder components together can 
lead to diffusion of HEMA molecules. This will raise the concerns of the amount of HEMA 
which could be used in dental restoration because of the higher potential of allergy (Lan et 
al.  2003;  Michelsen  et  al.,  2003;  Mine  et  al.,  2008;  Palmer  et  al.,  1999). Therefore, the 
manufacturers supply resin modified glass ionomer cements (RMGIC) in capsules. (Lan et 
al., 2003; Mine et al., 2008). RMGIC has a slower reaction than conventional glass ionomer 
cements due to the use of more compatible fillers which reduce its reactivity and by adding a 
silane coupling agent  which  leads  to  the polyacid reaction occurring after polymerisation 
(Young et al., 2004). 
 
A further problem with early RMGICs was excessive water sorption due to the hydrophilicity 
of (HEMA) leading to pressure on and potentially cracking of the tooth (Smith 1998). In more 
modern materials water sorption has been better controlled (Cefaly et al., 2006). Moreover, 
some RMGICs contain chemical cure initiators that ensure regions not exposed to light are 
fully polymerised soon after formulation mixing (eg potassium persulphate and ascorbic acid 42 
 
in Vitremer). Modern RMGICs achieve better controlled water sorption by greater monomer 
crosslinking  caused  by  raised  polymerisation  and  dimethacrylate  inclusion  (Cefaly  et  al., 
2006)  
 
In more recent studies, further enhancement of RMGIC mechanical properties has been 
gained through the development of multi-arm polyacids with several attached methacrylate 
groups. These would increase crosslinking even more (Xie et al., 2007). Ideally sufficient 
water  should  be  absorbed  (~  3  vol%)  to  just  enable  the  associated  material  expansion 
(Sidhu  et  al.,  2004)  to  overcome  the  polymerisation  shrinkage.  Additionally  this  water 
sorption  should  be  sufficient  to  drive  the  polyacid  neutralisation  process  to  completion 
(Young et al., 2004). Regarding fluoride release from modern resin modified glass ionomer 
cements; early fluoride release can be comparable to that of conventional glass ionomer 
cement. This may be due to an increase of the glass fluoride content  (Xu and Burgess 
2003a).  Although  RMGIC  couldn’t  replace  amalgam  and  composite  filling  in  posterior 
permanent teeth; they have been proven in primary molars (Qvist et al., 2004) 
 
 
1.2.5.2  Compomers (acid- modified composite) 
In  many  studies  it  has  been  shown  that  compomers  have  lower  flexural  strength  than 
composites (Piwowarczyk et al., 2002; Chung et al., 2004; Gomec et al., 2005; Janda et al., 
2006). According to the ISO 4049 ( polymer- based restorative materials ) compomers have 
sufficient strength to be used as restorative materials but still there are concerns due to the 
declination of the flexural strength and mechanical properties with time (Rodrigues Filho et 
al., 2006). Despite the significant increase in strength in the first twenty four hours due to 
water  sorption  (Piwowarczyk  et  al.,  2002)  and  continuing  polymerisation  (Young  et  al., 
2004), compomers flexural strength is lower than the clinician’s expectation (Meyer et al. 43 
 
1998; Nicholson 2007; Piwowarczyk et al., 2002). According to the ISO 1491 requirement 
compomers strength are within the acceptable level (120- 260 MPa) but as it is mentioned 
above compomers are lower than composite strength wise (Gomec et al., 2003)  
Compomers  are  similar  to  composites  but  have  more  monomers/polymers  with  acidic 
chemical  groups  which  will  increase  the  water  sorption  and  then  react  with  additional 
inorganic particulate phase that contains the fluoride particle (Meyer et al., 1998; Nicholson 
2007).  Water  sorption  by  compomers  is  higher  than  in  composites.    Swelling  may 
compensate the shrinkage during polymerisation (Huang et al., 2002) but water sorption is 
not enough to  enhance the high level of acid / glass reaction in the bulk of the material 
(Young et al., 2004). Manufacturers supply it as a paste which contains monomer / polymers 
and it is polymerised by using light activation. 
 
Compomers  release  fluoride  in  comparable  amount  with  conventional  glass  ionomer 
cements (Meyer et al.,1998), however, in the early stages its release is quarter the amount 
of fluoride release from the conventional glass ionomer cement.  
 
1.3  Current Problems with current aesthetic restoration 
 
1.3.1  Composite 
 
Di-methacrylate-based  resin  composites  still  demonstrate  some  negative  or  questionable 
aspects: wear resistance, surface roughness, handling property, proximal contact adhesion 
and contouring or sculpturing, marginal adaptation and polymerisation shrinkage (Inoue et 
al., 2003; Kidd & Beighton 1996; Peutzfeldt and Asmussen 1996). The excessive wear loss 
of composite fillings could be noticeable under the enamel margins, or proximal contact in 
class II restorations, which may lead to open proximal contacts (Piwowarczyk et al., 2002; 44 
 
Rodolpho et al., 2006). This phenomenon may arise from a combination of factors, including 
polymer or filler composite, filler size, and filler-polymer matrix binding quality, especially in 
early resin composite systems (Kusy and Leinfelder 1977). 
 
Polymerisation  shrinkage  is  an  inherent  property  of  resin  restorative  materials.  During 
polymerisation,  the  formation  of  the  polymer  network  results  in  formation  of  a  denser 
structure, causing changes in volume which lead to shrinkage (Bowen 1963) – this causes 
microleakage  Microleakage may be defined as the passage of bacteria, fluids, molecules or 
ions between a cavity wall and the restorative material applied to it (Kidd 1976). 
 
Many  laboratory  techniques  have  been  developed  to  study  marginal  permeability  at  the 
interface between tooth and restoration. These include the use of dyes, radioactive isotopes, 
air pressure, bacteria, neutron activation analysis and artificial caries techniques. The results 
of these studies emphasise that margins of restorations are not fixed, inert and impenetrable 
borders, but ‘dynamic micro-crevices’  which contain a busy traffic of ions and molecules. 
 
When monomers in proximity react to establish a covalent bond, the distance between the 
two  groups  of  atoms  is  reduced  and there  is a  reduction  in free  volume,  both  of  which 
translate into volumetric shrinkage. The magnitude of volumetric shrinkage experienced by a 
composite  is  determined  by  its filler  volume fraction  and the  composition  and  degree of 
conversion of the resin matrix. Shrinkage values reported for BisGMA (5.2%) and TEGDMA 
(12.5%) are substantially higher than those displayed by typical composites, which range 
between  2  and  3%.  This  difference  is  due  to  the  fact  that  in  hybrid  composites, 
approximately  60%  of  the  volume  is  occupied  by  filler  particles.  Microfilled  composites, 
though their inorganic content is typically about 40 vol%, have shrinkage values similar to 
hybrids, due to the presence of pre-polymerized composite particles, sometimes referred to 45 
 
as ‘organic fillers’, which render them similar to hybrid composites in terms of the actual 
volume fraction of polymerising resin. 
 
1.3.2  Glass ionomer cement  
 
In clinical investigations the 50% survival time for GICs in primary teeth was found to be less 
than 4 years on average. Use of GICs instead of amalgam, however, significantly reduced 
progression of caries on adjacent teeth (Qvist et al., 2004b; Qvist et al., 2004c). In class V 
restorations  (gingival  and  non-load  bearing)  average  annual  failure  rates  for  GICs  were 
better than obtained with resin adhesive (De et al., 2005; Peumans et al., 2005). In contrast, 
there is strong evidence suggesting that the use of GICs as a liner beneath a composite may 
prevent recurrent caries (Rodolpho et al., 2006). Fluoride– releasing, tooth adhesive GICs 
therefore play a major role in restorative dentistry but their use could be greatly extended if 
their mechanical properties strength could be raised. 
 
1.3.3  Resin Modified Glass Ionomer Cement  
 
One  main  potential  problem  of  RMGICs  is  low  surface  hardness  and  wear  resistance 
(Peutzfeldt 1997; Xie et al., 2000). This may be primarily due to the low level of crosslinking 
arising with use of high levels of monomethacrylates. Additionally, the fast polymerisation 
kinetics  designed  to  overcome  HEMA  toxicity  concerns  may  have  resulted  in  more  but 
shorter, faster - wearing polymer molecules. Furthermore, reaction of the glass particles may 
interfere with the silane bond between the matrix and filler phase. A further problem with 
early RMGICs could be excessive water sorption due to the hydrophilicity of poly (HEMA) 
leading to pressure on and potentially cracking of the tooth (Smith 1998). 
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1.3.4  Compomers  
 
Compomer  flexural  strengths  and  moduli  at  24  hours  are  typically  lower  than  those  of 
composites (Chung et al., 2005; Janda et al., 2006; Piwowarczyk et al., 2002). Although 
compomer mechanical properties can meet the ISO 4049 requirements they tend to decline 
more with time than those of composites (Rodrigues  et al., 2006). This is most likely due to 
higher water sorption and fluoride release of the compomers. Compressive strengths (120-
260  MPa)  of  compomers  have  also  been  found  to  be  lower  than  those  of  composites 
(Gomec et al., 2005; Xu and Burgess 2003). 
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1.4  History of restorations with antibacterial properties  
 
1.4.1  Introduction 
 
Dental biofilm can be established on any surface intra-orally, that could be on the tooth or 
restoration surface. This biofilm can initiate recurrent caries at the interface zone in resin 
restoration.  Therefore,  it  was  well  observed  that  composite  resin  compared  to  other 
restoration has the higher level of cariogenic biofilms (Beyth et al., 2007; Moura et al., 2004; 
Svanberg et al., 1990; Vermeersch et al., 2005).  This may be explained by the limitation of 
antibacterial properties in the current dental composite used. In addition some studies have 
proven that some resin monomers act as a perfect media for cariogenic bacteria to grow 
(Hansel et al., 1998) 
 
In order to be able to assess the antibacterial effect of a dental restoration, a measurement 
of minimum inhibitory concentration (MIC) is used. It is one of the mostly common used 
methods (Musanje et al., 2001). Direct contact and agar diffusion tests are also commonly 
used because this test is readily available, inexpensive and widely approved as a simple 
screening method (Slutzky et al., 2006; Tobias et al., 1988). Usually it has been used in 
evaluation of the antibacterial activity of materials that release water-soluble components in 
the  surrounding medium. It is also used to quantify the ability of materials to inhibit the 
growth of bacteria facing the contact surface. In agar diffusion; the materials are inserted 
onto agar plates which have been inoculated with intraoral bacteria, mainly stretoccocus and 
lactobacillus species.  
  
Another  test  introduced  to  measure  the  activity  of  biofilms  in  dental  restoration  is  the 
Constant Depth Film Fermentor (CDFF). This test was originally developed to mimic the 
media  in  oral  cavity  by  growing  microbial  biofilm  in  the  laboratory,  under  controlled 48 
 
conditions.  This  model  is  particularly  suitable  for  studying  antibacterial  properties  of 
restoration materials as it enables biofilms similar to those in the oral cavity to be grown 
(Wilson 1996) 
 
Several studies have been carried out to assess the antibacterial activity of dental restorative 
materials, mostly through the agar diffusion assay, direct contact tests (Matalon et al., 2004; 
Slutzky et al., 2006; Tobias 1988), measurement of minimum inhibitory concentration (MIC) 
(Imazato  et  al.,  2002)  and  inhibition  of  bacterial  growth  in  biofilm  models  such  as  the 
Constant Depth Film Fermentor (CDFF) (Leung et al. 2005; Mehdawi et al., 2013)  
 
In the last ten years, most have been done on antimicrobial aesthetic restorations which 
have the ability to inhibit the bacterial growth in different methods, which could be by adding 
direct antimicrobial agent or indirect addition. These techniques will be reviewed in the next 
part of this chapter which will include also the mode of action of different antibacterial actions 
and chemical components.    49 
 
1.4.2  Composites with antibacterial properties 
 
Different antibacterial agents, such as chlorhexidine, triclosan, benzalkonium chloride (BAC) 
and fluoride, have been introduced in both commercial and experimental dental composites. 
1.4.2.1  Chlorhexidine:  
Chlorhexidine  is considered as a potent antimicrobial agent, which is  commonly used in 
dentistry,  mainly  in  periodontal  diseases.  Subsequently,  chlorhexidine  was  introduced  to 
resin restorations such as composites, GIC and adhesives. The mechanical and antibacterial 
properties  of  commercial  dental  composites  containing  various  chlorhexidine  salts  have 
been evaluated (Jedrychowski et al., 1983). Formulations incorporating either chlorhexidine 
gluconate or chlorhexidine dihydrochloride inhibited the growth of tested bacterial strains, in 
an agar diffusion assay, for up to four days.  Whereas chlorhexidine  gluconate reduced 
mechanical  properties,  chlorhexidine  dihydrochloride  could  be  added  at  levels  of  10  % 
without an observable effect.   
 
Experimental  dental  composites,  containing  hydrophilic  monomer  (HEMA)  with  10  wt% 
chlorhexidine diacetate added have been formulated (Wilson and Wilson 1993).  With these 
materials, the degree of conversion increased significantly upon addition of chlorhexidine 
(Leung et al. 2005).  In this study, it was observed that the polymerisation rate decreased 
upon  raising  HEMA  wt%,  whereas  the  rate  of  chlorhexidine  release  and  volumetric 
expansion  increased.  Composites  containing  50  or  90  %  HEMA  /  chlorhexidine  in  the 
monomer phase both had reduced oral biofilm growth on their surfaces up to one week in a 
CDFF when compared with controls without chlorhexidine or commercial fluoride - releasing 
materials.  After 10 weeks in a CDFF, bacterial penetration into a bovine dentine cylinder 
restored by these experimental composites was also substantially reduced when compared 
with a commercial composite.  50 
 
 
 In one contrary study, a dental composite containing chlorhexidine exhibited no antibacterial 
effect when tested against S. mutans in an agar diffusion assay or direct contact test. The 
release  of  chlorhexidine,  however,  was  marginally  close  to  its  minimum  inhibitory 
concentration.  This might be due to the use of chlorhexidine base which has lower aqueous 
solubility  when  compared  with  chlorhexidine  salts  (e.g:  diacetate  and  gluconate). 
Additionally, with use of conventional hydrophobic composite formulations there may have  
limited water sorption.  This may be required to plasticise regions to enable faster  drug 
diffusion through polymer chains. 
Antibacterial properties of composites often rely upon water sorption to promote release of 
an antibacterial agent.  This strategy can produce effective antibacterial composites, which 
suppress bacterial growth in both planktonic culture (Jedrychowski, Caputo, & Kerper 1983) 
and  a  biofilm  model.  Water  sorption  and  active  drug  release,  however,  often  lead  to 
deterioration of mechanical properties (Jedrychowski et al., 1983). Furthermore, release of 
soluble antibacterial from resin matrix may be characterized by high initial release, followed 
by rapid drug release rate decline (Wilson & Wilson 1993). Therefore, new approaches and 
techniques have to be developed for the production of an effective antibacterial restorative 
material.  
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1.4.2.2  Triclosan 
Triclosan  (2,4,4-trichloro-2-hydroxidiphenilethere)  (Figure1-10)  is  considered  as  a  wide 
spectrum antibacterial agent (Kolenbrander 2000) which has the ability to inhibit bacterial 
growth by interrupting their enzymatic activities (Wierzbicka et al., 1987).  It is a widely used 
antibacterial agent within toothpastes, detergents and cosmetic products.  
 
Triclosan was initially promoted as an antibacterial component of toothpaste.  Subsequently, 
it  was  introduced  into  commercial  dental  composites  and  its  anti-bacterial  activity  was 
investigated  against  lactobacilli  (Badet  and  Thebaud  2008).    This  study  showed  that  a 
composite containing 1 wt% triclosan has a significant inhibition of bacterial growth when a 
direct contact test was used (Badet & Thebaud 2008).  On the other hand, another study on 
a  dental  composite  containing  0.3%  triclosan,  no  antibacterial  activity  against  the  same 
bacteria, either in an agar diffusion assay or in a direct contact test was observed.  In this 
study  it  was  proposed  that  triclosan  is  released  at  levels  below  its  minimum  inhibitory 
concentration due to its limited solubility in water (Sehgal et al., 2007).  
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Figure 1-9 Triclosan chemical structure (C12H7Cl3O3) (molecular weight 289.5 g mol-1) 
 
1.4.2.3  Benzalkonium chloride 
Benzalkonium chloride (BAC) is a wide spectrum quaternary ammonium antibacterial agent 
(see Figure 1-10), which acts as antibacterial agent with the ability to induce the antibacterial 
action through attraction to the negatively charged bacterial membrane (Allmyr et al., 2006)  
(Beyth et al., 2007; Sehgal et al., 2007). BAC is broadly used as a preservative in ophthalmic 
solution and nasal spray.  Its effect on the antibacterial and mechanical properties of dental 
restorative materials (mainly in light cured dental composite) has been evaluated at levels of 
0.25%, 0.75%, 1.25%, 1.75%, 2.5%, and 5% (wt) (Saito et al., 2007). It was reported that 
this type of antibacterial agent has a significant effect as an inhibitor against S. mutans and 
S.sorbinus,  in  an  agar  diffusion  assay  and  direct  contact  test  (Saito  et  al.,  2007).   This 
antibacterial  activity  was  enhanced  upon  raising  benzalkonium  chloride  content.    The 
mechanical properties of the composite were not affected by incorporation of benzalkonium 
chloride (Othman et al., 2002).  
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In  contrast,  one  study  has  shown  no  significant  effect  of  BAC  on  Escherichia  coli  and 
Staphylococcus aureus. (Khajavi et al., 2007) 
 
 
 
 
 
 
1.4.2.4   Fluoride - releasing dental composites:  
In  order  to  develop  a  new  fluoride  releasing  composite,  different  techniques  have  been 
developed in the last decade. These include incorporation as inorganic water-soluble salts, 
addition to glass fillers, bonding to a resin component and as an organic fluoride salt (Han et 
al., 2002; Dionysopoulos et al., 2013).  Fluoride is well known as an ion suitable for tooth 
remineralisation  enhancement  and  this  will  increase  resistance  to  demineralisation  by 
cariogenic  bacteria  (Bowden  1990;  Han  et  al.  2002;  Itota  et  al.  2002;  Kameyama  et  al. 
2002).  The inorganic water soluble salts, sodium fluoride (NaF) and strontium fluoride (SrF2) 
added to the resin phase of a composite (Sales et al., 2003) are washed out easily leaving 
porous structures and reduced mechanical properties (Arends and van der Zee 1990; Rawls 
1987; Xu and Burgess 2003).  Conversely, ytterbium trifluoride (YF3) and fluoride - leaching 
glass fillers have provided composites with adequate mechanical properties despite release 
of fluoride (Boeckh et al., 2002; Itota et al., 2002) 
 
Fluoride  -  releasing  monomers  based  on  acrylic-amine-hydrofluoride  salts  have  been 
incorporated into the resin phase of dental composites  (Rawls 1987).  These monomers 
Figure 1-10 Chemical structure 
of benzalkonium chloride (BAC) 
(C22H40ClN)(molecular weight 
339.99 g mol-1) . 54 
 
released fluoride through an ion exchange mechanism, which, it was proposed, might have 
less effect on mechanical properties (Ling et al., 2009).   
 
New  fluoride-releasing  monomers  based  on  a  dimethacrylate  monomer  and  ternary 
zirconium fluoride chelate were introduced; however, formulation of a dental composite with 
sustained fluoride release in addition to good mechanical properties is difficult (Ling et al., 
2009).  The  success  of  developing  dental  composites  with  sustained  fluoride  release  is 
considerably less compared with the percentage that has been released from glass ionomer 
and compomer (Boeckh et al., 2002; Bowden 1990; Itota et al., 2002) 
 
Furthermore, the amount of fluoride released from dental composites has generally been 
insufficient to produce significant antibacterial action.  For example, even a dental composite 
containing  15.6%  ytterbium  trifluoride  did  not  affect  the growth  of  S.  mutans  in  an  agar 
diffusion test (Bapna et al., 1988). 
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1.4.2.5   Silver - containing dental composites: 
Silver has been added to the filler phase in composite due to it is potent antibacterial efficacy 
(Ryu et al., 2012) and its high biocompatibility (Kang et al., 2009; Park et al., 2009). Dental 
composite  containing  silver  showed  a  bacteriostatic  effect  against  three  strains  of  oral 
streptococci (Streptococcus oralis, Streptococcus sanguinis and Streptococcus mitio) 
Silver has been applied widely as an antibacterial coating or filler for surgical catheters , 
bone cements  and wound dressings (Alt et al., 2004; Rupp et al., 2004)   The bactericidal 
effect of silver ions has been attributed to their interference with bacterial enzymatic activities 
(Jelinek et al., 2013; Liu et al., 2013). Silver - containing glass fillers have been shown to 
exhibit antibacterial effects against three strains of oral streptococci (Streptococcus oralis, 
Streptococcus  sanguinis  and  Streptococcus  mitior)  that  are  commonly  isolated  from  the 
surfaces of dental composites (Lansdown 2002; Yamamoto et al.,1996).  
 
One disadvantage of using silver as an antibacterial agent in dental resins is the colour 
stability (van der Burgt and Plasschaert 1985). Those containing silver zeolite for example 
exhibited  extensive  discoloration  following  24  h  in  a  storage  solution.    The  composite 
containing 10% silver-apatite, however exhibited better colour stability.   
 
The incorporation of other silver compounds such as silver-zirconium phosphate or silver-
silica gel into  dental composites has also been reported  (Syafiuddin  et al.,1997). Dental 
composites containing either 5 % silver-zirconium phosphate or 7 % silver-silica gel inhibited 
the growth of S. mutans (Yamamoto et al.,1996)     
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1.4.2.6  Antibacterial pre-polymerized resin fillers: 
The antibacterial property of a filler system consisting of pre-polymerised resin fillers with 
immobilized MDPB (PPRF) have been investigated (Imazato et al., 2003). This filler system 
contained milled pre-polymerised methacrylate and antibacterial MDPB monomers (at 15.8 
wt%) with glass silica particles.  After 18 h contact with this filler growth of S. mutans was 
completely  inhibited.  The  authors  reported  some  elution  of  unpolymerised  MDPB  (  ~  1 
μg/ml) following 24 h immersion in water but since this is approximately 16 fold less than the 
MIC of  MDPB against S. mutans , direct contact between particles and bacteria was the 
most likely mode of antibacterial action.     
 
In further studies, an  experimental dental composite with 17.9 wt%  of the above PPRF, 
suppressed accumulation of S. mutans in vitro (Ebi et al., 2001).  This was attributed to 
interference with bacterial adhesion, glucan synthesis and bacterial growth.  In addition, the 
authors reported no elution of unpolymerised MDPB.   Furthermore, incorporation of this filler 
had no effect on either surface roughness or hydrophobicity, which is known as contributing 
factors affecting adhesion of bacterial biofilms to surfaces.      
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1.4.3  Dental adhesives with antibacterial properties 
1.4.3.1  Introduction  
Incomplete infiltration into the demineralized collagen network within the hybrid layer is a 
major problem with current dental adhesives (Yuan et al., 2007). This will lead to what is 
known as nanoleakage (Sano et al., 1995).  It increases penetration of fluids and bacterial 
byproducts with subsequent degradation of the resin adhesive (Wang and Spencer 2003) 
and collagen fibrils (Pashley et al., 2004). Ultimately, this will lead to deterioration of bond 
strength  (Koshiro  et  al.,  2004),  and  subsequently  increase  the  risk  of microleakage  and 
secondary caries (Banerjee et al., 2001; Banerjee et al., 2000).  
 
Another problem reported with adhesive systems can be incorporation of a smear layer that 
harbours bacteria. One solution could be a dentine-bonding agent with antibacterial activity.  
Inclusion of specific components, such as glutaraldehyde and acidic comonomers that can 
provide the dental adhesives with some antibacterial activity as discussed below  
 
1.4.3.2   Glutaraldehyde:  
Glutaraldehyde  (Figure  1-12)  is  a  well  -  known  fixative  agent  with  effective  disinfectant 
properties  (McDonnell  and  Russell  1999)  that  is  frequently  used  for  tissue  fixation  and 
disinfection of medical and dental equipment. Glutaraldehyde was initially introduced into 
dental adhesives to maintain the integrity of collagen fibrils within the hybrid layer.  This was 
expected to promote bond strength (Cilli et al., 2009) and minimise the risk of postoperative 
hypersensitivity (Chermont et al., 2010).  The maximum level of glutaraldehyde added to 
dental adhesives is usually 5 %. 
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Figure 1-11 Chemical structure of glutaraldehyde (C5H8O2) (molecular weight 100.12 mol-1)  
 
One in vivo study showed that dental adhesives containing glutaraldehyde could eliminate 
bacteria  from  dentinal  tubules  (Yu  et  al.,  2010).  Furthermore,  cured  dental  adhesives 
containing glutaraldehyde showed strong inhibition against a variety of bacteria including 
known cariogenic species, S. mutans, Streptoccocus sorbinus, L.casei and A. viscosus  (Cilli 
et al., 2009; Yu et al., 2010).  In the former studies, since an agar diffusion assay was used, 
the  antibacterial  activity  was  induced  through  release  of  glutaraldehyde.  Glutaraldehyde, 
however, is known to induce toxic and mutagenic effects, which has given major concern 
regarding its use in clinical applications (Takigawa and Endo 2006)  
 
1.4.3.3       Acidic co-monomers: 
Co-monomers  containing  phosphoric  and  carboxylic  acid  groups  are  incorporated  into 
primers of self-etching adhesive systems, mainly to help in dentine demineralisation and 
facilitate  resin  infiltration  in  the  absence  of  an additional  etching  step  (Tay  and  Pashley 
2001).    Some  studies  have  shown  that  un-cured  self-etching  primers  have  antibacterial 
activity (Elsaka and Elnaghy 2012). Using agar diffusion assay, the growth of S. mutans and 
A. viscosus was inhibted by self-etching primers (Cehreli et al., 2003; Kitasako et al., 2004) .  
These authors reported complete elimination of S. mutans after 30 seconds contact with 
self-etching primers.  Using a model cavity test and an agar diffusion assay, a self-etching 59 
 
primer solution was also observed to inhibit growth of S. mutans. This antibacterial activity 
was attributed to lower pH values of un-cured self-etching primers (Kuramoto et al., 2005; Ye 
et al., 2007).  
 
This immediate antibacterial property of un-cured self-etching adhesives could contribute to 
eradication of residual bacteria in the cavity.  This antibacterial activity however, can be 
significantly reduced after light curing or buffering by dentinal fluid (Ye et al., 2007).  
 
1.4.3.4   Antibiotics:  
Incorporation of antibiotics into dentine bonding agents has also been tried. Vancomycine or 
metronidazole has been added to the dentine bonding system based on 4-META/MMA-TBB 
(4-methacryloxyethyl trimellitate anhydride/methyl methacrylate-tri-n-butyl borane) (Kudou et 
al., 2000).  The effect of adding vancomycine at 1, 2, and 5 wt% and metronidazole at 1 wt% 
on inhibition of six bacterial strains and tensile bond strength to dentine were investigated.  
The authors reported that resin adhesive containing vancomycine at 1-5 wt% was effective 
in  inhibition  of  the  growth  of  all  tested  streptococci  and  actinomyces  strains  in  an  agar 
diffusion assay.  The adhesive resin with 1 wt% metronidazole however, exhibited milder 
antibacterial activity, which was limited to three bacterial strains.  Furthermore, tensile bond 
strength  of  the  bonding  agent  was  not  affected  by  addition  of  either  vancomycine  or 
metronidazole.  The lower release of antibiotics however, may promote the development of 
resistant  bacterial  strains.    Therefore,  antibiotic  incorporation  is  not  an  ideal  strategy  to 
develop dental adhesives with antibacterial activity.  
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1.4.3.5   Fluoride: 
Several fluoride releasing dentine adhesives are available for clinical application (Han et al. 
2002a;Han et al., 2002b; Kameyama et al., 2002b; Okuyama et al., 2006).  These adhesives 
released  fluoride  to  restoration  margins  and  the  hybrid  layer.    The  fluoride  releasing 
adhesives may inhibit development of secondary caries through enhancing tooth resistance 
to demineralization (Dubroc et al. 1994; Xu & Burgess 2003).  Some reports, however, have 
indicated that fluoride - releasing adhesives have limited ability to inhibit secondary caries 
(Bapna et al.,1988; Marya et al., 2010) or maintain bond strength to dentine.    
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1.4.3.6  Chlorhexidine 
Deterioration of bond strength between adhesives and dentine has been partially attributed 
to  enzymatic  degradation  of  demineralised  collagen  fibrils,  which  are  unprotected  by 
adhesive  resin.    This  collagenolytic  activity  is  mediated  through  endogenous  enzymes 
known  as  matrix  metalloproteinases  (MMPs)  (Gendron  et  al.,  1999).    Chlorhexidine  has 
been reported to act as an inhibitor of MMPs (Van et al., 2003) and thereby helps maintain 
the integrity of the hybrid layer (Carrilho et al., 2007; Hebling et al., 2005). This stabilising 
effect of chlorhexidine on the hybrid layer has promoted many studies of chlorhexidine – 
containing dental adhesives (Carrilho et al., 2007). One in vivo study showed that surface 
treatment of dentine with 2% chlorhexidine solution could preserve the bond strength of 
dental adhesives for up to 14 months (Hebling et al., 2005).  In a further in vitro study, similar 
chlorhexidine  pre-treatment  was  found  to  decrease  the  deterioration  in  composite  bond 
strength after 6 months storage in artificial saliva (Carrilho et al., 2007). In one recent study, 
a  dental  adhesive  system  used  in  association  with  either  0.2  or  2  wt%  of  chlorhexidine 
digluconate, showed less decline in bond strength following 6 months storage using in vivo 
like conditions (Carrilho et al., 2007; Stanislawczuk et al., 2009; Zhou et al., 2009).    
 
The  preservation  effect  of  chlorhexidine  on  the  marginal  seal  of  dental  composites  is 
considered  as  a  significant  property that  should further  promote  use of  this  antibacterial 
agent in developing antibacterial restorative materials.  
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1.5  Demineralisation and remineralisation of tooth structure:  
 
The carious process results from the loss of normal equilibrium between remineralisation 
and  demineralisation  and  an  overall  increase  in  the  latter.    Therefore,  providing  extra 
sources of calcium and phosphate in the oral environment may help increase the process of 
tooth remineralisation.   
1.5.1  Calcium phosphates:    
Calcium  phosphates  include  various  salts  of  tribasic  phosphoric  acid  (H3PO4).    H2PO4
-, 
HPO4
2- or PO4
3- ions can all be formed through progressive removal of H
+ ions from this acid.  
Their natural occurrence in skeletal tissues and teeth makes them of particular interest to 
both clinicians and biomedical scientists.  These compounds are highly biocompatible and 
osteoconductive materials (Goto et al., 2006) and widely used as bone substitutes and as 
carriers for drug delivery (Ginebra et al., 2006).   
 
Several calcium phosphate species are known to dissolve in neutral or basic solution and re-
precipitate as hydroxyapatite (Ca10(PO4)6(OH)2 which is similar in structure to apatite found 
in bone and teeth.  The solubility of calcium phosphate phases in aqueous solution is an 
important  property  and  mainly  correlated  with  the  calcium  (Ca)  /  phosphorous  (P)  ratio.  
Generally the higher the Ca/P ratio, the lower the solubility. At physiological pH, the solubility 
of calcium phosphate species for example decreases in the order MCPM > DCPD = DCPA > 
OCP > β-TCP > HA (Table 1-1) (Figure 1-13)  
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Name  Abbreviation  Formula  Ca/P ratio 
Monocalcium phosphate monohydrate       MCPM     Ca(H2PO4)2.H2O               0.5 
Dicalcium phosphate anhydrate (monetite)         DCPA  CaHPO4     1.0 
Dicalcium phosphate dihydrate (brushite)           DCPD  CaHPO4.2H2O                 1.0 
Octacalcium phosphate                                          OCP  Ca8H2(PO4)6.5H2O           1.33 
β-Tricalcium phosphate                                         β-TCP              Ca3(PO4)2                                     1.5 
Amorphous calcium phosphate                             ACP  Ca3(PO4)2.nH2O             1.5 
α-Tricalcium phosphate                                        α-TCP                α-Ca3(PO4)2                    1.5 
Hydroxyapatite  HA  Ca10(PO4)6(OH)2               1.67 
Tetracalcium phosphate                                        TetCP  Ca4(PO4)2O                     2.0 
 
Table 1-1 The main Calcium phosphates arranged according to Calcium (Ca) and phosphorus 
(P) ratio   (Bohner et al., 2006) 
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(a)  MCPM anion (Ca (H2PO4)2.H2O) (molecular weight 252 g mol
-1). 
 
 
O 
║ 
O
- ─  P ─ O
- 
│ 
O
- 
(b)  β-TCP anion (Ca3(PO4)2) (molecular weight 310 g mol
-1). 
 
Figure 1-12 (a) and (b):  The chemical structure of MCPM and β-TCP. 
 
1.5.1.1  Calcium phosphate dental composites:  
In order to formulate restorative materials with remineralising activity, many studies have 
incorporated  soluble  calcium  phosphate  species  within  dental  monomers.    If  these 
phosphate fillers are more soluble than hydroxyapatite they can be released from the set 
resin and re-precipitate within a tooth lesion.         
    
Amorphous  calcium  phosphate  (ACP)  in  particular,  has  been  extensively  studied. 
Additionally,  composites  containing  dicalcium  phosphate  anhydrate  (DCPA),  tetracalcium 65 
 
phosphate  (TetCP)  and  monocalcium  phosphate  monohydrate  (MCPM)  have  been 
investigated.  
 
1.5.1.2    Amorphous calcium phosphate: 
Amorphous  calcium  phosphate  (ACP)  has  been  incorporated  up  to  40%,  in  various 
methacrylate dental monomers.  Upon immersion in water, the set ACP composites release 
calcium and phosphate that increases upon raising filler mass fraction (Skrtic et al., 1996) 
and filler particle size (Lee et al., 2007).  Furthermore, this release can advantageously be 
enhanced upon lowering the pH of the storage media.  The levels of calcium and phosphate 
release  from  ACP  composites  were  sufficient  to  promote  tooth  remineralisation,  in  vitro 
(Cheng  et al.,  2012;  Skrtic and Antonucci 2007).  These composites however, exhibited 
lower biaxial flexure strength than the base polymer or conventional glass filled composites. 
This was attributed mainly to the tendency of the ACP filler particles to agglomerate within 
the composite and increase water sorption (Regnault et al., 2008) 
 
Several studies therefore, have been carried out to improve the mechanical properties, for 
example through enhancing interaction between the filler and resin matrix, ACP hybridization 
with glass fillers, reduction in water sorption (Skrtic & Antonucci 2007) , or lowering of filler 
particle  size.    The  maximum  biaxial  flexure  strengths  of  these  wet  ACP  composites, 
however, achieved to date is ~ 50 MPa, which is in the range of glass ionomer cements.  
Therefore, the ACP composites are not suitable for use as restorative material in stress 
bearing areas.          
   
ACP composites however, have sufficient strength to be considered as dental adhesives or 
liner/base  materials.    In  one  study,  the  shear  bond  strength  of  an  experimental  ACP 
composite to dentine was 18 MPa (Schumacher et al., 2007).  Upon water storage, some 66 
 
decline in this strength was observed but the failure mechanism also changed from adhesive 
to  adhesive/cohesive.    Recently,  ACP  composites  have  been  commercialised  as  an 
adhesive cement and pit and fissure sealant.  With commercial ACP orthodontic adhesive 
(Aegis Ortho) the shear bond strength was 7 MPa, which was comparable with that of a 
commercial RMGICs type orthodontic adhesive but approximately half that of a conventional 
resin adhesive (Uysal et al., 2010).    
 
In  the  last  five  years,  a  lot  of  work  has  been  done  introducing  chlorhexidine  as  an 
antimicrobial agent in restorative dentistry and calcium phosphate as a remineralising agent. 
Some studies showed weak strength with slightly increase in adhesion properties.  Others 
used the chlorhexidine as conditioning just before placing the final filling; on the other hand 
different types of calcium phosphate were used. In table 1-2 is a summary of those studies; 
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Author/ year  Aim of the study    Results 
Cheng L et al 
( 2012) 
 The  objectives  of  this 
study  were  to  develop 
nanocomposites 
containing  amorphous 
calcium  phosphate 
(ACP) or calcium fluoride 
(CaF(2))  nanoparticles 
and  CHX  particles,  and 
investigate 
Streptococcus  mutans 
biofilm  formation  and 
lactic acid production for 
the first time. 
 
Adding CHX fillers to ACP and CaF(2) 
nanocomposites  greatly  increased   
their antimicrobial capability.  ACP  and 
CaF(2)  nanocomposites with CHX that 
were  inoculated  with  S.  mutans  had a 
growth medium pH>6.5 after 3 d, while 
the control commercial composites had 
a cariogenic pH of 4.2. Nanocomposites 
with CHX reduced the biofilm metabolic 
activity by 10-20 folds and reduced the 
acid  production,  compared  to  the 
controls. CFU on nanocomposites with 
CHX  were  three  orders  of  magnitude 
less than that on commercial composite. 
Mechanical  properties  of 
nanocomposites  with  CHX  matched  a 
commercial composite without fluoride 
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Author/ year  Aim of the study    Results 
Cheng  L,  et 
al 
( 2012) 
The  objective  of  this 
study  was  to  develop 
antibacterial  and 
mechanically  strong 
nanocomposites 
incorporating  a 
quaternary  ammonium 
dimethacrylate  (QADM), 
nanoparticles  of  silver 
(NAg), and nanoparticles 
of  amorphous  calcium 
phosphate (NACP). 
Flexural strength and elastic modulus of 
NACP+QADM,  NACP+NAg,  and 
NACP+QADM+NAg  matched  those  of 
commercial  composites  with  no 
antibacterial property (p>0.1). 
The 
NACP+QADM+NAg composite decreas
ed  the  titer  counts  of  adherent  S. 
mutans  biofilms  by  an  order  of 
magnitude, compared to the commercial 
composites (p<0.05) 
Rodrigo 
Stanislawczu
k et al 
 (2011) 
This study evaluated the 
effect  of  modified 
tetracycline on the resin-
dentin  bond  strength 
(µTBS),  silver  nitrate 
uptake  (SNU)  and 
solution  homogeneity 
(SH) of two adhesives. 
 
 
The µTBS has no significant difference 
among  groups  for  the  SB  adhesive 
(p > 0.05). 
As regards SNU, significant differences 
were  observed  for  both  adhesives 
(p < 0.05).  Lower  %  of  SNU  was 
observed for PB and SB when CH and 
MI  was  used  in  comparison  with 
DO(p < 0.05) 
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Auther/ year  Aim of the study    Results 
 
Claro-Pereira 
D et al 
(2011) 
The  aim  of  this  study 
was to compare, in situ, 
the  initial  dental  plaque 
formation  on  a  recently 
developed  silorane-
based composite resin, 
Filtek Silorane, and on a 
widely  used 
methacrylate-
based composite resin, 
Synergy  D6,  and  to 
relate  possible 
differences  to  surface 
free  energy, 
hydrophobicity  and  type 
of organic matrix. 
 
In contrast to previous in vitro studies, 
the  present  in  situ  study  found  no 
statistically  significant  differences  with 
respect  to  bacterial  adhesion  between 
Filtek Silorane and Synergy D6, despite 
the  differences  found  for  surface  free 
energy and hydrophobicity. 
 
 
 
 
 
 
 
 
 
 
 
 
 
Auther/ year  Aim of the study    Results 
Borges et al  The purpose of this study  There  were  no  statistically  significant 70 
 
( 2011)  was  to  provide 
information regarding the 
marginal  adaptation 
of composite resinonlays 
in  primary  teeth 
previously  treated  with 
1%  sodium  hypochlorite 
(NaOCl)  (pulp  irrigant) 
using  two 
different resin lutingagent
s 
 
differences (p>0.05) among the groups. 
The relative risk test revealed that some 
groups  were  more  apt  to  have  a 
presence of gaps than others. 
 
Milward Pj et 
al 
(2011) 
The  aim  of  this  paper 
was  to  develop 
experimental compomers 
with  enhanced 
properties,  based  on 
adhesive  monomers 
vinyl  phosphonic  acid 
and  pyromellitic 
dianhydride  glycerol 
dimethacrylate,  and  to 
compare their properties 
to those of commercially 
Based  on  the  results  of  this  study, 
higher amounts of vinyl phosphonic acid 
(VPA), pyromellitic dianhydride glycerol 
dimethacrylate  (PMGDM)  and  reactive 
glasses  render  the  material  with 
enhanced fluoride release and adhesion 
with properties similar to glass-ionomers 
whereas their decrease gives properties 
similar to conventional dental composite 
resinswith improved properties such as 
strength and wear resistance 71 
 
available products. 
Singla M et al 
(2011) 
 
 
 
 
 
 
 
 
 
This study evaluated the 
effect  Off 
2% chlorhexidine cavity 
disinfectant  on 
microleakage  in  class  II 
cavities  restored  with 
light  cured  composites 
using  a  single  bottle 
adhesive  in  an  in  vitro 
mode 
 Chlorhexidine cavity  disinfectants 
produced  significantly  higher 
microleakage  while  restoring  the 
cavities using a self-etching single bottle 
adhesive. 
 
Hiraishi N 
April 2010 
The  purpose  was  to 
investigate  the 
chlorhexidine  release 
and  the  antibacterial 
effect  of  chlorhexidine-
incorporated  PMMA-
based luting cement 
 
Super-Bond C&B that contained 3.0 and 
4.0%  of  chlorhexidine  exhibited 
prolonged release of chlorhexidine for 5 
weeks,  whereas  those  containing  1.0 
and  2.0%  depleted  at  1  week  and  2 
weeks, respectively. 
 
 
H.S.Siso et al 
(2009) 
The  current  study 
evaluated  the  influence 
of  KTP  (Potassium-
Titanyl-Phosphate)  laser 
There  were  no  significant  differences 
among  the  four  groups  at  the  gingival 
surface  (p>0.05).  Microleakage  at  the 
occlusal margins of all the groups was 72 
 
irradiation,  2% 
chlorhexidine  gluconate 
and Clearfil Protect Bond 
on  the  microleakage  of 
Class  V  composite 
restorations. 
 
compared; differences between the KTP 
laser and chlorhexidine gluconate group 
and the KTP laser and Clearfil Protect 
Bond  group  were  found  to  be 
statistically significant (p<0.05). 
 
Hiraishia N 
(2008) 
  Using  2% chlorhexidine gluconate  did 
not interfere with the microtensile bond 
strength  of  glass  ionomer  cements 
and composite. 
Table 1-2 Summary of latest studies using CHX in resin restoration 73 
 
 
 
1.6  The need to develop a new dental material for paediatric dentistry 
 
There is strong evidence showing that invasive types of dental procedures are the 
most anxiety provoking in dentistry (Oosterink et al., 2008). A study in 2002, found 
that children with many carious lesions at the age of five years are likely to be 
dentally anxious at 10 years of age, probably because they have had pain and other 
negative  treatment  experiences  (Raadal  et  al.,  2002).  This  anxiety  results  in 
avoidance behaviour only detectable by a compulsory examination system such as 
school visits. However, it is usually associated with high caries rate and the need for 
oral rehabilitation (Eitner et al., 2006). Indeed, several studies reported the strong 
relationship between dental anxiety and avoidance of dental care  (Arnrup et al., 
2003). Furthermore, dental anxiety has been reported to decrease with repeated 
exposure  to  dental  treatment,  possibly  due  to  habituation  Therefore,  different 
techniques have been established.  
 
Historically dentists were taught to remove all infected dentine but identification of 
all  diseased  tissue  can  be  difficult.    Furthermore,  complete  removal  of  caries 
increases the risk of pulpal exposure, pain, tooth weakening and ultimately tooth 
loss (Banerjee et al., 2000; Kidd 1999). Moreover, there is increasing evidence to 
suggest that bacterial action may be halted by “restoration sealing”.  This is used in 
the  more  tooth  conservative  approach  (Banerjee  et  al.,  2001).  The  atraumatic 
restorative technique (ART) was originally developed for regions of the world with 
no access to dentists and associated infrastructure eg dental chair, electricity, light 74 
 
gun, compressed air etc (Mehdawi et al., 2013; Molina et al., 2009; Takahashi et al., 
2006).    Moreover,  it  is  also  favoured  by  children  due  to  reduced  use  of  local 
anaesthetics / drills and greater procedure simplicity (Molina et al., 2009; Peumans 
et al., 2005).  It uses hand instruments to remove carious tissue and then a glass 
ionomer cement (GIC) to seal the cavity. 
 
Therefore In this study, we addressed the need to develop a novel composite with 
antimicrobial  and  remineralising  properties  to  improve  the  quality  of  dental 
treatment for anxious child for paediatric dentistry using ART approach.  
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Chapter Two: Aim & 
objectives 
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2  Aims and objectives  
 
2.1  Aim  
 
The study aim was formulation of composites with high monomer conversion, high 
mechanical  strength,  early  release  of  antimicrobial  agent  and  remineralising 
properties, without compromising the standard values of mechanical and biological 
properties of resin restorations. 
 
2.2  Hypothesis  
 
Our  hypothesis  was  that  the  addition  of  water-soluble  MCPM  fillers  should 
encourage water sorption into the set resin materials, which in turn should enhance 
the  release  of  chlorhexidine  and  calcium  phosphate  species.  Subsequently, 
however, the absorbed water should promote reaction between MCPM and βTCP 
and brushite formation within the polymerised methacrylate. As this reaction can 
bind water and encourage reprecipitation of less soluble species in material regions 
from which components have been released, it was also anticipated that it might 
limit  the  reduction  in  strength  normally  associated  with  water  sorption  and 
component release (Figure 2-1) 
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Figure 2-1 Schematic diagram explaining the hypothesis of this study     
2 Composite 
1  Residual 
caries 
4  
Expansion 
3 
Shrinkage 
6 Remineralised  
HA 
 5 CHX release 78 
 
2.3  Objectives  
 
To formulate and test systematically varying dental composites containing UDMA 
base monomer,  25 wt%  PPGDMA diluent,  and 5 wt%  of  adhesive methacrylate 
dental resins (HEMA or HEMA phosphate).  These are combined with 80 wt% filler 
containing 10 or 40 wt% reactive calcium phosphate fillers (MCPM and β-TCP) and 
5 or 10 wt% chlorhexidine diacetate dispersed in a conventional dental glass. 
 
  Poly (propylene glycol) Dimethacryate monomer was introduced due to its 
high molecular weight which subsequently should ensure lower shrinkage 
and less heat generation per mole of monomer conversion than standard 
TEGDMA diluent.  
  Chlorhexidine diacetate was added to to provide antibacterial properties 
   Mono  calcium  phosphate  and  tri  calcium  phosphate  reactive  filler  were 
included to enhance remineralisation 
  Hydrophilic  adhesive  monomers  (HEMA  &  HEMA  phosphate)  would 
enhance water sorption to promote swelling to compensate polymerisation 
shrinkage 
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3  Materials  
3.1  Monomer 
3.1.1  Urethane Dimethacrylate (UDMA)  
It  is  high  molecular  weight  monomers  which  was  developed  and  introduced  in 
commercial materials to overcome the limitations of BisGMA-based systems. As an 
example, formulations based on urethane dimethacrylate (UDMA; MW=470 g/mol) 
became  increasingly  common,  due  to  this  monomer's  low  viscosity  and  high 
flexibility in relation to BisGMA (Floyd 2006). UDMA copolymers in general present 
higher flexural strength, elastic modulus and hardness (Tanimoto et al., 2005). 
In  general,  shorter  chain  monomers  with  lower  molecular  weight  have  greater 
polymerisation shrinkage per mole of monomer conversion. A high molecular weight 
monomer  reduces  the  polymerisation  shrinkage,  due  to  lower  concentrations  of 
C=C.      Reducing  shrinkage  minimizes  marginal  contraction gaps,  microleakage, 
marginal  staining  and  caries  recurrence,  whilst  also  dissipating  and  reducing 
functional stresses across the restorative-tooth interface (Braga et al., 2005). For all 
materials used in this study see (Table 3-3) 
 
3.1.2  Poly ( propylene glycol) Dimethacrylate 
 
   (C4H5O)
.(C3H6O)n
.(C4H5O2) 
Figure 3-1 The chemical structure of PPGDMA 
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PPGDMA  has  a  flexible  long  polypropylene  glycol  (PPG)  chain  in  between  two 
methacrylate functional groups.  Its low viscosity improves handling properties of 
the UDMA.  
  
3.1.3  Hydroxyethyl methacrylate  
Hydroxyethyl methacrylate (HEMA) is a hydrophilic monomer which has the ability 
to  improve  degree  of  conversion,  decrease  viscosity  and  improve  handling 
properties.  
 
 
3.1.4  Hydroxyethyl methacrylate phosphate 
 
   C6H10O6P 
Figure 3-2 The chemical structure of HEMA phosphate 
 
HEMA-phosphate (also called MEP, 2-methacryloyloxyethyl dihydrogen phosphate) 
(Figure 3-2), can be hydrolytically unstable (Salz et al., 2005). 
 
In  aqueous  solutions,  it  can  partially  hydrolyse  into  HEMA  and  strongly  acidic 
phosphoric acid. Adhesive systems that contain  this monomer may therefore be 
quite acidic. (Table 3-1) 
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3.2  Commercial composite used  
3.2.1  Gradia  
Gradia  Direct  is  classified  as  a  micro-fine  hybrid  resin  composite  with 
prepolymerised resin filler. These so-called colloidal systems, like Gradia Direct, are 
known in the clinical situation to have much-appreciated advantages in terms of 
esthetics,  polishability,  and  wear  resistance.  The  average  particle  size  is  0.85 
microns.  The  material  itself  uses  urethane  dimethacrylate  (UDMA)  and 
dimethacrylate co-monomers for its matrix. (Table 3-2) 
 
Gradia Direct uses a combination of camphorquinone and amine as the catalyst for 
photoactivation. Light activation can be carried out with quartz halogen, plasma, or 
LED curing lights 
 
3.2.2  3M™Filtek Z250  
 Filtek Z250 is a hybrid resin composite with particle size distribution from 0.01μm to 
3.5μm with an average particle size of 0.6μm resin filler. The new resin system of 
3M™Filtek™ Z250 Universal Restorative consists of 3 major components. In Filtek 
Z250 restorative, the majority of TEGDMA has been replaced with a blend of UDMA 
(urethane dimethacrylate) and Bis-EMA (Bisphenol A polyethey- lene glycol diether 
dimethacrylate). Both of these resins are of higher molecular weight and therefore 
have fewer double bonds per unit of weight. The high molecular weight materials 
also impact the measurable viscosity.  (Table 3-2) 
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Monomer   Abbreviations
                   
 supplier                   Product 
code 
   MW   % wt 
Urethane 
Dimethacrylate 
UDMA  Esstech  X850 
0000 
470  68% 
Poly(propylene 
glycol) 
Dimethacrylate 
PPDdma  Esstech  04380- 
250 
660  20% 
Hydroxyethyl 
methacrylate/  
phosphate  
HEMA 
HEMA 
phosphate 
Esstech 
 
X9687044 
 
130  5% or 
5% 
 
Table 3-1 Types of Monomer used in experimental; composite  
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Composite  Resin  Filler   Fillers  by  
Wt % 
Fillers  by 
Vol% 
 Fillers 
Size 
Filtek Z250  
 
Bis-GMA 
Bis-EMA  
UDMA 
 
Zirconia/silica   78  60  0.01-3.5µm 
Gradia 
Direct 
 
UDMA  
 
Silica 
Prepolymerized 
filler 
73  64  0.85µm 
 
Table 3-2 Commercial composite used in this study adapted from (Watanabe et al., 
2008) 85 
 
 
3.3  Fillers 
3.3.1  Chlorhexidine  
Chlorhexidine is known as a gold standard for chemical plaque control.  It is anti-
plaque,  anti-inflammatory  and  bactericidal  or  bacteriostatic  at  low  versus  high 
concentration. Chlorhexidine diacetate used in this study has a molecular weight of 
625.6  g/mol  (Figure  3-3).  Reported  bacterial  resistance  to  chlorhexidine  is  rare. 
Chlorhexidine can be effective against ninety five percent of oral bacteria (Tirali et 
al., 2013) 
The mode of antibacterial action of CHX is reduction of membrane formation and 
modification  of  bacterial  cell  walls,  causing  bacterial  cell  lysis  and  prevention  of 
bacterial  adherence  to  teeth.  This  is  facilitated  by  electrostatic  forces,  since 
chlorhexidine  is  positively  charged,  while  the  phosphate  and  carboxyl  groups  of 
bacterial  cell  walls  carry  negative  charges.  Binding  of  CHX  to  phosphate  and 
carboxyl groups of bacterial cell walls causes disruption of the osmotic barrier and 
interference with membrane transport.  
CHX  can  be  adsorbed  on  enamel  and  soft  tissue  and  has  a  high  intraoral 
substantively  (Addy  and  Dowell  1986)  in  the  mouth  (Schwach-Abdellaoui  et  al., 
2000). Prolonged retention at bacteriostatic levels would explain the effectiveness 
of CHX. In – vitro, chlorhexidine- treated enamel prolongs the lag phase of bacterial 
division  of  adherent  organisms.  When  delivered  orally,  systemic  toxicity  and 
microbial resistance is reduced, and supra infections do not usually occur.  
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Figure 3-3 SEM images of CHX particles 87 
 
3.3.2  Inorganic filler 
In the following experimental composites, silanated glass was used as the major 
component of the filler phase (Figure 3-4). Ideally, around 80 wt% is incorporated in 
the  resin  matrix  phase,  mainly  to  enhance  physical  properties  and  decrease 
polymerisation shrinkage (Bohner 2000) 
 
 
                 
                                    Figure 3-4 IF 2019 glass 5µm 88 
 
3.3.3  Calcium phosphate  
In this study MCPM and TCP was used. (figure 3-5 and  figure 3-6 ) 
     
    
                          Figure 3-6   SEM image TCP 
      
Figure 3-5 SEM image for MCPM   89 
 
Abbreviation  Chemical name  Supplier  MW  Properties 
CHX  Chlorhexidine- 
diacetate 
S-
Aldrich 
  Antibacterial,  increases 
the setting time 
MCPM/b-
TCP(CaP) 
Monocalcium 
phosphate  ,β  tri 
calcium 
phosphate 
 
Himed 
 
310/
252 
For  brushite  and 
hydroxyapatite  formation, 
Decrease  brittlness, 
release  of  Ca  and  PO4 
ions 
IF2019-
Glass 
particle 
Silanized  barium 
boro  alumino 
silicate glass 
Sci-
pharm 
  Decreases  polymerisation 
heat  and  shrinkage, 
Increases strength 
UDMA(Base 
monomer) 
Urethane 
dimethacrylate 
Esstech  470  High  molecular  weight 
monomer  ensures  low 
shrinkage / heat  
generation,  cross linking 
provides  strength  and 
wear resistance 
PPG DMA  polypropylene-
glycol-
dimethacrylate 
Polyscie
nces 
660  Flexible,  cross  linking 
monomer  that  improves 
handling  by  lowering 
viscosity 
HEMA  Hydroxyethyl  
methacrylate 
Esstech  130  Low  viscosity  monomer 
that  improves  conversion 90 
 
and handling 
HEMA 
Phosphate 
Hydroxyethyl 
methacrylate 
phosphate 
Esstech  210  Low  viscosity  monomer  – 
adhesion properties  
CQ   camphorquinone  S-
Aldrich 
166  Source of free radicals 
DMPT(accel
erator) 
N,N-dimethyl  -p-
toluidine 
S-
Aldrich 
135  Stabilizes free radicals 
Table 3-3 List of materials, companies’ names and properties                                        
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4  Methods  
4.1  Specimen manufacture:  
 
For all experimental formulations, filler and monomers were weighed using a four-
figure balance. Initiator (CQ and DMPT) were dissolved in the monomers (UDMA, 
PPG,  and  HEMA  or  HEMA  phosphate)  and  combined  with  filler  material.  The 
mixture was loaded in to 10mm diameter spilt brass ring.   The samples were fully 
covered  by  an  acetate  sheet  (to  decrease  air  inhibition  of  the  polymerisation 
process)  and  a  glass  microscope  slide,  which  was  pressed  gently  to  express 
excess material.  Light cure of samples was initiated by irradiation for 60 seconds 
with a blue light-curing unit (460-480 nm), for which the power output was 1000 
mW/cm
2.  The samples were removed from the moulds, excess material removed to 
get smooth edges and then stored at room temperature until usage (Figure 4-1). 
Eight samples were developed from each formula for biaxial flexure strength (BFS) 
test and were left in distilled water for 24 hours before testing. While five samples 
for each individual formula were developed for testing monomer conversion, mass 
changes and CHX release tests.   
In all studies PLR was 4:1. Variable factors were: 
1) high and low MCPM and TCP (5 or 20 wt% of each) (reactive CaP phase) 
2) CHX at 5 or 10 wt% of the powder phase,  
3) 5 wt% HEMA or HEMA Phosphate 
Formulations with 0 wt% of CaP or CHX were used as a control                                                      
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4.1.1  Series 1 Formulations  
For control formulations, monomer mixtures were prepared using 68 wt% UDMA, 
25 wt% PPG and 5 wt% HEMA (sample F1) or HEMA phosphate (sample F5). This 
Figure 4-1 sample preparation 94 
 
was  combined  with  1  wt%  DMPT,  1  wt%  CQ  and  80  wt%  glass  powder.  Z250 
Composite and Gradia were additionally tested in this control group. 
4.1.2  Series 2 Formulations  
For series 2, monomer mixtures were prepared using 68 wt% UDMA, 25 wt% PPG, 
1 wt% DMPT, 1 wt% CQ and 5 wt% HEMA. In this group, 5 or 10 wt% CHX, 5 or 20 
wt% β-TCP and 5 or 20 wt % MCPM were introduced with 50, 55, 80 or 85 wt % 
non reactive fillers (glass) ( Table 4-1). 
                                  Powder            Liquid  
       
 
                                                4 
                   
 
1 
                       CaP                                                    CHX                Glass 
 
Monomer mixture  
68% UDMA 
25% PPG 
5% HEMA 
1% CQ 
1 DMPT 
 
                MCPM           β-TCP 
F2  5%  5%   5%  85 % 
F3      5%    5%   10%                   80% 
F4  20%  20%  5%  55% 
F5  20%  20%    10% 
 
50% 
Table 4-1 Powder and liquid concentrations for series 2 formulations 
                      
4.1.3  Series 3 Formulations 
Monomer mixtures were prepared using 68 wt% UDMA, 25 wt% PPG and 5 wt %, 
HEMA Phosphate and 1 wt% DMPT, 1 wt% CQ. In this group reactive fillers such 
as 5, 10 wt% CHX, 5, 20 wt % β-TCP and 5, 20 wt % MCPM were introduced, 
finally adding 50, 55, 80, 85 wt % non reactive fillers (glass). (Table 4-2) 95 
 
 
 
                                                  Powder            Liquid  
                                                        4                    1 
                    
    CaP    
              
  CHX                 Glass 
 Monomer mixture  
68% UDMA 
25% PPG 
5% HEMA Phosphate  
1% CQ   
1 DMPT 
 
              MCPM          β -TCP 
F7  5%  5%  5%                   85% 
F8     5%    5%  10%                          80% 
F9  20%  20%   5%                  55% 
F10  20%  20%  10%                   50% 
        Table 4-2 Powder concentrations based on factorial design 
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4.2  Degree of conversion and polymerisation reaction profile 
4.2.1  Fourier transform infrared spectroscopy  
 
Infrared (IR) spectroscopy is a chemical analytical technique that uses the intensity 
of infrared light to determine the functional groups in compounds. The infrared light 
can be classified according to the wavenumber into far infrared (10-200 cm
-1), mid 
infrared (200-4000 cm
-1) and infrared (4000-12800 cm
-1). The mid infrared region 
provides greater information on molecular structures; hence, it is most commonly 
used.  FTIR spectroscopy has been used in this study to measure the rate and level 
of monomer conversion of the novel composite being formulated. 
   
4.2.2  Principles of infrared absorption: 
When a molecule or atom absorbs IR radiation, it gains energy as it undergoes 
transition from one energy level (Einitial) to another (Efinal).  According to Planck’s law, 
the  energy  of  transition  and  the  frequency  of  absorbed  radiation  f  (Hz)  are 
correlated by equation (4.1):  
Et  = hf                                                                                   Equation 4-1 
                                                     
Where Et is the energy of transition ( Efinal- Einitial ) and h is Planck’s constant.   
Since f = vc, where v and c are the wavenumber (v) (cm
-1) and velocity of light 
(8×10
8 m s
-1), equation (4.1) can be replaced by equation (4.2):    
Et  = hvc                                                                             Equation 4-2 
The wavelength (λ) (nm) is related to frequency ( f ) by the following equation: 
λ = c/f                                                                                Equation 4-3 
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Therefore, equation (4.2) can also be given as: 
Et = hc/ λ                                                                           Equation 4-4 
                                                            
Energy absorbed by a molecule must match exactly that required for a molecular 
transition. When a molecule absorbs Infrared radiation, it will be excited to a higher 
vibration energy state.  IR absorption depends on molecular vibrations. This can be 
1) a stretching vibration due to change in bond length 2) a bending vibration caused 
by change in bond angle.  
   
In order to observe these changes in FTIR spectra, the vibrational motion should be 
accompanied by change in dipole moment at both ends of the vibration. The FTIR 
spectrum is generally displayed as a plot of IR absorbance versus wavenumber 
(cm
-1) (see for example Figure 4-2). Peaks in the spectrum correspond with different 
vibrational  transitions.    Generally  the  FTIR  spectrum  can  be  classified  into  two 
regions.  The  absorption  between  4000-1300  cm
-1  is  mainly  due  to  vibrations 
associated with specific functional groups, while the second region between1300-
500 cm
-1 is known as the fingerprint region and associated with vibrations of the 
whole molecule.  
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Figure 4-2 Example FTIR spectra of setting composite  
 
             
                       
4.2.3  Fourier transforms infrared spectroscopy instrumentation:  
 
FTIR  instruments  consist  of  a  light  source,  interferometer  and  detector.    The 
interferometer contains a beam splitter and two mirrors. 
 
The light beam that includes all frequencies of IR radiation is split into two optical 
beams via the beam splitter.  The beams are reflected back to the splitter by the 
mirrors.  One mirror is stationary while the second is allowed to move along the 
path of light beam.  The time required for light to travel from mirrors to splitter will be 
different for both beams and dependent on the wavelength.  The reflected beams 
are recombined at the splitter and the resultant used to produce an interferogram.  
After interaction with the sample, the resultant interferogram can be converted to 
absorbance  versus  wavenumber  through  computer  software  and  Fourier 
transformation.   
A0 
Amax 
1750  1650  1550  1450  1350  1250 99 
 
 
 
4.2.3.1   Attenuated total reflectance (ATR) -FTIR: 
Before  generating  any  FTIR  spectra  background  was  scanned  first  without  any 
sample on the ATR diamond piece so that the ratio of light intensity through the 
instrument  with  and  without  the  sample  could  be  calculated  by  the  computer. 
Chemical reactions of different formulations of composite containing CHX, MCP and 
TCP  were  then  monitored  and  the  reactant  and  end  products  identified  by 
comparison of spectra of pure compounds.  
To  investigate  reaction  kinetics  each  formulation  was  mixed  and  loaded 
immediately into a metal mould (10 mm diameter and 1mm thickness) on the centre 
diamond  of a golden gate
TM heated ATR top-plate (Specac Ltd, UK) in an FTIR 
spectrometer (Perkin Elmer series 2000, UK ).  The temperature was kept at 37 ºC 
(to simulate normal human body temperature) and number of samples was five for 
each formula. The top surface of the sample was then covered with acetate sheet to 
prevent  oxygen  inhibition  of  the  polymerisation.    FTIR  spectra  of  the  sample  in 
contact with the diamond were obtained with resolution set at 4 cm
-1  and wave 
number range between 600 and 2000 cm
-1.  Number of scans was fixed at 8 and 
the total run time was 20 minutes for all specimens.     
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For a simple single reaction change in absorbance versus wavenumber has the 
same profile irrespective of time. For the methacrylate polymerisation reaction high 
absorbance change is observed at 1320 cm
-1 (C-O stretch in the monomer) and 
also 1700 cm
-1 (C=O stretch).  The degree of monomer conversion was quantified 
through change in the absorbance due to the monomer peak at 1320 cm
-1 (C-O 
stretch) above the background at 1335 cm
-1.   % degree of monomer conversion 
was calculated using equation (4-5) 
 
o
t
A
A A 

0 100
                          Equation 4-5                                         
                                                                                         
                                                                                                        
A0 and  At are the peak height due to the C–O bond stretch peak at 1320 cm
-1 
initially and at time t after start of the experiment respectively. 
 
4.2.4  Heat Generation and Shrinkage (Polymerisation): 
Polymerisation heat and shrinkage can be calculated from molecular weight (Mw) of 
monomers, powder liquid ratio (PLR) and final conversion levels (C) of the different 
formulations. One mole of polymerising C=C bonds typically generates 57 kJ of 
heat  (Lewis  2006)  and  gives  volumetric  shrinkage  of  23  cm
3  (Kobayashi  et  al., 
1998). The total heat generation and shrinkage due to the composite curing process 
can therefore be estimated using equations 4-6, 4-7, 4-8, 4-9 and 4-10 
 
 
                                                                                                        Equation 4-6 
100 * 23 (%) N vol 
%  Degree  of 
conversion  101 
 
                                                                                                                                     
               
 
                                                                                                         Equation 4-7 
                                                                                                                                     
N is the number of moles of reacted bonds per unit volume.  This can be estimated 
using 
 
                                                                                                         Equation 4-8 
                                                                                                                                      
m is the total monomer mass fraction and C the final fractional monomer conversion 
calculated from FTIR.  ∑ indicates a sum over all the monomers in the liquid phase. 
ni, Wi and xi are number of c=c bonds per molecule, molecular weight (g/mol) and 
mass  fraction  of  monomer  i  respectively.    PPG,  UDMA  and  HEMA  molecular 
weights were taken as 560, 470 and 130 g/mol. Assuming the formulation density, 
ρcomp (g/cm
3), behaves “ideally” it can be estimated using a simple rule of mixtures 
 
                                                                                                            Equation 4-9 
ρmonomer and ρfiller are the average densities of the monomer mixture and filler and m 
is the mass fraction of monomer. The filler density was similarly calculated using      
1/P filler= mc/pC+mT/pT+mM/pM                                                   Equation 4-10 
  
 
 
Where G, T and M represent glass, TCP and MCPM with densities of 3.0, 3.15 and 
N cc kJ Heat 57 ) / ( 
N =mCrcomp
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2.22 g/cm
3 respectively. 
 
4.3  Mechanical behaviours: 
 
4.3.1  Biaxial flexural strength  
 
In this study, biaxial flexural strength was determined. Flexural strength is obtained 
from the maximum stress experienced in the material at failure when subjected to 
bending  load.  The  rationale  for  using  this  type  of  test  was  based  on  possible 
applications of this composite as dental material which can be subjected to flexural 
stresses  during  mastication  (Chung  et  al.,  2004).    The  biaxial  flexural  test  was 
chosen over the uniaxial test in this study. In this test the disc shaped composite is 
supported near its periphery by a continuous ring shaped structure and later loaded 
by a coaxially located ball. In addition the disc shape is circularly symmetrical; the 
stress  field  is  equibiaxial  in  the  central  region  in  which  it  is  at  a  maximum. 
Therefore,  this  method  will  minimise  the  effect  of  the  test  specimen  edge 
preparation compared to uniaxial test because the generated stresses are lowest at 
the test specimen edges (Figure 4-3).  
 
For  strength  testing  8  discs  of  each  composition  of  10  cm  diameter  and 
approximately  1mm  thickness  were  prepared  and  their  thickness  accurately 
measured  to  0.001  mm.  Samples  were  tested  after  24  hours  dry,  and  then 
composite compositions were hydrated in distilled water for 24 hours at 37º C just 
prior  to  testing.  Again  after  one  week  after  immersion.  Flexural  strength  was 103 
 
determined using the Instron Model 4505 Universal Testing Machine provided with 
a load cell of 1kN and the crosshead speed was fixed at 1 mm/min. Before load 
application,  each  sample  was  measured  for  thickness  t  (mm)  at  three  different 
points and the average thickness was obtained.  
The hydrated disc specimen was placed on the knife edge ring support (radius a = 
4mm) and then loaded by the spherical tip in an Instron mechanical tester. The 
maximum load (kN) at fracture, P and load versus central displacement gradient, 
dP/dw were determined. From the maximum load and the average thickness of the 
composite, the strength for each sample was calculated using the following formula 
by Timoshenko (theory of plates and shells); 
 
 
                                                                                       Equation 4-11 
Where  
σ   is biaxial flexural strength. 
P  is maximum load. 
a   is support radius. 
t   is average thickness of specimen. 
Ω         is poisson’s ratio= 0.3 
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Figure 4-3 Schematic diagram of biaxial test    105 
 
 
4.3.2  Biaxial flexural modulus  
 
Elastic modulus is a measure of stiffness of the material. This can be experimentally 
determined  from  the  slope  of  a  stress-strain  curve  created  during  tensile  tests 
conducted on a sample of the material and which is known by Young modulus.  
 
 The Instron machine produces data in pound (lbs) and inches, so the data needed 
to be converted to Newton (N) and millimeters (mm). From the load -displacement 
data,  a  graph  was  plotted  for  each  sample  (Load  against  displacement)  to 
determine the slope required for the calculation of modulus based on the following 
equation; 
 
                                                                                                                                                         
Equation 4-12 
Where : 
∆P/∆W      = change in force/change in displacement  
                 = gradient of the force displacement curve. 
    E           = elastic modulus of the disc (from BFS test). 
   βc       = central deflection function.  For a ball on ring geometry βc is 0.502.  
(Higgs et al., 2001) 
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4.3.3  Toughness  
Toughness can be determined by measuring the area underneath the stress-strain 
curve and its energy needs for mechanical deformation per unit volume prior to 
fracture. The explicit mathematical description is 
 
                                                  Equation 4-13 
 
Where; 
      is strain 
    is the strain upon failure 
     is stress 
 
4.3.4  Resilience   
Resilience  is  the  ability  of  a  material  to  absorb  energy  when  it  is  deformed 
elastically.  It is given by 
 
                                                                               Equation 4-14 
Where; 
  σy  Biaxial flexural strength   
  E    Young’s elastic modulus 
     107 
 
4.4   Chlorhexidine Release profiles  
 
The absorbance of different storage solutions was obtained at each time point using 
UV  spectrometry  (UV)  for  a  period  of  up  to  4  weeks.  For  determination  of  a 
calibration curve, standard solutions were prepared in water. CHX solutions of 20, 
10, 5, 2.5, and 1.25 ppm were made. 1 cm path length quartz cells were used. The 
spectrum was recorded between 200 - 400 nm. Maximum absorption for the CHX 
standards was found at 231 and 255 nm (Figure 4-4).  
Five specimens of each formulation were prepared, were placed in water (5 ml at 
37°C).  Samples were removed and replaced in fresh medium at 2, 6, 24 and 48 
hours,  and  1,  2,  3,  and  4  weeks.    Samples  were  stored  at  37°C  prior  to  CHX 
quantification. 
 
 
Figure 4-4 Absorbance vs wave number cm 
-1 for CHX standards 
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The CHX concentration calibration curve was obtained by plotting the absorbance 
at 230 nm and 255 nm against the concentration of CHX in samples (Figure 4-5). 
Each  of  the  storage  samples  were  diluted  with  distilled  water  (dilution  factor 
recorded) and analysed using UV spectrometry. The absorbance at 230 nm and 
255 nm were recorded and analysed using Microsoft Excel 2010.   
 
 
 
Figure 4-5 Chlorhexidine diacetate calibration curve (absorption at 255 nm). 
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The amount of CHX released (D, in grams) from the specimen was calculated 
Equation 4-15 
Cumulative  mass  of  CHX  release  in gram  (CD)  at  time “t”  was  calculated  using 
?? = ?󵑫?                                                                              Equation 4-16 
    
                                                                      6 
The percentage release (P (%)) at time “t” was calculated using 𝐏 = 
??
?𝑴
 ×???%                                                                        
Equation 4-17 
                                                                   
? = (
𝑨
??  ) × 𝑽?                                                                          Equation 4-15 
 
                                                                   
?? = ∑ ??
?
?                                                                               Equation 4-16 
    
                                                                       
𝐏 = 
??
?𝑴
 × ???%                                                                        Equation 4-17 
                                                                   
Where  
 
A   =    absorbance due to CHX at 255 nm, 
k   =    gradient of the calibration curve for CHX. 
VS  =   storage solution volume (ml). 
CM =   original CHX mass in specimen. 
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4.5  Mass changes 
 
For each composition, five discs were used for the mass and volume change test. 
All composites were individually coded and immersed in 10ml of distilled water in a 
sterilin tube. The tubes were then incubated at 37°C. At different time points 2, 4, 6, 
24 hours, 48 hours, one week, two weeks, 3 weeks and 4 weeks.  Each sample 
was removed from the sterilin tube and blotted dry on tissue paper. The storage 
solutions were kept aside for UV analysis to determine drug release profile. The 
disc was then weighed using a four figure balance and re-immersed in a new sterilin 
tube containing fresh 10ml distilled water stored at 37°C. 
 
 
   ∆𝑚 ( %) = 100  ×
𝑚𝑡−𝑚0
𝑚0    
                                                                                                           Equation 4-18 
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4.6  Microstructure study of experimental composites  
 
In this study, the effect of the monocalcium phosphate, tri calcium phosphate and 
chlorhexidine on microstructure of composites were investigated using a scanning 
electron  microscope  (SEM).  SEM  uses  a  beam  of  highly  energetic  electrons  to 
examine  objects  on  micron  scale.  A  stream  of  electrons  is  formed  under  high 
vacuum (by electron guns). This stream is accelerated towards the specimen with a 
positive electrical potential while being confined and focused using metal apertures 
and  magnetic  lenses  into  a  thin,  focused,  monochromic  beam.  Each  sample  is 
irradiated by the beam and interactions occur inside the irradiated sample, affecting 
the electron beam. These interactions and effects are detected and transformed 
into an image. 
 
4.7  Data Analysis  
In order to assess mechanical behaviour, chlorhexidine release and mass changes 
at  each  formula,  data  were  analysed  by  comparing  the  mean  and  standard 
deviation. The effect of the chlorhexidine, Calcium phosphate, HEMA and HEMA 
phosphate on development composite was analysed using univariate analysis of 
variance for all variables and simple t test where appropriate 
 
4.7.1  Simple T test 
 This  test  is  used  for  comparing  the  means  of  two  samples,  even  if  they  have 
different  numbers  of  replicates.  In  simple  terms,  the  t-test  compares  the  actual 
difference between two means in relation to the variation in the data (expressed as 112 
 
the standard deviation of the difference between the means). In this study, the T 
test where used with series one formulation (Control group) 
 
4.7.2  Univariate Analysis of Variance 
Univariate  analysis  is  the  simplest  form  of quantitative  (statistical)  analysis,  it  is 
explores each variable in a data set, separately. It looks at the range of values, as 
well as the central tendency of the values. It describes the pattern of response to 
the variable as it’s describes each variable on its own.  
In this study, eight samples were made for each formula for testing the effect and 
changes of CHX, CaP, HEMA, HEMA phosphate on the mechanical behaviour on 
the new development composite any evidence of differences between them at the 
significance level 0.05. Five samples were made for testing the same variables on 
monomer conversion, CHX release and mass changes using SPSS 2012 (Windows 
software) (see Appendix 1)  
 
4.7.3  Factorial analysis  
To quantify the effects of different variables on the degree of conversion, BFS, CHX 
release and mass changes, results were fitted to a factorial expression  
lnP=ln<P>+F1a1+F2a2+F3a3+F1F2a12+F1F3a13+F2F3a23+F1F2F3a123  
Equation 4-19   
 
ln represents natural logarithm.  Fi takes values of -1 or +1 when the variable, i, has 
its low and high value respectively.  ai quantifies the effect of the three variables 
(HEMA/ Hp, CaP % and CHX %) on the property P.  a12, a13, a23 and a123 are 2 and 
3 variable interaction terms.  It can be shown that 113 
 
<PH>/<PL>=exp (2ai)              Equation 4-20 
 
<PH> and <PL> are the geometric mean property values of all samples with the 
variable, i, at its high or low value respectively (Mehdawi et al., 2009) (see Appendix 
2).  The effect of a variable was considered significant if its 95% confidence interval 
was  smaller  than  the  magnitude  of  ai  and  interaction  effects  were  small  in 
comparison.  
 
Throughout this study, error bars refer to 95 % confidence interval of the mean (CI) 
assuming CI= 1.96ￗSD/√n. In factorial analysis plots of ai error bars not crossing 
zero indicate the effect of a variable or interaction is significant.   
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5  Results  
5.1  Setting Kinetics and Final conversion 
  In table 5-1 a summary of all formulations used is provided 
 
CODE  UDMA  PPGDMA  HEMA  HEMA   
Ph 
βTCP 
  
MCP  CHX  Glass  PLR 
F1  68  25  5  0  0  0  0  100  4/1 
F2  68  25  5  0  5  5  5  85  4/1 
F3  68  25  5  0  5  5  10  80  4/1 
F4  68  25  5  0  20  20  5  55  4/1 
F5 
F6 
F7 
F8 
F9 
F10 
68 
68 
68 
68 
68 
68 
25 
25 
25 
25 
25 
25 
5 
0 
0 
0 
0 
0 
0 
5 
5 
5 
5 
5 
20 
0 
5 
5 
20 
20 
20 
0 
5 
5 
20 
20 
10 
0 
5 
10 
5 
10 
50 
100 
85 
80 
55 
50 
4/1 
4/1 
4/1 
4/1 
4/1 
4/1 
Table 5-1 Composition of experimental composites  
 
 
 
5.1.1  Conversion Profile: 
 Figure 5-1 provides example cure profiles. Polymerisation began soon after the 
light  was  turned  on  for  all  samples  (~20s  from  the  start  of  the  experiment).  116 
 
Commercial  composites  exhibited  much  lower  final  conversion  than  the 
experimental materials.    
 
 
 
Figure 5-1 Degree of monomer conversion of example experimental and commercial 
(Gradia - 3M Z250) composites.  Both commercial samples showed less than 50% 
monomer conversion while experimental samples had monomer conversions 
between 70% and 80%    
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5.1.2  Final monomer conversions  
 
In  series  one,  the  experimental  composites  final  level  of  polymerisation  was 
statistically higher (P<0.05) than commercial composites (Gradia and Z250) (Figure 
5-2). Commercial composites (Gradia and Z250) final monomer conversions were 
50 ±2% and 42 ± 3% respectively (n=5). There was no significant difference in final 
conversion between F1 with HEMA and F6 with HEMA phosphate (P<0.05) (simple 
T test).  
 
Figure 5-3 illustrates the final monomer conversion of all experimental composites. 
Results varied between 71% - 81%.  For each pair of formulations with the same 
CHX and CaP level (e.g F2  and F7) no significant effect of changing HEMA to 
HEMA phosphate was observed.   
 
Statistical analysis, however, showed that both increasing CHX and CaP caused a 
significant increase in conversion (3 and 7% respectively) with no interaction effect.  
This was for both series 2 and 3.   
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Figure 5-2 Degree of monomer conversion of experimental control composites (filled 
only with glass) and commercial composites. Errors bars shown are 95% CI, (n =5) 
 
 
Figure 5-3 Final degree of monomer conversion of all experimental composite series 
one, two and three. Errors shown are 95% CI, (n=5) 
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5.1.3  Volume shrinkage and heat generation  
 
Polymerisation reaction produces heat and increase in volume that is proportional 
to the number of reacting bonds in a given volume. PLR, final conversion, and type 
of  monomer  used  therefore  all  have  an  effect  on  the  polymerisation  heat  and 
shrinkage. Higher PLR and monomer molecular weight, or reduced final conversion, 
will decrease both. The amount of heat generated and level of shrinkage calculated 
using equations 4-6, 4-7, 4-8 and 4-9 are provided in Table 5.2. Samples which 
have high level of CHX and high CaP (F5 and F10) show higher percentage of 
volume shrinkage.  
Formulas  % 
shrinkage(V) 
(cc/g) 
Heat 
(H)(kcal/g)    HEMA  HEMA 
phosphate 
CaP  CHX 
F1  5  0  0  0  3.0  0.0752 
F2  5  0  10  5  3.2  0.0784 
F3  5  0  10  10  3.1  0.0816 
F4  5  0  40  5  3.2  0.0848 
F5  5  0  40  10  3.4  0.0912 
F6  0  5  0  0  3.0  0.0736 
F7  0  5  10  5  3.2  0.0767 
F8  0  5  10  10  3.1  0.0777 
F9  0  5  40  5  3.2  0.0818 
F10  0  5  40  10  3.3  0.0828 
Table 5-2 Calculated heat and shrinkage for all experimental composite and 
commercial product 
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5.2  Mechanical behaviour  
 It was noticed that whenever CHX was added to the mixture it made sticky which 
made it difficult to handle.  Adding the CaP had a different effect which made the 
samples more putty-like with gritty texture. 
 
5.2.1  Biaxial flexural strength  
Figure 5-4 illustrates that the biaxial flexural strength of control composites (series 
one) containing HEMA, F1, or HEMA phosphate, F6.  After 24 hours in deionised 
water, both had statistically greater strength than Z250 or Gradia (P<0.05) 
 
For a fixed level of CHX and CaP, changing from HEMA to HEMA phosphate had 
no significant effect (Figure 5-5).  Furthermore, average results on changing this 
monomer were not significantly different.  Increasing CHX and CaP, however, both 
significantly decreased strength on average by 10 and 14% respectively 
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Figure 5-4  Biaxial flexural test of control group with 5% HEMA (F1)  or 5% HEMA  
Phosphate (F6) and commercial composites after 24 hours in deionised water (series 
one). Errors bars shown are 95% CI, (n =8).  
 
 
Figure 5-5 Biaxial flexural strength after 24 hours in deionised water of series two and 
series 3 Errors bars shown are 95% CI, (n =8) 
 
5.2.1.1  Summary of biaxial strength 
Upon immersion in deionised water there was a significant decline in strength for all 
experimental materials over a week (P < 0.05) (Table 5-3). The greatest rate of 
decline, however, occurred in the first 24 hours.  
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HEMA  HEMA 
phosphate 
CaP  CHX  Dry  24 h/W  1week/W 
F1  5  0  0  0  191  ±5  182  ±3  178  ±7 
F2  5  0  10  5  182  ±7  172   ±9  164  ±4 
F3  5  0  10  10  176  ±4  164  ±8  157  ±5 
F4  5  0  40  5  170  ±8  157  ±11  143  ±6 
F5  5  0  40  10  154  ±6  136  ±9  129  ±2 
F6  0  5  0  0  194  ±7  185  ±4  176  ±3 
F7  0  5  10  5  183  ±6  175  ±12  167  ±5 
F8  0  5  10  10  173  ±2  165  ±11  159  ±6 
F9  0  5  40  5  169  ±3  155  ±12  143  ±2 
F10  0  5  40  10  158  ±8  131  ±14  124  ±3 
 
 Table 5-3 Biaxial flexure strength for series one, two and three experimental 
composites, before and following 24 h and 1 week immersion in deionised water.  The 
errors represent 95% C.I of the mean (n=8). 
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5.2.2  Biaxial flexural modulus 
In Figure 5-6 elastic modulus of the control samples are provided. Statistically, there 
were no  significant differences comparing F1  or F6  with commercial composites  or 
each other.  
 
In  series  two  and  three  (Figure  5-7),  only  F5  with  both  high  CHX  and  CaP  has  a 
significantly lower modulus than the control F1.  Additionally in series three only F10 is 
significantly different from the control F6 (P< 0.05) 
 
 
 
Figure 5-6 Elastic Modulus on control group without reactive filler with 4:1 PLR, 80% 
glass 5% HEMA,5% HEMA  Phosphate  experimental composite and commercial 
composite after 24 hours in deionised water ( series one). Errors bars shown are 95% CI, 
(n =8). 124 
 
   
Figure 5-7  Elastic modulus of series 2 after 24 hours in deionised water. Errors bars 
shown are 95% CI, (n =8). 
  
5.2.3  Toughness  
 
In  series  one  (Figure  5-8),  both  commercial  composite  (Gradia  and  Z250)  had  not 
shown any significant higher resistance to fracture than the experimental control group 
F1 and F6  
 
 The CaP content had the largest effect on the fracture behaviour of the material and 
toughness.  More  CaP  led  to  a  less  brittle  failure  mode.  Figure  5-9  explains  the 
difference in the fracture behaviour of the low and high level of CaP, in series two and 
three. As the low CaP content formulations behave in a brittle manner at failure, the 
ability to carry load drops off suddenly as the material cracks. In contrast, the high level 
of  CaP  results  in  a  non-brittle  failure.  However,  this  effect  was  statistically  not 
significant, as both CaP and CHX have no effect on toughness  125 
 
 
 
Figure 5-8 Toughness on control group without reactive filler with 4:1 PLR, 80% glass 5% 
HEMA,5% HEMA  Phosphate  experimental composite and commercial composite after 
24 hours in deionised water ( series one). Errors bars shown are 95% CI, (n =8). 126 
 
  
 
Figure 5-9 Samples with low CaP as (a) showed less area under the curve while samples 
with high CaP (b) showed larger area under the curve 
 
a 
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Figure 5-10 Effect of 5% HEMA, 5%, 10% CHX and 10%, 40% CaP( series two) on 
toughness after 24 hours in deionised water  Errors bars shown are 95% CI, (n =8). 
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5.2.4  Modulus of resilience 
With the  control group (Figure 5-11); there were no significant differences  between 
commercial and experimental composite modulus of resilience (F1, F6).  Furthermore, 
factorial analysis showed interaction effects were larger than any effect of a variable.  
 
      
Figure 5-11  Resilience of control group without reactive filler with 4:1 PLR, 80% glass 
5% HEMA,5% HEMA  Phosphate  experimental composite and commercial composite 
after 24 hours in deionised water ( series one). Errors bars shown are 95% CI, (n =8). 
      
Figure 5-12 Effect of 5% HEMA, 5%, 10% CHX and 10%, 40% CaP on resilience. Errors 
bars shown are 95% CI, (n =8). 
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5.3  Chlorhexidine Release   
 
Specimens were placed in distilled water.  Storage solutions were analysed using UV 
spectroscopy, after 2, 4, 6, 24 hours, 48 hours, one week, two weeks, 3 weeks and 4 
weeks. 
 
5.3.1  Chlorhexidine in water 
Cumulative CHX release was linear to the square root of time as expected with minor 
burst release in the first hours (Figure 5-13). Release rate therefore decreases with 
time.  At week one, CHX release from F5 and F10 were 1.2 and 1.6 % respectively.  At 
4 weeks these numbers increased to 5.1 % and 7.2 % respectively (Figure 5-13)   
 
Changing  HEMA  to  HEMA  phosphate,  increasing  CHX  and  increasing  CaP  all 
significantly enhanced CHX percentage release.  Interaction effects were insignificant 
(Figure 5-14). 
 
 
Figure 5-13 Chlorhexidine release into  distilled water  as a function of the square root of 
time/hours (SQRT) for composites F5 and F10 with 4:1 PLR, 40% wt CaP, 10% wt CHX. 
Errors bars shown are 95% CI, (n =5). 
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Figure 5-14 Final Chlorhexidine release in 4 weeks into distilled water 10ml with 4:1 PLR, 
5% HEMA, 5%HEMA phosphate, 10%, 40%wt CaP, 5%, 10%wt CHX with experimental 
composite. Errors bars shown are 95% CI, (n =5) 132 
 
5.4  Mass change: 
Specimens were placed in distilled water and mass determined at after 2, 4, 6, 24 
hours,  48  hours,  one  week,  two  weeks,  3  weeks  and  4  weeks.  Cumulative  mass 
increase was linear to the square root of time as expected for a little burst increase in 
the first hours for both F10 and F5 (Figure 5-15). Increase rate decreases with time.  
Initial  burst  release  (24hrs)  was  0.6  %  for  both  samples.  At  week  one,  F5  or  F10 
increased  in  the  mass  by  2.5  or  2.6  %  respectively.    At  4  weeks  these  numbers 
increased to 3.6 % and 3.9 % respectively (Figure 5-15) 
 
 
Figure 5-15 Samples mass change into  distilled water  as a function of the square root of 
time/hours (SQRT) for composites F5 and F10 with 4:1 PLR, 40% wt CaP, 10% wt CHX. 
Errors bars shown are 95% CI, (n =5). 
 
 
 
5.4.1  Final mass change  
Figure 5-16 shows maximum mass increase obtained by each experimental composite. 
These ranged from 1.2 % to 3.9 %. Changing HEMA to HEMA phosphate, increasing 133 
 
CHX  and  increasing  CaP  all  significantly  increased  final  mass.    Factorial  analysis 
demonstrated that the CaP had the biggest effect.  
 
 
 
Figure 5-16 Final mass changes  in 4 weeks  into distilled water 10ml as a function of the 
square root of time (SQRT) with 4:1 PLR, 5% HEMA, 5%HEMA phosphate, 10%, 40% wt 
CaP, 5%, 10% wt CHX with experimental composite. Error bars shown are 95% CI, (n =5  
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5.5  Microstructure study of experimental composite 
 
The  top  and  fracture  surface  microstructure  of  the  cured  composite  was  observed 
under a scanning electron microscope (SEM) at different magnifications. Specimens 
were  scanned  dry  and  after  being  immersed  in  deionised  water  for  different  time 
periods.  
5.5.1  Dry specimen (surface) 
 
 
Figure 5-17  Scanning Electronic imaging of dry specimen (surface) with 4:1 PLR, 5% 
HEMA  , 40% wt CaP, 10% wt CHX (F5) 
 
 
In Figure 5-17 and 5-18 the surface and core of composite (F5) at x200 magnification 
showed  a  homogenous  surface  with  small  areas  of  porosity  and  voids.  This  was 
characteristic of all dry samples (featureless).  135 
 
 
5.5.2  Dry specimen (Core composite) 
 
 
 
Figure 5-18  Scanning Electronic imaging of dry  specimen (fractured) with 4:1 PLR, 5% 
HEMA  , 40% wt CaP, 10% wt CHX (F5) 
 
 
5.5.3  Water specimen (7 and 14 days) 
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Figure 5-19 SEM image after 7 days in  deionised water   with 4:1 PLR, 5% HEMA , 40% wt 
CaP, 10% wt CHX with experimental composite 
 
 
After placement in water samples F1-F4 and F6-F9 had no obvious new features by 
SEM.   With F5 and F10, however, surfaces were largely covered by layers of spheres 
which  looks  like  hydroxyapatite  balls  of  between  0.1  µm  -1µm  diameter  (see  for 
example Figure 5-19). These features were more extensive at 14 days (Figure 5-20) 
compared with at 7 days.  Additionally at 14 days some needle – like crystals could 
also be observed on these samples. 137 
 
             
           
Figure 5-20 SEM image 14 days in  deionised water with 4:1 PLR, 5% HEMA , 40% wt CaP, 
10% wt  CHX with experimental composite. This image shows layers of sharp crystals 
that could be Brushite and early formation of what looks like HA in (a) surface and (b) 
higher magnification of fractured composite  
 
After 14 days in deionised water, the sample showed thicker layer of what looks like 
HA with more nucleation. In addition, this sample showed more homogeneous texture 
of formation of HA in some areas. Furthermore, it showed the characteristics of small 
crystals (needle – like appearance) of what looks like brushite (Figure 5-20) 
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6  Discussion  
6.1  Degree of Conversion  
 
The degree of conversion is a fundamental characteristic that affects the performance 
of  resin  based  restorative  materials.      The  physical,  mechanical  and  biological 
properties of these materials generally improve with increasing degree of monomer 
conversion (Demarco et al., 2012; Rho et al., 2013). Studies have reported that the 
higher the physical and mechanical properties the less probability of material failure 
under  masticatory  loads.  They  also  improve  the  efficiency  of  bonding  at 
tooth/restoration  interface,  hence  lowering  the  risk  of  bacterial  microleakage  and 
recurrent caries (Kidd 1976, Blazic et al., 2004; Gomec et al., 2005) 
 
Furthermore, higher degree of conversion can substantially reduce the possibility of 
cytotoxic  effects  upon  release  of  unreacted  monomers  which  subsequently  lead  to 
post-operative hypersensitivity (Goldberg 2008; Tseng et al., 2007). In addition, the 
degree of monomer polymerisation could have an impact on the release of reactive 
fillers (Skrtic and Antonucci 2007); the higher the polymerisation, the lower the drug 
release obtained. This may be linked to the higher crosslinking  with high monomer 
conversion (Moszner et al., 2005).  
 
According to the literature reviews, both direct and indirect techniques have been used 
in measuring the degree of monomer polymerisation. Microhardness for example, has 
been used widely as an indirect measurement of the degree of monomer conversion 
(Santini et al., 2012; Sebra et al., 2007). Indirect assessment has also been carried out 
using  differential  thermal  calorimetry  (DTC)  (Sebra  et  al.,  2007),  and  differential 
scanning calorimetry (DSC) (Atai et al. 2007; Viljanen et al., 2007), However, these 
techniques measure relative  polymerisation rate rather than the absolute  degree of 141 
 
conversion.  In  contrast,  NMR,  Fourier  transform  infrared  (FTIR)  and  Raman 
spectroscopies  have  been  commonly  applied  for  direct  quantification  of  monomer 
conversion  measurement  and  degree  of  polymerisation  (Ilie  et  al.,  2013;  Richard-
Lacroix and Pellerin 2013; Wang and Spencer 2003) 
 
In  this  study,  high  monomer  conversion  was  obtained  (Figure  5-3)  due  to  high 
monomer flexibility. Average final conversion of experimental composite was as high 
as 72-82% compared to Z250 and Gradia which only had 50 ±2, 46 ± 3 respectively. 
This could prevent the leakage of monomer into the underlying pulp tissues and reduce 
hypersensitivity  reactions  or  inflammation.  Moreover,  composite  with  high  monomer 
conversion usually has better mechanical strength (Palin et al., 2003). Furthermore, 
degree of monomer conversion could have an impact on release kinetics of bioactive 
substances  (e.g:  CHX  as  in  this  study),  as  resin  permeability  and  water  sorption 
generally decrease upon raising the degree of conversion  (Braga  et  al.,  2005a). In 
contrast, Z250 had low monomer conversion while still maintained a good quality of 
mechanical properties.  This could be due to the monomer type, which is the key in 
determining the final possible level of conversion. UDMA is less rigid and more flexible 
than Bis-GMA which is the main bulk in the monomer of Z250.  This lowers the glass 
transition temperature (Tg) for better handling and high conversion with more cross-
linked polymer at a given temperature. On the other hand, Gradia’s main monomer is 
UDMA which is the main bulk of experimental composite in this study with the addition 
of  silica  prepolymerised  filler  (Watanabe  et  al.,  2008).  Despite  of  the  similarity  of 
monomers between experimental composite and Gradia, experimental composite has 
higher monomer conversion. This could be due to the addition of the diluent monomer 
PPGDMA and HEMA to the composite.   
 
 In general, the reaction is initiated by light-activated break down of the CQ into free 
radicals  that  are  stabilised  by  the  DMPT.  These  initiate  the  formation  of  monomer 142 
 
radicals and a chain reaction. The reaction is terminated when free radicals combine. 
Once  the  light  source  is  removed,  free  radicals  are  no  longer  generated  and  the 
termination step causes the reaction to slow. Previous results suggest that CHX may 
stabilise the free radicals slowing the  termination step.  This  was  explained by the 
presence  of  amine  groups  which  as  in  DMPT  (Leung  et  al.,  2005;Mehdawi  et  al., 
2013).  Addition  of  PPGDMA  and  UDMA  leads  to  crosslinked  structures  that  may 
reduce  molecular  diffusion  rates,  slowing  in  particular  the  termination  step  thereby 
enhancing the overall reaction rate (Elliott et al., 2001;Sharifi et al., 2008). 
 
In contrast, it was clear adding chlohexidine to the formulations will increase the level 
of polymerisations by (10-14) as it was reported in previous study (Leung et al., 2005) 
 
In  this  study,  there  were  no  significant  effects  of  HEMA  and  HEMA  phosphate  on 
degree of conversion as both series showed comparable results and there were no 
significant differences  
 
6.2  Mechanical Behaviour 
 
One of the aims in this study was to improve the quality of adhesive restoration without 
compromising the mechanical properties to withstand the stresses of the masticatory 
forces  or  residual  internal  stresses  which  occur  during  curing  (Heo  et  al.  2013; 
Karmaker et al., 2007; Oliveira et al., 2012)  
 
According  to  the  International  organisation  of  standardisation  (ISO)  ISO4049:2009 
recommendations,  strength  should  be  evaluated  using  a  three-  point  bending  test 
(uniaxial flexure strength)  (Chung, Yap, Chandra,  & Lim 2004;Ikejima et  al.,  2003). 
However,  in  this  study  biaxial  strength  has  been  used.    This  test  offers  many 143 
 
advantages over the three-point bending test.  The former test requires preparation of 
samples of large dimensions (25×2×2 mm
3) and therefore, multiple curing with small 
light sources.  This leads to samples with inhomogeneous polymerisation and therefore 
enhanced variability of the observed results (Yamazaki et al., 2008) (Van  et al., 2007). 
In addition, the test is sensitive to the presence of flaws at the edges of samples.  
These flaws are unavoidable, in specimens with such large dimensions.  The biaxial 
flexure strength test however, requires preparation of smaller sample size that could be 
cured in a single curing step.  Furthermore, the test results are less dependent upon 
presence of flaws (Jivraj et al., 2006). 
 
 In the present study, the mechanical properties of the newly developed formulations 
were  further  evaluated  using  biaxial  flexural  strength,  toughness  and  modulus  of 
resilience.  This  has  previously  been  used  with  resin  based  restorative  materials 
(Hatton et al., 2006; Tyas 2006)    
 
For better understanding of the effect of reactive calcium phosphate fillers and CHX on 
the mechanical properties, series one formulations were studied without any reactive 
filler.  In series two and three, reactive fillers were added. 
 
To  enhance  the  mechanical  properties  of  new  generations  of  composite,  different 
researchers  have  focused  on  silanisation  of  fillers  (Wasson  and  Nicholson  1993) 
changing filler fraction and particles size and shape, a heat treatment, incorporation of 
fibers (Knight 1994;Tyas et al., 1989), nanoparticles (Ikejima et al., 2007) and ceramic 
whiskers (Firoozmand et al., 2013; Bowen 1963; Xu et al., 2002).  Recently, addition of 
silica that has been fused onto silicon carbide or silicon nitride whiskers, was found to 
enhance mechanical properties whilst maintaining the ion release activity of calcium 
phosphate based dental composites (Xu et al., 2002; Xu and Quinn 2001). The silica 
nanoparticles were fused to the whiskers through heat treatment.  This was mainly to 144 
 
facilitate their silanisation and retention in the resin matrix phase and thereby increase 
the mechanical properties of the composite. 
 
In the present study, unreactive fillers are defined here as silica based materials that 
are largely biologically inert. The silane coupling agent used has one functional group 
that can adhere to the glass surface and a methacrylate group that can polymerise with 
the monomer. This provides a chemical bond between the polymer and filler phases in 
the  cured  material  allowing  loads  to  be  transferred  between  the  two  phases  – 
improving the strength of the composite (Yoshida et al., 2002) 
 
In current study there was a significant increase in biaxial strength of experimental 
composite  comparing  with  commercial  composite.  This  might  be  explained  by  the 
presence of the dilutent monomer PPGDMA and high level of conversion. 
 
All  the  studied  formulations  additionally  exhibited  a  much  greater  decline  in  biaxial 
flexure strength after 24 h of immersion in  distilled  water  (see table 5-3).  This is 
presumably  due  to  the  soluble  MCPM  encouraging  high  water  sorption,  which  is 
considered a key factor reducing composite mechanical properties (Ortengren et al., 
2000). This occurs via plasticisation and disruption of the polymer matrix (Abou Neel et 
al., 2010; Mehdawi et al., 2013; Regnault et al., 2008).  Filler release arising upon 
water sorption will also, however, be a contributory factor causing decline in strength 
(Mehdawi et al., 2013). The lack of further deterioration in strength between 24 h and 
one week of water immersion is likely due to both  cessation of water sorption and 
substantial  reduction  in  calcium  phosphate  release  rate  during  this  period.  
Furthermore, the formation of brushite potentially binds water and reduces the amount 
of free water that could plasticize the polymer network.   
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The ability of a notched specimen to resist fracture and crack propagation is defined as 
fracture toughness. Thus, the fracture toughness has become an important criterion in 
dental materials longevity (Watanabe et al., 2008). Fracture toughness is a function of 
several factors including crosslink density, materials homogeneity, network flexibility, 
molecular  weight  and  free  volume.  Fracture  is  a  component  in  the  previously 
mentioned modes of failure. These values are dependent on the physical properties 
and chemical composition of the individual components of the restorative material (Kim 
et al., 2000). A material which has high fracture toughness has the ability to better 
resist  crack  initiation  and  propagation.  Thus,  the  property  of  fracture  toughness 
becomes one of the highest recommendations in resin restoration (Kim and Okuno 
2002).  
 
Identifying the types of forces that can cause a crack is crucial to the understanding of 
fracture mechanics. A force or load may lead to the development of a crack and this is 
described, in engineering terms, in three modes: Mode I is an opening mode, Mode II 
is the sliding mode, and Mode III is the shearing mode (Watanabe et al., 2008). What 
were concerned about in this experiment were Mode I and Mode II as they are related 
to dental materials. 
One of the down sides of this study was not using the glass fibers as it has reported in 
several  studies  previously,  the  benefits  of adding glass  fibres  over  using the glass 
alone in composite preparation (Asakawa et al., 2013; Chong et al., 2007; Kim et al., 
2011; Rashidan et al., 2010). However, initially the idea in the current study was not to 
use the fibre glass and count on formulas contained high CaP%. Assuming the addition 
of CaP to the experimental composite will increase the volume surface in particular β-
TCP (Lopes 1998), which should create residual stresses. This will lead to a possible 
compressive stresses field around crack tip occurred and extra energy will be required 
to  extend  the  crack,  leading  to  the  higher  fracture  toughness  of  the  composites 146 
 
compared to other composite without CaP reactive fillers (Lopes 1999). But this result 
was not significant in this current study.    
 
6.3  Chlorhexidine Release  
 
Increasing CaP filler mass fraction substantially enhanced the release of chlorhexidine 
(Figure 5-14).  This could be attributed to higher water sorption upon raising filler wt%. 
Despite the fact that most of the water has been absorbed in the first 24 hours, the 
release of this drug also continued for several weeks. Brushite crystals and blades 
structure  were  formed  and  precipitated  as  it  shown  in  SEM  images.   A  possible 
explanation is that precipitation of brushite gives a composite structure with channels 
through the polymer that allow drug diffusion.  
  
Early release of chlorhexidine from the experimental composite in both series (two and 
three) was proportional to the square root of time as expected for a diffusion-controlled 
process (see Figure 5-13 ), but with time, the amount of CHX released was less. This 
could be possibly because of drug being trapped in the centre bulk of the materials 
(Leung et al., 2005).  In this study, chlorhexidine release had limited effect on mass 
changes because its percentage mass is relatively low and it is likely to be replaced in 
the bulk of the material by water of similar density.  
 
In comparison, several studies with chlorhexidine releasing composite (Leung et al., 
2005;  Pallan  et  al.,  2012;  Tirali  et  al.,  2013)  showed  comparable  results  with  the 
current experimental formulations. It showed less amount of percentage release than 
expected,  this  was between 2.5  wt%  and 7.1 wt%  in accumulative average in four 
weeks (see figure 5-13). This could be explained by the high level of polymerisation, 
which did not enhance drug release. Furthermore, there was one study which reported 147 
 
the correlation between HEMA and CHX release increase  (Leung et al., 2005). On 
raising HEMA content in the Leung study, water sorption increased, which increased 
CHX  release.  However,  in  current  study  only  5  wt%  of  HEMA  was  used,  but  high 
amount Calcium Phosphate was introduced, but this substantially decreases composite 
strength.    In  other  study  (Mehdawi  et  al.,  2009),  the  addition  of  reactive  calcium 
phosphate fillers rather than increasing HEMA content could be a more appropriate 
approach to encourage chlorhexidine release from matrix resins, particularly with the 
remineralisation benefits of the calcium phosphate filler, which is relevant to what have 
been done in current study. 
 
 As  with  ion  release  (see  above),  formulations  with  higher  water  sorption  exhibited 
faster  chlorhexidine  release.    Increased  release  of  chlorhexidine  from  methacrylate 
based polymers has also previously been observed upon raising resin hydrophilicity 
(Huang et al., 2002; Leung et al., 2005; Mehdawi et al., 2009).  
 
Fast early release of chlorhexidine is important to eliminate residual bacteria and/or 
early  colonisation  of  the  gaps  between  a  tooth  and  restoration  and  this  could  be 
particularly useful if the drug can then be trapped within such gaps.  In addition, the 
release of chlorhexidine from new composite formulations could potentially maintain 
the  durability  of  bond  strength  through  interfering  with  endogenous  enzymatic 
degradation of the hybrid layer (Hashimoto et al., 2000; Hebling et al., 2005). 
Finally, replacing HEMA with HEMA phosphate in series three had increased the CHX 
release as it was significant difference this could be contributed to high water sorbtion 
with HEMA phosphate  which will eventually enhance release. The break down into 
phosphoric acid could cause the greater water sorption.  
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6.4  Mass change 
 
 It is well known that resin based materials have high a potential water sorption upon 
immersion in aqueous medium.  In conventional materials this property is controlled 
predominantly by the resin phase (Boaro et al., 2013; Sideridou et al. 2004).  When 
water  is  absorbed  into the material  structure,  it  can  induce  various  changes  in  the 
physico-chemical, mechanical and biological properties. On water sorption, the resin 
based  restorative  materials  will  release  unreacted  monomers,  which  could  induce 
cytotoxic  effects  (Reichl  et  al.,  2006)  and  promote  growth  of  cariogenic  bacteria.  
Furthermore,  water  sorption,  if  excessive,  can  lead  to  plasticization  and  hydrolytic 
degradation and a decline in the mechanical properties (Braga et al., 2005; Ferracane 
2006)  
 
The  adhesive  formulations  in  the  present  study  were  developed  primarily  for  tooth 
restoration. Evaluation of their behaviour in a wet environment was therefore extremely 
important.  In addition, through water sorption studies, it was possible to understand 
better the chemical, mechanical and antibacterial properties of various formulations. 
 
The mass change was measured using Archimedes’ principle, which is a commonly 
applied method (Ruttermann et al., 2007; Ruttermann et al., 2011). The ISO standards 
4049  for  assessment  of  resin  based  restorative  materials  indicate  that,  for  water 
sorption studies the samples should be of 1 mm thickness and 15 mm diameter. To 
cure samples with such diameter, an overlapping light is required, which prolongs the 
required  time  of  light  exposure.    In  the  current  study,  however,  samples  of  1  mm 
thickness and 10 mm diameter were used, which was closer to the diameter to the light 
tip  (8  mm).  They  could  therefore  be  cured  in  a  single  step.    The  time  of  storage 
according to ISO standards 4049 is one week compared with 4 weeks in the present 
study.  The prolonged period was considered important to study because all studied 149 
 
formulations  had  hydrophilic  elements,  which  could  encourage  water  sorption,  and 
associated changes over a more prolonged period. 
The mass increase in all studied formulations was mainly controlled by the reactive 
calcium phosphate (MCPM/β-TCP) filler content, followed by the chemical structure of 
the resin matrix.  On increasing of reactive filler mass fraction both mass and volume 
increases  were  substantially  enhanced  and  by  adding  hydrophilic  monomers  wt% 
HEMA/ HEMA phosphate subsequently will increase the drug release. 
 
The maximum mass increase was faster and greater in samples which had 40% wt 
CaP due to higher water sorption. Despite, using two different hydrophilic monomers, 
there were significance differences in both series two and three (see Figure5-19). On 
the other hand, samples which had 10% wt Cap declined approximately by 5% in both 
series.  
 
In a previous study, the average maximum mass increase was mainly affected by the 
percentage  of  CaP  with  decreasing  the  MCPM  level  having  a  greater  effect  than 
increasing the HEMA content (Mehdawi et al., 2009)  
 
Water sorption can induce mass expansion in the material, which with some restoration 
materials may have a benefit in reducing gaps at tooth/restoration interfaces that arise 
upon polymerisation shrinkage (Braga et al., 2005; Oliveira et al., 2012).  Furthermore, 
the expansion could relieve the stress created by polymerisation shrinkage; thereby 
help maintain the integrity of the tooth/restoration interface.  Therefore, the volumetric 
expansion could play an important role in lowering the risk of bacterial microleakage, 
recurrent caries and enhance longevity of the restoration. As this is one of the aims in 
this study,   however, excessive mass expansion could result in cracking and fractures 
of weakened tooth structures.  Expansion of some formulations in this study might be 
considered excessive comparing it with ISO. 150 
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6.5    Microstructure study (Scanning electronic microscope ) 
 
The  gap  following  leakage  at  tooth  restoration  interfaces  could  be  exposed  to  a 
continuous de- and re-mineralisation process (Gao et al., 2001). The acid production 
by  cariogenic  bacteria  can  diffuse  to  tooth  tissue,  resulting  in  the  partial 
demineralisation of tooth structure. If the rate of demineralisation is higher than the rate 
of remineralisation, the net result is the gradual loss of mineral content that will lead to 
an  irreversible  carious  cavity  (Aoba  2004).  On  the  contrary,  if  the  rate  of 
remineralisation or crystal growth exceeds the rate of mineral loss, the demineralised 
tooth  structure  can  be  retained  with  the  re-precipitation  of  mineral  contents 
(Featherstone, 2004a, 2009). 
 
It  is  generally  accepted  that  the  precipitation  of  calcium  phosphate  compounds  in 
aqueous solutions mainly include dicalcium phosphate dihydrate (DCPD or brushite), 
octacalcuim  phosphate  (OCP)  and  hydroxyapatite  (HA)  (Koutsoukos  and 
Nancollas1981;  Zapant  1981;  Lu  and  Leng,  2005).  HA  is  considered  the  most 
thermodynamically stable in physiological environment while OCP and DCPD have 
been  regarded  as  the  precursors  of  HA.  However,  DCPD  precipitation  rate  is  the 
highest among the calcium phosphate phases (Aoba, 2004). 
 
The limitation of this study was that the amount of HA formation on the surface of the 
various dental composite formulations was not analysed or confirmed by Raman and 
EDX. However, in previous published data Raman spectra were used to determine the 
phosphate peak and confirmed the precipitation of calcium phosphate ions on similar 
materials to this study (Piyaphong Panpisut, 2013)  
 
The  surface  of  composite  showed  signs  of  early  formation  of  what  looked  like 
hydroxyapatite. This is an unexpected finding as samples were stored in deionized 152 
 
water only.  In  previous studies  the same features  were seen  after storage in body 
stimulated fluid (BSF) (Han et al., 2013;Li et al., 2006). The surface of composite (F5) 
showed the characteristics of small crystals (needle – like appearance) (see Figure 5-
22). This is expected finding as increased acidity will lead to form brushite cement 
(Baroud et al., 2006;Bohner 2000)  
 
When comparing the SEM images of each formulation, it was apparent that very few 
precipitations were seen in F2, F3, F4, F7, F8, and F9, while, F5 and F10 showed 
higher precipitation. A possible explanation for this might be that MCPM/TCP promotes 
water sorption into the dental composite, thus enhancing the release of ions. Moreover, 
the CHX released on the surface may also enhance the HA crystallisation process. 
Future studies for this investigation are therefore recommended. 
 
Formation of HA on composite surface will enhance the remineralisation phenomena 
and  therefore  formation  of  reparative  dentine  and  subsequently  may  decrease  the 
sensitivity and microleakage  
   153 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Chapter Seven: Conclusion & 
further work 
   154 
 
7  Conclusion  
Novel  CHX-releasing  calcium  phosphate-filled  methacrylate-based  dental  materials 
have been developed that could be used as a permanent filling in paediatric dentistry 
with high monomer conversion. These new formulations have high degree of monomer 
conversion, high strength that is suitable for several clinical applications. Through the 
addition  of  MCPM,  water  sorption  by  the  polymerised  materials  is  encouraged, 
increasing CHX release. Brushite formation within the polymer is encouraged through 
the further addition of β-TCP, providing a novel means to control water sorption and ion 
release.  MCPM  and  β-TCP  are  precipitated  within  24  h  after  placement  of  the 
polymerised  formulations  in  water,  which  could  be  advantageous  for  early  dentine 
remineralisation. This calcium phosphate was observed to re-precipitate as a mixture 
of brushite and hydroxyapatite on the material surface and fracture line. The level of 
calcium phosphate release required for remineralisation processes would depend upon 
the thickness of the demineralized dentine layers but could be increased by raising the 
amount  of  excess  MCPM,  e.g.  by  increasing  the  calcium  phosphate,  CHX  release 
increased, as it was reported in previous study, it inhibited the bacteria formation on 
both agar plates and in biofilms (Leung et al., 2005; Mehdawi et al., 2009; Mehdawi et 
al., 2013) using an in vitro model for assessment of cell compatibility. 
 
In  conclusion,  experimental  composites  containing  antibacterial,  remineralising  and 
adhesion promoting components have been produced with higher flexural strengths 
and higher monomer conversion than commercial materials. 
 
7.1  Further work  
7.1.1  Adhesion properties of HEMA and HEMA phosphate: 
 155 
 
Adhesion between the tooth and the composite is very important. Adhesion properties 
of HEMA, HEMA phosphate will be assessed through push out test. Increase adhesive 
properties of the composite will prevent the leakage of composite and will ensure good 
bonding with the dentine 
 
7.1.2  Antibacterial studies: 
 
Antibacterial release of different antimicrobial will be assessed through UV and HPLC. 
Subsequently  effectiveness  of  antibacterial  CHX  will  be  studies  through  various 
techniques of microbiology (such as MIC, agar diffusion test, etc.) the ability of CHX to 
be trapped under restoration  
 
7.1.3  Cell compatibility of CHX: 
 
Effect  of  CHX  on  odontoblast  will  be  assessed  through  cell  compatibility  test  and 
compared with other commercial composite 
 
7.1.4  Mechanical Properties: 
 
The  formulations  being  developed  in  this  project  require  further  assessment  of 
mechanical  properties  for  more  prolonged  time.    In  addition,  other  mechanical 
properties  such  as  modulus  of  elasticity  and  surface  hardness  should  also  be 
evaluated.  Furthermore, alternative approaches to improve the mechanical properties 
could be tried (e.g.:  incorporation of glass fibres or addition of strontium compound). 
Increase toughness of the material is desirable in bone as it will not allow the material 
to break abruptly and even if small cracks appear, it can heal or the gap will be filled 
with remineralising CaP. Surface topography with and without fracture will be assessed 156 
 
through SEM and Raman at different time period in different solution. 
 
7.1.5  Shelf life of the monomer mixtures: 
 
Monomer  mixture  will  be  assessed  for  cure  profile  at  different  period  of  time  and 
temperature, thus giving us an idea of the stability of the monomer mixture at different 
time and temperature, particularly the HEMA phosphate 
 
7.1.6  Microstructure study of experimental composite 
 
Further  studies  needs  to  be  done  using  Raman  to  prove  the  formation  of 
hydroxyapatite in composite surface  
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9  Appendix 1 
9.1  Statistical analysis  
9.1.1  Univariate Analysis of Variance for polymerisation (FTIR) 
HEMA = HEMA 
Between-Subjects Factors
a 
  Value Label  N 
CHX_low_high 
0  CHX low  10 
1  CHX high  10 
CaP_low_high 
0  CaP low  10 
1  CaP high  10 
 
a. HEMA = HEMA 
 
Tests of Between-Subjects Effects
a 
Dependent Variable:   FTIR   
Source  Type III Sum 
of Squares 
df  Mean 
Square 
F  Sig. 
Corrected Model  136.200
b  3  45.400  8.486  .001 
Intercept 
121992.200  1  121992.200  22802.28
0 
.000 
CHX_low_high  39.200  1  39.200  7.327  .016 
CaP_low_high  39.200  1  39.200  7.327  .016 
CHX_low_high  * 
CaP_low_high 
57.800  1  57.800  10.804  .005 
Error 
85.600  16  5.350    
Total 
122214.000  20      
Corrected Total 
221.800  19      
 
a. HEMA = HEMA 
b. R Squared = .614 (Adjusted R Squared = .542) 
 
HEMA = HEMA P 178 
 
 
Between-Subjects Factors
a 
  Value Label  N 
CHX_low_high 
0  CHX low  10 
1  CHX high  10 
CaP_low_high 
0  CaP low  10 
1  CaP high  10 
 
a. HEMA = HEMA P 
 
 
Tests of Between-Subjects Effects
a 
Dependent Variable:   FTIR   
Source  Type III Sum 
of Squares 
df  Mean Square  F  Sig. 
Corrected Model  117.200
b  3  39.067  19.533  .000 
Intercept  124188.800  1  124188.800  62094.400  .000 
CHX_low_high  88.200  1  88.200  44.100  .000 
CaP_low_high  16.200  1  16.200  8.100  .012 
CHX_low_high  * 
CaP_low_high 
12.800  1  12.800  6.400  .022 
Error 
32.000  16  2.000    
Total 
124338.000  20      
Corrected Total 
149.200  19      
 
a. HEMA = HEMA P 
b. R Squared = .786 (Adjusted R Squared = .745) 
 
 
 
T-Test 
HEMA = HEMA P 
Group Statistics
a 179 
 
  Formula  N  Mean  Std. Deviation  Std. Error Mean 
FTIR 
8.0  8  14.000  3.7796  1.3363 
10.0  8  18.625  2.1339  .7545 
 
a. HEMA = HEMA P 
 
Independent Samples Test
a 
  Levene's Test for Equality 
of Variances 
t-test for Equality 
of Means 
F  Sig.  t  df 
FTIR 
Equal variances assumed  .991  .336  -3.014  14 
Equal  variances  not 
assumed 
    -3.014  11.051 
 
Independent Samples Test
a 
  t-test for Equality of Means 
Sig. (2-
tailed) 
Mean 
Difference 
Std. Error 
Difference 
FTIR 
Equal variances assumed  .009  -4.6250  1.5346 
Equal  variances  not 
assumed 
.012  -4.6250  1.5346 
 
Independent Samples Test
a 
  t-test for Equality of Means 
95% Confidence Interval of the 
Difference 
Lower  Upper 
FTIR 
Equal variances assumed  -7.9163  -1.3337 
Equal variances not assumed  -8.0007  -1.2493 
 
a. HEMA = HEMA P 
 
T-Test 
 
HEMA = HEMA P 180 
 
 
Group Statistics
a 
  Formula  N  Mean  Std. Deviation  Std. Error Mean 
FTIR 
7.0  8  19.038  3.7842  1.3379 
9.0  8  15.250  2.3755  .8399 
 
a. HEMA = HEMA P 
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Independent Samples Test
a 
  Levene's Test for 
Equality of 
Variances 
t-test for 
Equality of 
Means 
F  Sig.  t  df 
FTIR 
Equal  variances 
assumed 
2.383  .145  2.398  14 
Equal  variances 
not assumed 
    2.398  11.77
5 
 
Independent Samples Test
a 
  t-test for Equality of Means 
Sig. (2-
tailed) 
Mean 
Difference 
Std. Error 
Difference 
FTIR 
Equal  variances 
assumed 
.031  3.7875  1.5797 
Equal  variances  not 
assumed 
.034  3.7875  1.5797 
 
Independent Samples Test
a 
  t-test for Equality of Means 
95% Confidence Interval of 
the Difference 
Lower  Upper 
FTIR 
Equal variances assumed  .3995  7.1755 
Equal  variances  not 
assumed 
.3384  7.2366 
 
a. HEMA = HEMA P 
 
T-Test 
 
HEMA = HEMA 
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Group Statistics
a 
  Formula  N  Mean  Std. Deviation  Std. Error Mean 
FTIR 
3.0  8  14.250  3.2842  1.1611 
5.0  8  16.350  2.8998  1.0252 
 
a. HEMA = HEMA 
 
 
Independent Samples Test
a 
  Levene's Test for 
Equality of Variances 
t-test for 
Equality of 
Means 
F  Sig.  t  df 
FTIR 
Equal  variances 
assumed 
.145  .709  -1.356  14 
Equal  variances  not 
assumed 
    -1.356  13.78
9 
 
Independent Samples Test
a 
  t-test for Equality of Means 
Sig. (2-
tailed) 
Mean 
Difference 
Std. Error 
Difference 
FTIR 
Equal  variances 
assumed 
.197  -2.1000  1.5490 
Equal  variances  not 
assumed 
.197  -2.1000  1.5490 
 
Independent Samples Test
a 
  t-test for Equality of Means 
95% Confidence Interval of the 
Difference 
Lower  Upper 
FTIR 
Equal variances assumed  -5.4222  1.2222 
Equal variances not assumed  -5.4270  1.2270 
 
a. HEMA = HEMA 183 
 
 
T-Test 
HEMA = HEMA 
Group Statistics
a 
  Formula  N  Mean  Std. Deviation  Std. Error Mean 
FTIR 
2.0  8  15.088  3.6651  1.2958 
4.0  8  15.750  1.9086  .6748 
 
a. HEMA = HEMA 
 
Independent Samples Test
a 
  Levene's Test for Equality 
of Variances 
t-test for Equality 
of Means 
F  Sig.  t  df 
FTIR 
Equal variances assumed  5.110  .040  -.453  14 
Equal  variances  not 
assumed 
    -.453  10.537 
 
Independent Samples Test
a 
  t-test for Equality of Means 
Sig. (2-
tailed) 
Mean 
Difference 
Std. Error 
Difference 
FTIR 
Equal variances assumed  .657  -.6625  1.4610 
Equal  variances  not 
assumed 
.659  -.6625  1.4610 
 
Independent Samples Test
a 
  t-test for Equality of Means 
95% Confidence Interval of the 
Difference 
Lower  Upper 
FTIR 
Equal variances assumed  -3.7960  2.4710 
Equal variances not assumed  -3.8954  2.5704 
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a. HEMA = HEMA 
 
 
UNIANOVA CHX BY CHX_low_high CaP_low_high 
  /METHOD=SSTYPE(3) 
  /INTERCEPT=INCLUDE 
  /SAVE=PRED RESID 
  /PLOT=PROFILE(CHX_low_high*CaP_low_high) 
  /CRITERIA=ALPHA(0.05) 
  /DESIGN=CHX_low_high CaP_low_high CHX_low_high*CaP_low_high. 
 
 
 
9.1.2  Univariate Analysis of Variance for BFS 
HEMA = HEMA 
Between-Subjects Factors
a 
  Value Label  N 
CHX_low_high 
0  CHX low  16 
1  CHX high  16 
CaP_low_high 
0  CaP low  16 
1  CaP high  16 
 
a. HEMA = HEMA 
 
Tests of Between-Subjects Effects
a 
Dependent Variable:   BFS   
Source  Type III 
Sum of 
Squares 
df  Mean 
Square 
F  Sig. 
Corrected Model  5933.943
b  3  1977.981  11.522  .000 
Intercept 
814130.11
4 
1  814130.1
14 
4742.5
61 
.000 
CHX_low_high  1626.382  1  1626.382  9.474  .005 185 
 
CaP_low_high  4098.112  1  4098.112  23.873  .000 
CHX_low_high  * 
CaP_low_high 
209.449  1  209.449  1.220  .279 
Error 
4806.611  28  171.665    
Total 
824870.66
8 
32      
Corrected Total 
10740.554  31      
 
a. HEMA = HEMA 
b. R Squared = .552 (Adjusted R Squared = .505) 
 
9.1.3  Univariate Analysis of Variance for Elastic modulus 
Between-Subjects Factors
a 
  Value Label  N 
CHX_low_high 
0  CHX low  16 
1  CHX high  16 
CaP_low_high 
0  CaP low  16 
1  CaP high  16 
 
a. HEMA = HEMA 
 
 
Tests of Between-Subjects Effects
a 
Dependent Variable:   EM   
Source  Type III 
Sum of 
Squares 
df  Mean 
Square 
F  Sig. 
Corrected Model  15.776
b  3  5.259  4.702  .009 
Intercept 
1002.400  1  1002.400  896.32
2 
.000 
CHX_low_high  4.278  1  4.278  3.825  .061 
CaP_low_high  3.990  1  3.990  3.568  .069 
CHX_low_high * 
CaP_low_high 
7.508  1  7.508  6.713  .015 
Error  31.314  28  1.118    
Total  1049.490  32      
Corrected Total  47.090  31      
 
a. HEMA = HEMA 186 
 
b. R Squared = .335 (Adjusted R Squared = .264) 
 
 
 
 
 
HEMA = HEMA P 
 
 
Between-Subjects Factors
a 
  Value Label  N 
CHX_low_high 
0  CHX low  16 
1  CHX high  16 
CaP_low_high 
0  CaP low  16 
1  CaP high  16 
 
a. HEMA = HEMA P 
 
 
Tests of Between-Subjects Effects
a 
Dependent Variable:   EM   
Source  Type III Sum of 
Squares 
df  Mean Square  F  Sig. 
Corrected Model  30.438
b  3  10.146  15.798  .000 
Intercept  898.880  1  898.880  1399.619  .000 
CHX_low_high  3.511  1  3.511  5.467  .027 
CaP_low_high  20.801  1  20.801  32.389  .000 
CHX_low_high * CaP_low_high  6.125  1  6.125  9.537  .005 
Error  17.983  28  .642    
Total  947.300  32      
Corrected Total  48.420  31      
 
a. HEMA = HEMA P 
b. R Squared = .629 (Adjusted R Squared = .589) 
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9.1.4  Univariate Analysis of Variance for Toughness  
 
HEMA = HEMA P 
 
 
Between-Subjects Factors
a 
  Value Label  N 
CHX_low_high 
0  CHX low  16 
1  CHX high  16 
CaP_low_high 
0  CaP low  16 
1  CaP high  16 
 
a. HEMA = HEMA P 
 
 
Tests of Between-Subjects Effects
a 
Dependent Variable:   BFS   
Source  Type III 
Sum of 
Squares 
df  Mean 
Square 
F  Sig. 
Corrected Model  9924.858
b  3  3308.286  16.634  .000 
Intercept 
759312.45
3 
1  759312.4
53 
3817.7
11 
.000 
CHX_low_high  899.940  1  899.940  4.525  .042 
CaP_low_high  9021.603  1  9021.603  45.359  .000 
CHX_low_high  * 
CaP_low_high 
3.315  1  3.315  .017  .898 
Error 
5568.979  28  198.892    
Total 
774806.29
0 
32      
Corrected Total 
15493.837  31      
 
HEMA = HEMA 
 
 
Between-Subjects Factors
a 189 
 
  Value Label  N 
CHX_low_high 
0  CHX low  16 
1  CHX high  16 
CaP_low_high 
0  CaP low  16 
1  CaP high  16 
 
a. HEMA = HEMA 
 
 
Tests of Between-Subjects Effects
a 
Dependent Variable:   Toughness   
Source  Type III 
Sum of 
Squares 
df  Mean 
Square 
F  Sig. 
Corrected Model  19.508
b  3  6.503  .717  .550 
Intercept 
7549.133  1  7549.133  832.5
53 
.000 
CHX_low_high  .113  1  .113  .012  .912 
CaP_low_high  15.263  1  15.263  1.683  .205 
CHX_low_high * 
CaP_low_high 
4.133  1  4.133  .456  .505 
Error  253.889  28  9.067    
Total  7822.530  32      
Corrected Total  273.397  31      
 
a. HEMA = HEMA 
b. R Squared = .071 (Adjusted R Squared = -.028) 
 
 
 
HEMA = HEMA P 
 
 
Between-Subjects Factors
a 
  Value Label  N 
CHX_low_high 
0  CHX low  16 
1  CHX high  16 
CaP_low_high 
0  CaP low  16 
1  CaP high  16 
 190 
 
a. HEMA = HEMA P 
 
 
Tests of Between-Subjects Effects
a 
Dependent Variable:   Toughness   
Source  Type III Sum 
of Squares 
df  Mean 
Square 
F  Sig. 
Corrected Model  148.471
b  3  49.490  5.102  .006 
Intercept  8954.565  1  8954.565  923.104  .000 
CHX_low_high  5.528  1  5.528  .570  .457 
CaP_low_high  1.403  1  1.403  .145  .707 
CHX_low_high * 
CaP_low_high 
141.540  1  141.540  14.591  .001 
Error  271.614  28  9.700    
Total  9374.650  32      
Corrected Total  420.085  31      
 
a. HEMA = HEMA P 
b. R Squared = .353 (Adjusted R Squared = .284) 
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HEMA = HEMA P 
 
 
Group Statistics
a 
  Formula  N  Mean  Std. Deviation  Std. Error Mean 
Toughness 
7.0  8  19.038  3.7842  1.3379 
9.0  8  15.250  2.3755  .8399 
 
a. HEMA = HEMA P 
 
 
Independent Samples Test
a 
  Levene's Test for Equality 
of Variances 
t-test for Equality 
of Means 
F  Sig.  t  df 
Toughnes Equal variances assumed  2.383  .145  2.398  14 192 
 
s  Equal variances not 
assumed 
    2.398  11.775 
 
Independent Samples Test
a 
  t-test for Equality of Means 
Sig. (2-
tailed) 
Mean 
Difference 
Std. Error 
Difference 
Toughness 
Equal variances assumed  .031  3.7875  1.5797 
Equal variances not 
assumed 
.034  3.7875  1.5797 
 
Independent Samples Test
a 
  t-test for Equality of Means 
95% Confidence Interval of the 
Difference 
Lower  Upper 
Toughness 
Equal variances assumed  .3995  7.1755 
Equal variances not assumed  .3384  7.2366 
 
a. HEMA = HEMA P 
 
T-TEST GROUPS=Formula(8 10) 
  /MISSING=ANALYSIS 
  /VARIABLES=Toughness 
  /CRITERIA=CI(.95). 
 
 
 
T-Test 
 
 
HEMA = HEMA P 
 
 
Group Statistics
a 
  Formula  N  Mean  Std. Deviation  Std. Error Mean 
Toughness 
8.0  8  14.000  3.7796  1.3363 
10.0  8  18.625  2.1339  .7545 
 
a. HEMA = HEMA P 
 
 193 
 
Independent Samples Test
a 
  Levene's Test for Equality of 
Variances 
t-test for Equality of 
Means 
F  Sig.  t  df 
Toughness 
Equal variances assumed  .991  .336  -3.014  14 
Equal variances not assumed      -3.014  11.051 
 
Independent Samples Test
a 
  t-test for Equality of Means 
Sig. (2-tailed)  Mean Difference  Std. Error 
Difference 
Toughness 
Equal variances assumed  .009  -4.6250  1.5346 
Equal variances not assumed  .012  -4.6250  1.5346 
 
Independent Samples Test
a 
  t-test for Equality of Means 
95% Confidence Interval of the 
Difference 
Lower  Upper 
Toughness 
Equal variances assumed  -7.9163  -1.3337 
Equal variances not assumed  -8.0007  -1.2493 
 
a. HEMA = HEMA P 
9.1.5  Univariate Analysis of Variance for Resilience 
HEMA = HEMA 
 
 
Between-Subjects Factors
a 
  Value Label  N 
CHX_low_high 
0  CHX low  16 
1  CHX high  16 
CaP_low_high 
0  CaP low  16 
1  CaP high  16 
 
a. HEMA = HEMA 
 
 
Tests of Between-Subjects Effects
a 
Dependent Variable:   Resilience   194 
 
Source  Type III Sum 
of Squares 
df  Mean 
Square 
F  Sig. 
Corrected Model  7.883
b  3  2.628  8.678  .000 
Intercept  171.588  1  171.588  566.647  .000 
CHX_low_high  .090  1  .090  .298  .589 
CaP_low_high  7.703  1  7.703  25.438  .000 
CHX_low_high * 
CaP_low_high 
.090  1  .090  .298  .589 
Error  8.479  28  .303    
Total  187.950  32      
Corrected Total  16.362  31      
 
a. HEMA = HEMA 
b. R Squared = .482 (Adjusted R Squared = .426) 
 
 
 
 
 
 
 
HEMA = HEMA P 
 
 
Between-Subjects Factors
a 
  Value Label  N 
CHX_low_high 
0  CHX low  16 
1  CHX high  16 
CaP_low_high 
0  CaP low  16 
1  CaP high  16 
 
a. HEMA = HEMA P 
 
 
Tests of Between-Subjects Effects
a 
Dependent Variable:   Resilience   
Source  Type III Sum 
of Squares 
df  Mean Square  F  Sig. 
Corrected Model  1.268
b  3  .423  1.346  .279 
Intercept  171.588  1  171.588  546.349  .000 195 
 
CHX_low_high  .015  1  .015  .049  .827 
CaP_low_high  .090  1  .090  .288  .596 
CHX_low_high * 
CaP_low_high 
1.163  1  1.163  3.702  .065 
Error  8.794  28  .314    
Total  181.650  32      
Corrected Total  10.062  31      
 
a. HEMA = HEMA P 
b. R Squared = .126 (Adjusted R Squared = .032) 
 
 
 
 
9.1.6  Univariate Analysis of Variance for CHX 
 
 
HEMA = HEMA 
 
 
Between-Subjects Factors
a 
  Value Label  N 
CHX_low_high 
0  CHX low  10 
1  CHX high  10 
CaP_low_high 
0  CAP low  10 
1  CAP high  10 
 
a. HEMA = HEMA 
 
 
Tests of Between-Subjects Effects
a 
Dependent Variable:   CHX   
Source  Type III 
Sum of 
Squares 
df  Mean 
Square 
F  Sig. 
Corrected Model  21.266
b  3  7.089  124.363  .000 
Intercept 
246.402  1  246.402  4322.84
2 
.000 
CHX_low_high  4.418  1  4.418  77.509  .000 
CaP_low_high  16.200  1  16.200  284.211  .000 196 
 
CHX_low_high * 
CaP_low_high 
.648  1  .648  11.368  .004 
Error  .912  16  .057    
Total  268.580  20      
Corrected Total  22.178  19      
 
a. HEMA = HEMA 
b. R Squared = .959 (Adjusted R Squared = .951) 
 
 
 
Profile Plots 
 
 
 
 
 
 
HEMA = HEMA P 
 
 
Between-Subjects Factors
a 
  Value Label  N 197 
 
CHX_low_high 
0  CHX low  10 
1  CHX high  10 
CaP_low_high 
0  CaP low  10 
1  CaP high  10 
 
a. HEMA = HEMA P 
 
 
Tests of Between-Subjects Effects
a 
Dependent Variable:   CHX   
Source  Type III Sum 
of Squares 
df  Mean Square  F  Sig. 
Corrected Model  53.130
b  3  17.710  272.459  .000 
Intercept  452.201  1  452.201  6956.931  .000 
CHX_low_high  9.941  1  9.941  152.931  .000 
CaP_low_high  42.925  1  42.925  660.377  .000 
CHX_low_high * 
CaP_low_high 
.265  1  .265  4.069  .061 
Error  1.040  16  .065    
Total  506.370  20      
Corrected Total  54.170  19      
 
a. HEMA = HEMA P 
b. R Squared = .981 (Adjusted R Squared = .977) 
 
 
 
Profile Plots 
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T-TEST GROUPS=Formula(2 4) 
  /MISSING=ANALYSIS 
  /VARIABLES=Toughness 
  /CRITERIA=CI(.95). 
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T-Test 
 
 
HEMA = HEMA 
 
 
Group Statistics
a 
  Formula  N  Mean  Std. Deviation  Std. Error Mean 
CHX 
2.0  8  15.088  3.6651  1.2958 
4.0  8  15.750  1.9086  .6748 
 
a. HEMA = HEMA 
 
 
Independent Samples Test
a 
  Levene's Test for Equality of 
Variances 
t-test for Equality of 
Means 
F  Sig.  t  df 
CHX 
Equal variances assumed  5.110  .040  -.453  14 
Equal variances not 
assumed 
    -.453  10.537 
 
Independent Samples Test
a 
  t-test for Equality of Means 
Sig. (2-tailed)  Mean 
Difference 
Std. Error 
Difference 
CHX 
Equal variances assumed  .657  -.6625  1.4610 
Equal variances not assumed  .659  -.6625  1.4610 
 
Independent Samples Test
a 
  t-test for Equality of Means 
95% Confidence Interval of the 
Difference 
Lower  Upper 
CHX 
Equal variances assumed  -3.7960  2.4710 
Equal variances not assumed  -3.8954  2.5704 
 
a. HEMA = HEMA 200 
 
 
 
T-TEST GROUPS=Formula(3 5) 
  /MISSING=ANALYSIS 
  /VARIABLES=Toughness 
  /CRITERIA=CI(.95). 
 
 
 
T-Test 
 
 
HEMA = HEMA 
 
 
Group Statistics
a 
  Formula  N  Mean  Std. Deviation  Std. Error Mean 
CHX 
3.0  8  14.250  3.2842  1.1611 
5.0  8  16.350  2.8998  1.0252 
 
a. HEMA = HEMA 
 
 
Independent Samples Test
a 
  Levene's Test for Equality of 
Variances 
t-test for Equality of 
Means 
F  Sig.  t  df 
CHX 
Equal variances assumed  .145  .709  -1.356  14 
Equal variances not 
assumed 
    -1.356  13.789 
 
Independent Samples Test
a 
  t-test for Equality of Means 
Sig. (2-tailed)  Mean 
Difference 
Std. Error 
Difference 
CHX 
Equal variances assumed  .197  -2.1000  1.5490 
Equal variances not assumed  .197  -2.1000  1.5490 
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Independent Samples Test
a 
  t-test for Equality of Means 
95% Confidence Interval of the 
Difference 
Lower  Upper 
CHX 
Equal variances assumed  -5.4222  1.2222 
Equal variances not assumed  -5.4270  1.2270 
 
a. HEMA = HEMA 
 
 
UNIANOVA MASS BY CHX_low_high CAP_low_high 
  /METHOD=SSTYPE(3) 
  /INTERCEPT=INCLUDE 
  /SAVE=PRED RESID 
  /PLOT=PROFILE(CHX_low_high*CAP_low_high) 
  /CRITERIA=ALPHA(0.05) 
  /DESIGN=CHX_low_high CAP_low_high CHX_low_high*CAP_low_high. 
 
 
9.1.7  Univariate Analysis of Variance for Mass change 
 
 
HEMA = HEMA 
 
 
Between-Subjects Factors
a 
  Value Label  N 
CHX_low_high 
0  CHX low  10 
1  CHX high  10 
CaP_low_high 
0  CaP low  10 
1  CaP high  10 
 
a. HEMA = HEMA 
 
 
 
Tests of Between-Subjects Effects
a 
Dependent Variable:   MASS   202 
 
Source  Type III Sum 
of Squares 
df  Mean Square  F  Sig. 
Corrected Model  19.431
b  3  6.477  212.463  .000 
Intercept  93.226  1  93.226  3058.082  .000 
CHX_low_high  2.165  1  2.165  71.013  .000 
CaP_low_high  16.928  1  16.928  555.289  .000 
CHX_low_high * 
CaP_low_high 
.338  1  .338  11.087  .004 
Error  .488  16  .030    
Total  113.144  20      
Corrected Total  19.919  19      
 
a. HEMA = HEMA 
b. R Squared = .976 (Adjusted R Squared = .971) 
 
 
 
Profile Plots 
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HEMA = HEMA P 
 
 
Between-Subjects Factors
a 
  Value Label  N 
CHX_low_high 
0  CHX low  10 
1  CHX high  10 
CaP_low_high 
0  CaP low  10 
1  CaP high  10 
 
a. HEMA = HEMA P 
 
 
Tests of Between-Subjects Effects
a 
Dependent Variable:   MASS   
Source  Type III Sum 
of Squares 
df  Mean 
Square 
F  Sig. 
Corrected Model  4.002
b  3  1.334  37.573  .000 
Intercept  130.561  1  130.561  3677.761  .000 
CHX_low_high  .925  1  .925  26.042  .000 
CaP_low_high  2.813  1  2.813  79.225  .000 
CHX_low_high * 
CaP_low_high 
.265  1  .265  7.451  .015 
Error  .568  16  .036    
Total  135.130  20      
Corrected Total  4.570  19      
 
a. HEMA = HEMA P 
b. R Squared = .876 (Adjusted R Squared = .852) 
 
 
 
Profile Plots 
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T-Test 
 
 
 
 
HEMA = HEMA 
 
 
Group Statistics
a 
  Formula  N  Mean  Std. Deviation  Std. Error Mean 
 
3.0  8  14.250  3.2842  1.1611 
5.0  8  16.350  2.8998  1.0252 
 
a. HEMA = HEMA 
 
 
Independent Samples Test
a 
  Levene's Test for Equality of 
Variances 
t-test for Equality of 
Means 
F  Sig.  t  df 
Mass 
change 
Equal variances assumed  .145  .709  -1.356  14 
Equal variances not 
assumed 
    -1.356  13.789 
 
Independent Samples Test
a 
  t-test for Equality of Means 
Sig. (2-tailed)  Mean 
Difference 
Std. Error 
Difference 
Mass 
change 
Equal variances assumed  .197  -2.1000  1.5490 
Equal variances not assumed  .197  -2.1000  1.5490 
 
 
 
 
 
Independent Samples Test
a 
  t-test for Equality of Means 
95% Confidence Interval of the 
Difference 206 
 
Lower  Upper 
Mass change 
Equal variances assumed  -5.4222  1.2222 
Equal variances not assumed  -5.4270  1.2270 
 
a. HEMA = HEMA 
 
 
T-TEST GROUPS=Formula(2 4) 
  /MISSING=ANALYSIS 
  /VARIABLES=Toughness 
  /CRITERIA=CI(.95). 
 
 
 
T-Test 
 
HEMA = HEMA 
Group Statistics
a 
  Formula  N  Mean  Std. Deviation  Std. Error Mean 
Mass change 
2.0  8  15.088  3.6651  1.2958 
4.0  8  15.750  1.9086  .6748 
 
a. HEMA = HEMA 
 
 
Independent Samples Test
a 
  Levene's Test for Equality of 
Variances 
t-test for Equality of 
Means 
F  Sig.  t  df 
Mass 
change 
Equal variances assumed  5.110  .040  -.453  14 
Equal variances not 
assumed 
    -.453  10.537 
 
Independent Samples Test
a 
  t-test for Equality of Means 
Sig. (2-tailed)  Mean 
Difference 
Std. Error 
Difference 
Mass 
change 
Equal variances assumed  .657  -.6625  1.4610 
Equal variances not assumed  .659  -.6625  1.4610 
 
Independent Samples Test
a 
  t-test for Equality of Means 207 
 
95% Confidence Interval of the 
Difference 
Lower  Upper 
Mass change 
Equal variances assumed  -3.7960  2.4710 
Equal variances not assumed  -3.8954  2.5704 
 
a. HEMA = HEMA 
 
 
T-TEST GROUPS=Formula(8 10) 
  /MISSING=ANALYSIS 
  /VARIABLES=Toughness 
  /CRITERIA=CI(.95). 
 
 
 
T-Test 
 
 
 
HEMA = HEMA P 
 
 
Group Statistics
a 
  Formula  N  Mean  Std. Deviation  Std. Error Mean 
Mass change 
8.0  8  14.000  3.7796  1.3363 
10.0  8  18.625  2.1339  .7545 
 
a. HEMA = HEMA P 
 
 
Independent Samples Test
a 
  Levene's Test for Equality of 
Variances 
t-test for Equality of 
Means 
F  Sig.  t  df 
Mass 
change 
Equal variances assumed  .991  .336  -3.014  14 
Equal variances not 
assumed 
    -3.014  11.051 
 
Independent Samples Test
a 
  t-test for Equality of Means 208 
 
Sig. (2-tailed)  Mean 
Difference 
Std. Error 
Difference 
Mass 
change 
Equal variances assumed  .009  -4.6250  1.5346 
Equal variances not assumed  .012  -4.6250  1.5346 
 
Independent Samples Test
a 
  t-test for Equality of Means 
95% Confidence Interval of the 
Difference 
Lower  Upper 
Mass change 
Equal variances assumed  -7.9163  -1.3337 
Equal variances not assumed  -8.0007  -1.2493 
 
a. HEMA = HEMA P 
 
T-TEST GROUPS=Formula(7 9) 
  /MISSING=ANALYSIS 
  /VARIABLES=Toughness 
  /CRITERIA=CI(.95). 
 
 
 
T-Test 
 
HEMA = HEMA P 
 
 
Group Statistics
a 
  Formula  N  Mean  Std. Deviation  Std. Error Mean 
Mass change 
7.0  8  19.038  3.7842  1.3379 
9.0  8  15.250  2.3755  .8399 
 
a. HEMA = HEMA P 
 
 
Independent Samples Test
a 
  Levene's Test for Equality of 
Variances 
t-test for Equality of 
Means 
F  Sig.  t  df 
Mass  Equal variances assumed  2.383  .145  2.398  14 209 
 
change  Equal variances not 
assumed 
    2.398  11.775 
 
Independent Samples Test
a 
  t-test for Equality of Means 
Sig. (2-tailed)  Mean 
Difference 
Std. Error 
Difference 
Mass 
change 
Equal variances assumed  .031  3.7875  1.5797 
Equal variances not assumed  .034  3.7875  1.5797 
 
Independent Samples Test
a 
  t-test for Equality of Means 
95% Confidence Interval of the 
Difference 
Lower  Upper 
Mass change 
Equal variances assumed  .3995  7.1755 
Equal variances not assumed  .3384  7.2366 
 
a. HEMA = HEMA P 
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10 Appendix 2 
10.1  Factorial design analysis  
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11 Appendix 3 
11.1  SEM images 
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Abstract  
 
Background:  
Attending  dental  appointment  it’s  very  important  for  patient,  dentist  and  hospital. 
Failure to attend dental appointment (DNA) may have a negative impact on child’s 
health and my raise safeguarding issues and concerns. Beside these concerns failing 
to attend dental appointment has been considered as a waste of the National Health 
Services  (NHS)  financial  resources.  So  it  was  the  need  to  establish  a  pathway  to 
ensure  all  patients  are  followed  up  within  the  department  of  paediatric  dentistry  in 
Eastman Dental Hospital.  
Aim:  To  establish  robust  procedures  to  ensure  that  all  patients  who  DNA  their 
appointments are not lost to follow up. 
Standard: The standard set for this audit was 100% of patients should be followed up. 
Method: A six month, retrospective audit of patients who DNA’d appointments within 
the department of paediatric dentistry. Patients were divided into new patients (NP), 
treatment/follow up (Tx/FU), and general anaesthesia (GA) groups.  
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1 Background  
 
1.1 Introduction 
Dental  caries  is  one  of  the  common  diseases  afflicting  mankind,  and  has  been 
estimated to affect up to 40% of UK adults. The UK government spends millions every 
year on the prevention and treatment of dental caries. 175 million pounds has been 
spent on the placement of direct restoration by the NHS in both England and Wales 
since the 90’s (Dental Practice Board, 1996).  
Caries adversely affects and Dental caries is probably one the most common chronic 
diseases; although it has affected humans since prehistorical times. The prevalence of 
this disease has  increased due to the dietary change that occurs on human life style 
but now  there is  evidence of that this trend peaked and began to decline in certain 
segments  of  the  population  of  Western  Europe,  New  Zealand,  Unites  State,  and 
Australia. The main cause of the decrease is addition of the fluoride to toothpastes and 
it’s attributed to the addition of trace amount of fluoride ion to public drinking water. 
This declined in the developed countries has been prominent in the upper classes and 
middle classes, while the lower socioeconomic and rural classes have retained a high 
prevalence of tooth decay(Kidd and Fejerskov C35-C38;Kidd et al. 8-13).      
progressively destroys the tissues of the tooth, including the dental pulp, leaving teeth 
unsightly, weakened and with impaired function (Marya et al. 41-45;Davies et al. 5-11). 
 
Dental caries has been studied extensively during the last 60 years in both Europe and 
North America in which studies have been very useful in determination of extent of the 
need for, and effectiveness of, dental treatment. The most common epidemiological 
measure  of  caries  is  the  DMF;  this  is  a  measure  of  the  number  of  teeth  that  are 
diseased, missing, or filled. Since 1973, national surveys of dental caries in children, 
one series directed decennially by the Office of Population Censuses and Surveys and 
another, using analogous methods, coordinated regionally on a regular basis by the 
British  Association  for  the  Study  of  Community  Dentistry,  have  produced  a 
comprehensive record of trends in caries experience of children in England and Wales 
(Davies  et  al.  5-11;Kidd  et  al.  8-13).  Between  1973  and  1993  a  decline 
in caries experience of 55 per cent in deciduous teeth of 5-year-old children, 75 per 
cent in permanent teeth of 12-year-old, and 74 per cent in 14-year-old children, was 
documented.  222 
 
 
Data from the  NHS Dental Epidemiology Programme for England (British Association 
for the Study of Community Dentistry) indicates that the mean number of decayed, 
missing or filled primary teeth (dmft) in 5-years-old in great Britain is 1.11 (2007-2008), 
and DMFT of permanent teeth in 11 year old in England and Wales is 7.4 (2008 – 
2009). In the UK, only 14% of teeth with dentine decay in 5 years old are restored ( 
NHS DEP) and if caries is not treated affected teeth are likely to become non-vital and 
may require extraction. Number of children who required hospital admissions for caries 
treatment  rose  by  66%  between  1997  and  2006  (Moles  and  Ashley  E14-E19). 
Therefore,  it  can  be  seen  that  attending  dental  appointments  is  considered  an 
important aspect of maintaining child’s health.   
 
In 1998 a study in Sweden founded that the mean DMFT of children who missed dental 
appointment at the age of 18 was significantly higher than those who attended their 
appointments in the same age group (Skaret et al., 1998).  
According  to  the  National  Diet  and  Nutrition  Survey  it  was  proven  that  Dental 
attendance patterns were vary with age, social class, and educational qualifications. 
(Hinds and Gregory, 1995)  Preschool children of all ages were more likely to be taken 
to the dentist if they came from non-manual households; their mothers had secondary 
education qualifications and were themselves regular dental attenders. Other factors 
which  have  been  associated  with  broken  appointments  include;  patient  dentist 
relationship, length of time between appointments, time and day of the week, weather 
conditions,  urgency  of  the  appointment  and  patient  satisfaction.  It  has  also  been 
observed that patient who fail to attend appointments have shown the same behavior 
in the past (Almog et al., 2003). 
There were so many studies investigating the reasons why parents failed to take their 
children to attend dental appointment, among these studies there was a study carried 
out in Sweden which concluded the reasons in to 1) being overloaded in daily life this 
was  especially  a  problem  for  single  parents  where  they  felt  overwhelmed  by  the 
amount of work and responsibilities, and they also complained that they were too busy 
to even remember to call and cancel an appointment. 2) Lack of dental healthcare 
traditions where parents themselves did not consider oral health care important and did 
not attend check-ups, therefore dental care for children fell low in priority. 3) A lack of 
trust in the dental healthcare system where parents felt that the dental team showed no 
empathy  or  understanding  when  scheduling  appointments.    4)  A  lack  of  parental 
confidence where parents found it difficult and challenging to persuade their children to 223 
 
attend  dental  appointments.  (Hallberg  et  al.,  2008).  A  study  was  conducted  in  the 
Eastman  Dental  Centre,  in  New  York,  to  compare  a  new  automated  appointment 
confirmation  system  with  manual  confirmation  strategies.  The  new  system  allowed 
patient details to be uploaded a day before the appointments were scheduled for, and 
then generated an automated, pre-recorded, interactive voice message, which allowed 
parents to either confirm, cancel, or leave a voice mail for the clinician. The techniques 
were conducted over a period of twelve months, and results showed a significant drop 
in the percentage of patients who failed to attend (Almog et al., 2003). By introducing 
this method to the appointment system a better patients attendance out comes will be 
obtained and better performances. 
According to the British Dental Association patient failing to attend was a real problem 
and waste for hospital resources, it has been showed that dentists in England had a 
loss  which  was  equivalent  of  two  weeks  a  year  due  to  patients  not  attending 
appointments. Therefore there was a suggestion of charging patients with a fee for not 
attending  their  appointments,  to  decrease  the  rate  of  failed  appointments.  But  this 
action was highly criticised. (British Dental Association, 2011).   
1.2 Safeguarding and Neglect 
Dental neglect is defined, as “the persistent failure to meet a child’s basic oral health 
needs, likely to result in the serious impairment of a child’s oral or general health or 
development” (Haris et al., 2009). While dental neglect is considered a more focused 
type  of  neglect,  it  is  occasionally  an    early  indicator  of  a  broader  general  neglect.  
Although failing to attend dental appointments is not an immediate indicator of dental 
neglect, its persistence may raise suspicions.  
Signs and symptoms of maltreatment may be either physical or psychological. These 
may be observed on the child himself, or in the parent-child-interaction. These effects 
have both short and long term impacts on the child’s health, development and well-
being. Psychological effects may lead to anxiety, depression, anti-social behaviours’, 
drug  abuse,  and  may  affect  inter-personal  relationships  as  well.  While  physical 
maltreatment may result in scarring or lifelong disability, which in extreme cases may 
be fatal (NICE clinical guideline, 2009). 
 
It  is  the  responsibility  of  every  person  who  interacts  with  children  to  be  able  to 
recognize  the  signs  and  symptoms  of  child  abuse  and  maltreatment,  from 
receptionists, nurses, therapists, to dentists. Physical signs of maltreatment include, 224 
 
bruises in areas of the body not common to have bruises in children, such as behind 
the ears, on the cheeks, or in young children who are not mobile, multiple bruises or 
bites, bone fractures when there is no medical reason (NICE clinical guideline, 2009).  
 
When it comes to identifying dental neglect, dental and non-dental findings should be 
taken into consideration. Caries is a very common disease as already mentioned, with 
prevalence of 39.5% in 5-year olds in Great Britain (British Association for the Study of 
Community Dentistry, 2006), but it is also known that the disease is multi-factorial, and 
that the disease level is not necessarily an indication of maltreatment. Other factors 
which contribute to the level of decay in children go beyond just frequency of sugary 
intake, poor oral hygiene, bacteria level, but also lack of parental knowledge regarding 
the  disease  and  its  aetiology,  parents  own  fear  and  anxiety  of  the  dentist  which 
therefore prevents them from taking their children for dental care. Furthermore, these 
factors may be intensified by poverty and/or stress (Haris et al., 2009). 
 
According to NICE guidelines, “Consider neglect if parents or carers fail to administer 
essential  prescribed  treatment  for  their  child,  if  parents  or  carers  repeatedly  fail  to 
attend essential follow-up appointments that are necessary for their child’s health and 
wellbeing,  if  parents  or  carers  have  access  to  but  persistently  fail  to  obtain  NHS 
treatment for their child’s dental caries (tooth decay), and if parents or carers fail to 
seek medical advice for their child to the extent that the child’s health and wellbeing is 
compromised, including if the child is in ongoing pain” (NICE clinical guideline, 2009).  
 
The  Children’s  Act  1989  states  “Whether  neglect  is  willful  or  not,  it  is  essential  to 
remember  that  the  welfare  of  the  child  is  the  paramount  consideration”  (HM 
Government, 1989). In 2006 it was reported, “The primary aim of intervention is not to 
blame the family, but to ensure that children receive the support needed to safeguard 
their welfare. A feature of particular concern is the failure of parents to respond to 
offers  of  acceptable  and  appropriate  treatment”  (American  Academy  of  Paediatrics 
Committee on Child Abuse and Neglect, 2006, Harris et al., 2006).  
 
When  dental  neglect  has  been  identified,  there  are  3  recommended  strategies  of 225 
 
intervention as suggested by the BSPD (Haris et al., 2009). The first is preventive dental 
team  management  with  dental  professionals  relieving  any  pain  the  child  is 
experiencing.  The second strategy is preventive multi-agency management. Here, if 
concerns continue,  or situations worsen with a child,  then the dental team  has the 
responsibility to seek parental consent to consult other professionals who have contact 
with the child, to see if concerns are shared. If they are then a meeting should take 
place to formulate a joint plan of action. The final strategy is a child protection referral. 
This is when there is a suspicion that the child is undergoing significant harm from 
dental or general abuse, and then a child protection referral should be made after local 
protection procedures.  
 
Every NHS trust, dental practice and community clinic must have a clear pathway to 
follow and a policy in place whenever there are concerns regarding the safeguarding of 
a child. The NICE guidelines published in 2009 suggested following the process as 
shown in figure1.  
 
 
 
Figure 1. NICE flow chart to follow any concerns to children’s safeguarding  
In  the  NHS  time  is  valuable  and  a  huge  amount  of  pressure  exists  and  heavy 
workloads.   In private practice DNA’s also have financial implications but here fees 
may be applied for missed appointments. The child may suffer directly from a missed 
appointment for example following dental trauma, or information may be missed like 
attendance at an emergency clinic for pain and / or swelling. 226 
 
 
Locally,  in  the  Department  of  Paediatric  dentistry  –  systems  loosely  exist  for  new 
patients in that they can DNA twice but are then discharged and for GA patients they 
get a second appointment too but if they DNA twice then they are removed from the 
waiting  list following  discussion  with  a  Consultant.  When  it  comes to treatment  or 
review 
Consider child maltreatment 
If  an  altering  feature  prompts 
you  to  consider  child 
maltreatment. 
*Look for other altering features 
maltreatment  in  the  child 
history.  
*And  do  one  or  more  of  the 
following: 
1- discusses your concern with 
a  more experienced  colleague, 
a  community  pediatrician,  child 
and  adolescent  mental  health 
service  colleague  or  a  person 
designated  for  safeguarding 
children. 
2- Gather collateral information 
from other agencies  
3- Insure review of the child at a 
date appropriate to the concern, 
looking  out  for  repeated 
presentations  of  this  or  any 
other altering features. 
At any stage during the process 
of considering maltreatment the 
level  of  concern  may  change 
and lead to exclude or suspect 
maltreatment. 
Suspect  child 
maltreatment 
If  an  altering 
feature  or 
considering  child 
maltreatment 
prompts  you  to 
suspect  child 
maltreatment 
refers  the  child  to 
Exclude  child 
maltreatment 
Exclude  child 
maltreatment  if  a 
suitable 
explanation  is 
found.  This  may 
be  the  decision 
after  discussion 
of  the  case  with 
Record 
Record in the child or young person’s clinical record exactly what is observed and 
heard from whom and when. Record why this is of concern. 
Listen and observe 
Take  into  account  the  whole  picture  of  the  child  or  young  person.  Sources  of 
information that help to do this include:  
*any history that is given.*report of maltreatment.*child appearance or 
behavior.*symptom.*physical signe.* result of an investigation. 
 
Seek an explanation 
Seek an explanation for any injury from both parent or carer and the child or young 
person in an open and non-judgmental manner. An unsuitable explanation is one that 
is: 
*Implausible, inadequate or inconsistent.  
Record 
Record all actions taken and the outcome. 227 
 
patients  –  the  action  taken  varies  widely  from  another  appointment  in  the  post,  a 
telephone  call,  to  a  letter  asking  the  parent  /  carer  to  contact.  This  means  that 
outcomes vary and potentially in all 3 groups children may be lost to follow-up.   
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1.3 Aim and Objectives  
The aim therefore of this audit was to examine, and establish robust procedures to 
ensure that all patients who DNA’d an appointment at the Eastman Dental Hospital, 
UCLH Paediatric Dental Department, were not lost to follow up. 
 
The gold standard was that all patients who did not attend their appointments (DNA) in 
all three groups were followed up appropriately and not lost in the system.  
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2 Materials and methods  
 
2. 1 Sample selection 
This  was  a  retrospective  audit  looking  at  patient  clinical  notes,  divided  in  to  three 
groups according to type of appointment. Data was collected over a six month period, 
from the 1
st January until June 31
st, 2012.   
2.2 Data collection 
Lists of DNA’d patients who their appointments in the six month period selected were 
needed  to  be  able  to  request  the  notes  from  medical  records  for  all  three  patient 
groups. 
Information gathered included patients details, type of patient, referral source, dental 
diagnosis, staff grade, DNA outcome and other findings on the form shown in figure 2. 
Medical records provided the notes, and the data extraction form was completed for 
each patient and kept in a folder. The completed data forms were fed into a scanner 
where information was transferred in to the Excel database created.  
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Figure 2. Audit data extraction form.  231 
 
In 2011, the first cycle of this audit was done by Ebtesam Alzain who was a graduate 
student in paediatric department at the Eastman Dental Hospital. She focused initially 
on the DNA’d patients in all three groups and established a protocol to track all patients 
data. This was obtained by having an action plan to be followed in each category of the 
DNA’s patients.  
 
3 First Cycle Result   
  All patients 
 
3.1 Sample 
In the six months period investigated, initially, the total number of patients who had 
evidently supposedly DNA their appointments in all three groups was 754 patients. 
However, the number of patients who were potentially eligible for inclusion in each 
group, and the number of notes actually retrieved are illustrated in table 1 below.  
  New patient  Treatment/follow 
up 
General 
anaesthesia 
Total  number  of  pt 
potentially eligible 
136  575  43 
Total number of  notes 
retrieved 
133  351  33 
Final  number  of  DNA 
patients 
133  260  4 
Table 1. Total number of patients who were potentially eligible for inclusion in each 
group, number of notes retrieved & final numbers.  
 
The  results  showed  that  the  total  number  of  patients  who  failed  to  attend  their 
appointments in all three groups was 397.  In  the new patient group, all 133 notes 
retrieved were for patients who actually DNA their dental appointment.  
 
In the treatment/follow up group, out of the 575 patients potentially eligible for inclusion, 
37 patients had repeated DNA, and out of the 351 notes retrieved, 91 had no obvious 
DNA and therefore were excluded, ending up with a sample of 260 notes, who actually 
did not attend their appointments.  232 
 
 
In the general anaesthesia group, out of the 33 patient notes retrieved, 29 patients did 
not DNA but actually cancelled their appointments according to what was written in the 
notes. If a patient cancels an appointment in the 24 hours before their surgery this is 
logged on the system as a DNA but for this audit these patients were not true DNA’s. 
The total number who actually DNA their appointment was 4 patients. 
 
The total number of patients who did not attend their appointments in the three patient 
groups is shown in figure 3.  
 
 
Figure 3. Total number of patients who DNA appointments in all three patient groups.  
 
The overall age range of patients that did not attend their appointments was 1 - 18 
years old with an average age of 10.3 years. There were 5 patients who were known to 
be a safeguarding risk. The ratio of male to female patients who did not attend their 
appointment was M: F = 1.1:1. Results also showed that, 44 (11%) patients had a 
significant medical history.  
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As to the patients’ referral source, results showed that the majority of referrals were 
from general dental practitioners (GDP), followed by other referrals such as, internal or 
from specialists. Then, they were followed by referrals from community dental services 
(CDS). The fewest referrals were from hospital dental services (HDS). These results 
are displayed in figure 4. 
 
 
Figure 4. Referral source to all patient groups 
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Reasons for referrals varied as shown below.  
Diagnosis  Number of referrals (%) 
Caries  126 (31.7%) 
Trauma  81 (20.4%) 
Anomalies  54 (13.6%) 
BM  7 (1.7%) 
Ortho  16 (4%) 
Oral medicine  11 (2.7%) 
Gingival problems  2 (0.5%) 
Med/special needs  1 (0.25%) 
Caries & BM  62 (15.6%) 
Caries + anomalies  15 (3.7%) 
Caries + med/spec.  2 (0.5%) 
Caries + BM + ortho  1 (0.25%) 
Caries + anomalies + ortho  2 (0.5%) 
Caries + trauma + BM  1 (0.25%) 
Caries + ortho  3 (0.75%) 
Caries + oral medicine  1 (0.25%) 
Trauma + med/spec.  2 (0.5%) 
Anomalies + med/spec.  1 (0.25%) 
Anomalies +ortho  4 (1%) 
Anomalies + BM + gingival  1 (0.25%) 
BM + ortho  4 (1%) 
 
Table 2. Reasons for referrals for all patients who DNA appointments 235 
 
Results showed that different grades of staff saw patients who DNA their appointments 
and  they  were  different  in  each  of  the  three  different  patient  groups,  these  are 
illustrated in the following.  
 
 
Figure 5. Prevalence of grade of staff who had DNA in each group   
 
As to the outcome of patient failed appointments, results revealed that clinician’s varied 
with regards to their action taken upon DNA, theses outcomes depending on patient 
groups are summarised in figure 6.  
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Figure 6. DNA outcome in all patient groups (%).  
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Results showed that, according to the notes, when considering the 3 individual groups 
as  one,  in  89  cases  (22.4%)  clinicians  did  not  take  any  action  following  a  missed 
appointment.  
The prevalence of patients  with significant medical history, whether they  were at  a 
known safeguarding risk and the main diagnosis for those children who DNA’d and no 
action was taken are shown in table 3.  
 
DNA with No action  Medical history  Safeguarding risk   Main diagnosis 
89  8  1  (17) Trauma  
(29) Caries  
 
Table 3. The frequency of different parameters in relation to patients who DNA’d and 
no action was taken.  
 
As to the distribution of no action taken according to the patient group, results are 
illustrated below. 
 
Figure 7. Frequency of no action taken after a DNA according to patient group.  
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The frequency of DNA with no action taken according to grade of staff is shown in 
figure 8. 
 
 Figure 8. Frequency of DNA with no action taken according to grade of staff.  
 
 Action plan 
A suggested protocol would be to have a system that would allow all patients who are 
due for appointments within 24 hours or 48 hours receive a text message to remind 
them of their coming appointment. The text message would have a message guiding 
parents to text back if unable to attend or wish to cancel the appointment. This would 
give reception the opportunity to book in patients who need appointments in the slots of 
patients who cancelled theirs. This however is not widely available at present.  
The  results  of  this  audit  will  be  presented  to  the  paediatric  department  staff  at  a 
meeting soon and clinician feedback will be sought with regards to finalising the 3 
proposed  pathways.  After  that,  the  protocols  will  be  distributed  to  ensure  that  all 
patients, in the three patient groups identified, are followed up. This protocol / system 
will be implemented for one year, followed by a re-audit.  
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Another audit will be carried out to look into the 89 patients who DNA’d and were lost to 
follow up.  
 
If patients do DNA, then according to the patient group, the provisional action in 
each of the three groups will be as shown (to be confirmed following staff meeting),  
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Figure 9. Action plan for patients who DNA in the new patient group. 
Discharged 
Second DNA 
New appointment 
First DNA 
New patients group 241 
 
 
Figure 10. Action plan for patients who DNA in the Treatment/follow up group. 
1) Call patient, or 2) Send new appointment, or 3) DNA letter 
Depending on consequence of DNA as discussed with 
consultant 
Discuss with consultant 
Second DNA 
1) Call patient or  2) Send  new app, or 3) DNA letter 
Document in notes 
Discuss with consultant 
First DNA 
Treatment/follow up 242 
 
 
 
Figure 11. Action plan for patients who DNA in the general anaesthesia group 
 
GA group 
First DNA 
Second GA appointment 
Second DNA  
Taken off W.L 
Given app. with consultant 
or minimum discussion 
with consultant  243 
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CASE NUMBER: 1 
 
Age of child at start of treatment: 5 years and 7months 
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CASE SUMMARY  
 
A healthy 5 year old boy was referred by his GDP for treatment of grossly carious 
primary teeth. In the referral, the dentist mentioned that Z.K was too anxious for 
dental treatment at his practice.  
Clinical  and  radiographic  examinations  revealed  severe  early  childhood  caries 
affecting almost all of the primary dentition. Although he was anxious, he allowed 
examination, and appeared cooperative. Utilizing different non-pharmacological and 
pharmacological  behaviour  management  techniques,  he  allowed  completion  of 
preventive  and  comprehensive  dental  treatment  successfully  under  local 
anaesthesia  and  inhalation  sedation.    Z.K  is  on  3  months  periodic  review 
programme to ensure good oral health. 
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PATIENT DETAILS  
 
  Initials: Z.K  
  Gender: Male 
  Age at start of treatment: 5 years, 7 months 
  Age at last review: 7 years, 2 months  
 
PRE-TREATMENT ASSESSMENT  
 
HISTORY OF PRESENTING COMPLAINT(S)  
 
  Pain when eating food on upper right side and occasionally at night for 6 
months 
  Controlled with paracetamol when required  
   History of facial swelling URQ 
 
  History of antibiotic given (Amoxicillin)  
 
RELEVANT MEDICAL HISTORY  
 
  Nil relevant  
 
DIET HISTORY 
 
  Eats sweets and biscuits daily 
  Drinks milk, water and apple juice  
 
TEETH BRUSHING 
  
  Brush once a day with children toothpaste (unsupervised)  
 
 FAMILY HISTORY 
  No history of dental anomalies   
 
DENTAL HISTORY  
 
  Regular attendee at GDP  
  History of dental treatment under local anaesthesia (LA)  249 
 
 
CLINICAL EXAMINATION  
 
Extra-oral:  
 
  Face: symmetrical, no swelling  
  No palpable lymph nodes  
  No tenderness of muscle of mastication  
  Normal tempromandibular joint movement  
  Normal mouth opening  
  Behaviour: Anxious  
 
Intra-oral:  
 
  Teeth present  
 
  URE, URD, URC, URB, URA, ULA, ULB, ULC, ULD, ULE 
  LRE, LRD, LRC, LRB, LRA, LLA, LLB, LLC, LLD, LLE 
  LR6 and LL6 partially erupted 
 
  Visible plaque accumulation on most surfaces of the teeth (60% score) 
  Generalised mild gingivitis  
  Localised buccal abscess URE area  and glass ionomer  
  Amalgam filling LRE 
  Caries affecting most teeth surfaces  
  Well aligned upper and lower arches with spacing in the upper but not lower 
arch  
 
Orthodontic assessment  
  Primary dentition stage  
   Mesial step primary molar relationship  
  Upper and lower arches well aligned  
  Skeletal: class I base 250 
 
 
 
RADIOGRAPHIC EXAMINATION  
 
 
       
 
 
  Bitewing radiographs were taken to assess caries and bifurcation 
involvement (3.03.12)  
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  Orthopantomogram (OPG) was requested to assess 
  Dentition development and presence of permanent successors 
  OPG was taken on the 3
rd visit ( 7.06.12)to confirm suspected 
hypodontia  
RADIOGRAPHIC FINDINGS:  
  Quality of OPG, vertical bitewings and  upper anterior occlusal : 
Diagnostically acceptable  
  Proximal caries into enamel : URA,URB, ULA and  ULB 
  Caries into dentine : URC, ULC  
  Restorations on LRE and URE 
  Occlusal  and proximal caries into pulp: URD,ULD,LRD and LLD 
  Caries into pulp : URE,ULE 
  Potential crowding in the upper arch 
  Missing UL5, LL5, LR4 and LR5 252 
 
PRE-TREATMENT PHOTOGRAPHS: EXTRA AND INTRA ORAL (3.03.12) 
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DIAGNOSTIC SUMMARY 
  Early childhood caries  
  Generalised gingivitis  
  Hypodontia UL5,LL5,LR4 and LR5 
  Anxious child  
 
 
 
 
AIMS AND OBJECTIVES OF TREATMENT  
 
  Acclimatise Z.K to dental treatment and instil a positive dental attitude to 
dental health  
  Relieve sources of pain and infection  
  Establish a preventive regimen consistent with the Department of Health 
preventive toolkit (third edition).  
  Incorporation of nitrous oxide inhalation sedation as a pharmacological 
behavioural management technique, due to amount of treatment 
  Restore aesthetic and function of carious teeth  
  Monitor the occlusion of developing dentition and treat as necessary  
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TREATMENT PLANE 
visits  Prevention  Treatment  Others 
 
 
1 
3.03.12 
 
  Oral hygiene 
instructions (OHI) 
  Plaque score  (PI) 
60% 
  Fluoride advice 
  Fluoride 
application 
  Issuing diet sheet 
 
 
 
  Examination , 
charting and 
radiographs  
  Treatment plan 
formulation  
 
  Anxiety Scale 
measurement 
Frankl (2) 
  Introduction to 
local 
anaesthesia 
and restorative 
procedures + 
inhalation 
sedation 
  Clinical 
photographs  
 
 
 
2 
23.03.12 
 
  OHI 
  PI 40% 
  Diet analysis and 
advice 
  Prophylaxis 
polishing 
 
 
  Composite 
restorations on URB 
and ULB 
  Composite 
restoration URA and 
ULA 
 
  Temporisation of 
primary molars with 
temporary fillings 
IRM 
 
  URE temporisation 
ledrmix + IRM  
 
 
  Nitrous oxide  
inhalation 
sedation (IS)  
  LA 
 
 
      
 
3 
7.06.12 
 
 
  OHI  
  PI 33% 
  Patient had pain 
on ULD 
 
 
  ULC : Labial 
restoration 
  ULE :  Ferric 
Sulphate Pulpotomy 
and preformed 
metal crown (PMC) 
  ULD : Extraction  
 
 
  
 
   LA 
   IS 
 
 
 
4 
16.06.12 
 
  
  PI 20% 
 
 
  URC : Labial 
restoration  
  URD : Extraction  
  Frankl (3) 
 
  LA 255 
 
 
 
 
  URE : Extraction 
 
 
  IS 
 
 
5 
23.06.12 
 
  Pl 10% 
 
 
  LLE: Ferric Sulphate 
pulpotomy and PMC 
  LLD: Extraction  
 
 
  LA 
  IS 
 
6 
30.06.12 
  
  Plaque score  
  OH has improved 
  PI 10% 
 
 
  LRD : Extraction 
  LRE : restoration 
and preformed metal 
crown   
 
 
  Frankl (4) 
  LA 
  No IS needed 
 
 
KEY STAGES IN TREATMENT PROGRESS 
Prevention  
  Stressed to the parents the importance of following the oral hygiene 
instructions and the caries preventive measure  
  Oral hygiene instructions  
  Brushing twice a day with parental help 
  Brushing last thing at night and on one other occasion  
  Spiting after brushing but not rinsing  
  Diet advice  
  Reducing the amount and the frequency of sugar and limiting it to meals 
time  
  Not to consume sugar more than four times a day  
  Plaque score and polishing with paste and rubber cup  
  Fluoride advice  
  1450 ppm fluoride toothpaste  
  Application of fluoride varnish 22,600 ppm every 3-4 times yearly 
  Fissure sealant all 6’s when they erupt  
Behaviour management  
  Non-pharmacological techniques: 256 
 
  Tell-Show-Do, enhanced control, distraction, and  positive 
reinforcement  
   Pharmacological technique  
  Inhalation sedation: Nitrous oxide 30% and 70% O2  
  Local analgesia : 
  Infiltration of 2% lignocaine with 1:80,000 epinephrine local 
anaesthetics with restoration  
  4% Articaine with 1:100,000 epinephrine infiltration was 
used to provide more profound analgesia in all extractions  
 
 Restorative and Extraction:  
All restorative treatment were completed using rubber dam isolation 
  Anterior Composite restoration on URC,URB,URA,ULA,ULB and ULC 
  Pulpotomy with 15.5% ferric sulphate & PMC ULE, LLE 
  Extraction URE,URD,ULD,LLD and LRD 
 
  Some changes in the treatment plan were made, mainly delaying extraction 
of URE as patient came in visit 3 complaining of pain on ULQ  
  Treatment completed over six months period 
 
 
Review: (3, 9, 12, 18 months) 
First  review  was  3  months  following  treatment  completion.  The  caries  risk 
assessment indicated low disease activity. Therefore, the recall interval adjusted 
into 6 months period. The following were considered:  
  Review of restorations  
  Reinforcing preventive advice 
  Application of fluoride varnish  
  Resin fissure sealants on all 6’s 
  Monitoring the eruption of permanent dentition  
  Upper and lower centrals incisors were erupted 
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POST-TREATMENT EXTRA ORAL AND INTRA ORAL PHOTOGRAPHS: last 
review visit (27/07/14) 
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POST-TREATMENT RADIOGRAPHS: (27/07/14) 
 
                 
 
 
LONG TERM TREATMENT PLAN AND FUTURE CONSIDERATIONS  
 
  Regular long-term diet monitoring and reinforcement of oral hygiene practice  
  Z.K is already Hypodontia clinic waiting list regarding missing UL5, LL5, LR4 
and LR5 
  Periodic review of the restorations and pulpotomies with radiographic 
assessment  
  Monitoring the eruption pattern of the permanent teeth  
  Monitoring retained primary molars ( infraocclusion) 
 
DISCUSSION 
Behaviour Management 
Z.K  had  an  amalgam  restoration  under  LA  with  his  GDP;  unfortunately  this 
experience  increased  his  anxiety  towards  dental  treatment.  In  addition,  he 260 
 
experienced  episodes  of  dental  pain  mainly  at  night  and  whilst  eating  that  was 
controlled with pain killers.  
Sedation will not necessarily convert an uncooperative child into a co-operative one. 
However, it can help to alleviate anxiety, improve a child’s tolerance of invasive 
procedures, and increase the child’s ability to cope with prolonged treatment. In this 
case,  Z.K  was  traumatised  from  a  previous  dental  experience  which  made 
treatment  under  local  anaesthesia  quite  difficult  to  obtain.  Therefore,  inhalation 
sedation with nitrous oxide was introduced as the flow was set initially very low then 
slowly the dose was titrated to 30 %-70% nitrous oxide and oxygen respectively 
1 
Furthermore, the mother was present during the dental treatment acting as passive 
observer. This was helpful in facilitating the treatment and reducing Z.K's anxiety.  
Several non-pharmacological behaviour management techniques were used in this 
case aiming to create positive dental attitude and long-term interest in prevention, 
and maintaining oral health. Tell-show-do is a widely used technique and easy to 
use.  Using  simple  language  was  implemented  to  familiarise  Z.K  with  new 
procedures.  Distraction,  with  the  help  of  the  dental  nurse,  and  positive 
reinforcement were also used. Explaining the duties of parents and dental nurse 
before starting treatment was important in achieving successful treatment. 
Z.K's  behaviour  was  initially  negative  towards  dental  treatment  but  improved 
through visits to definitely positive according to the Frankl rating scale. 
Prevention 
Prevention  plays  a  major  role  in  the  management  of  dental  caries.  Prior  to 
formulating a prevention plan, it is essential to understand the patient's caries risk 
2. 
Z.K was a high caries risk patient, so he was approached with a comprehensive 
prevention treatment plan that includes plaque control and tooth brushing, practical 
diet advice, and fluoride therapy.  
Restorative Management 
Restorations and extractions of damaged teeth were necessary to re-establish oral 
health and prevent further dental pathology. 
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Resin- based Fissure Sealant  
Pit and fissure sealants have been described as materials which are placed in order 
to obliterate the fissures and remove the sheltered environment in which caries may 
thrive. In this case all permanent molars were sealed as soon as they erupted  
Resin-based Composite Restorations 
In this case ULC, ULB, URA, ULA, URB and URC were restored with composite 
resin as these teeth exhibited no pulpal involvement and the size of the cavities 
were adequate for intra-coronal restoration. Composite restoration is a technique 
sensitive procedure. Thus, rubber dam isolation was employed.  
 
Pulp Therapy using Ferric Sulphate 
Pulpotomy is defined as the clinical procedure involving the removal of the inflamed 
and infected coronal pulp tissue while maintaining vital healthy radicular pulp. It has 
been reported that inflammation of the pulp precedes carious exposure. In addition, 
primary teeth with caries involving more than half bucco-lingual intercuspal distance 
or  more  than  50%  of  the  dentine  thickness  have  increased  risk  of  pulp 
inflammation
3. Accordingly, in this case pulpotomy was indicated to be performed 
on the ULE and LLE. Clinically, these teeth did not show any signs of infection, 
such as intra-oral swelling, sinus, pathological mobility, or pain on palpation of the 
teeth or the buccal sulcus.  
In this case 15.5% ferric sulphate was used as pulpotomy medicament. On contact 
with blood in the pulp chamber, a ferric ion-protein complex is formed promoting 
haemostasis 
4 Ferric sulphate gained wide popularity as a potential replacement of 
formocresol  which  is  associated  with  concerns  regarding  toxicity  and  possible 
carcinogenicity. Despite the high reported clinical and radiographic success of ferric 
sulphate  pulpotomy,  there  is  no  absolute  evidence  of  its  superiority  to  other 
pulpotomy medicaments.  
 
Preformed Metal Crowns (Stainless Steel Crowns SSCs)  
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In high caries risk patients not maintaining a satisfactory oral hygiene, the British 
Society  of  Paediatric  Dentistry  guidelines  indicate  the  use  of  PMCs.  It  is  the 
restoration  of  choice  when  extensive  multi-surface  restoration  is  required,  and 
following endodontic treatment. Several studies reported higher success rates when 
using  PMCs  compared  to  other  restorative  materials 
5.  Furthermore,  clinical 
experience still favours PMCs in restoring primary molars in the above mentioned 
situations compared to alternatives 
6. Aiming to achieve the best coronal seal and 
greater longevity, all primary molars with pulp therapy were restored with FMCs in 
this case.  
 
Extraction of Primary Molars 
A. Z.K had localised abscess, pain, and extensive caries associated with URE and 
non- restorable D’s. Extraction was unavoidable due to their poor restorability and 
long term prognosis. Z.K coped well with the extraction under local anaesthesia and 
inhalation sedation 
Space maintenance was not indicated in this case. The upper arch was well-aligned 
and extractions of these teeth are unlikely to result in space loss or substantial 
crowding. In addition, as Z.K is high-caries risk caries recurrence risk was deemed 
to outweigh the space loss risk if would it be as Z.K considered a hypodontia patient 
   
Lessons Learnt  
• Z.K presented initially with caries affecting most of his teeth and poor oral hygiene. 
Empathic approach was useful at initial consultation helping to obtain full dental 
history from parents in a non-judgmental manner. This approach was also useful in 
motivating Z.K and parents to follow prevention instructions for now then moving to 
adult dentition  
 
• It is important in these cases to spend time with parents educating them about the 
importance of prevention in maintaining dental health in the long term.  
 
  Z.K presented with hypodontia, therefore it was necessary to change his 
attitude toward dental treatment as he would need more dental treatment in the 
future.  263 
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CASE NUMBER: 2 
Patient’s age at start of treatment (8 years, 5 months) 
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CASE SUMMARY 
 
An 8 year-old boy with Axenfeld-Rieger’s syndrome (ARS) was referred by his GDP 
to  the  new  patient  clinic  regarding  missing  permanent  teeth.  T.D  had  been 
diagnosed  with  ARS  syndrome,  with  ventricular  septal  defect  (VSD)  which  was 
surgically corrected in his early years.   
Examination,  radiographs  and  history  were  carried  out.  He  was  diagnosed  with 
caries, malformed teeth (conical / microdont teeth), infraoccluded primary molars 
and  hypodontia.  Due  to  the  complexity  of  his  condition  a  multidisciplinary 
hypodontia clinic visit was needed for planning considering the fact that T.D was 
being  bullied  because  of  the  appearance  of  his  teeth.  After  liaising  with  his 
paediatrician, treatment was carried out under LA which included fissure sealants, 
fillings, upper overdenture and lower resin bonded bridge.  
T.D and his twin brother live with a foster family, and at each visit his social worker 
was updated with the progress of his treatment 266 
 
PATIENT DETAILS 
 
Initials: T.D 
Gender: Male 
Age at start of treatment: 8 years, 5 months 
Age at last review: 11 years, 2 months 
Follow up over 30 months 
 
 
PRE-TREATMENT ASSESSMENT  
 
HISTORY OF PRESENTING PATIENT’S COMPLAINT(S)  
  No history of dental pain or abscesses at presentation. However, T.D was 
concerned about his appearance and his foster mother mentioned he was 
being bullied at school due to his missing teeth 
 
RELEVANT MEDICAL HISTORY  
  ARS: vision and hearing impairment and ventricular septal defect which was 
corrected in his early years 
  Medication: multivitamins 
  T.D wears hearing aids 
 
 
SOCIAL HISTORY  
  T.D and his twin brother who has the same condition lived with a foster 
family for the last 4 years and recently they were adopted by the same 
family and they became  the legal guardians  
 
DENTAL HISTORY  
  Regular attendee at general dental practitioner (GDP) 267 
 
  No history of operative treatment  
  Tooth-brushing twice daily with children toothpaste ( unsupervised) 
 
CLINICAL EXAMINATION  
Extra-Oral Examination: 
  Hard tissue: prominent supraorbital ridges, broad nasal bridge and 
prominent forehead 
  Maxillary hypoplasia/prognathic profile 
  Thick glasses and hearing aids 
  Soft tissue, TMJ and lymph nodes: nothing abnormal detected 
  Behaviour : positive toward dental treatment (Frankl Scale:3) 
 
Intra-Oral Examination: 
  Teeth presented intra-orally  : 
  URD, URC, UR1, UL1,URC, URD 
  LR6, LRE, LRD, LRC, LLC, LLD, LLE and LL6 
  Good oral hygiene   
  Caries on LLD and LRD 
  Conical UR1,UL1 
  Infraoccluded primary molars (LRE ,LRD ,LLD ,LLE) 
  Hypomineralised  permanent molars 
 
Oral Hygiene  
  Good oral hygiene, no visible plaque deposits on teeth (Simplified plaque 
index score) 
 Orthodontic Assessment  268 
 
  Mixed dentition stage 
  Midline diastema (6mm space between upper central incisors) 
  Molar Relationship: right and left cross bite 
  Upper and Lower Arch: anterior segment spacing 
  Skeletal: Class III base  
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GENERAL RADIOGRAPHIC EXAMINATION  
 
 
 
  DPT (16.03.11): 
  was diagnostically acceptable in the right and left side but not 
in the middle section presumably because of patient 
movement   
  Hypodontia : 
  UR2, UR3, UR5, UR6,UR7, UL2, UL5, UL6 and UL7   
  LR5,LR2,LR1, LL1, LL2, LL5 and  LL7  
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PRE-TREATMENT PHOTOGRAPHS: EXTRA and INTRA-ORAL (16/03/ 2011) 
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DIAGNOSTIC SUMMARY  
 
  Caries in primary teeth LLD,LLE 
  Infraoccluded LLD,LLE,LRD and LRE 
  Severe hypodontia (Oligodontia) 
  Upper anterior spacing 
  Skeletal: Class III base  
Motivation  
  Good 
  continuous support from his foster mother to carry on treatment  
 
 
AIMS AND OBJECTIVES OF TREATMENT  
 
1. Rehabilitation of function and aesthetics  
2. Cosmetically improve appearance of anterior teeth 
3. Management of caries primary teeth 
4. Monitoring of developing dentition 
5. Oral health maintenance and preventive programme  273 
 
TREATMENT PLAN  
Visit  Treatment  and prevention provided 
 
1 
16.03.11 
 
  Examination and charting   
  Oral hygiene instructions (OHI)  
  Issue diet sheet  
  Refer to hypodontia clinic 
 
 
 
 
 
 
2 
11.05.11 
 
 
 
  OHI ,Simplified Plaque Index (PI), diet analysis & 
advice 
   Prophylaxis and fluoride application (F)   
  Composite restoration LLD,LLE 
  Silicon impression for  construction resin bonded 
bridge (RBB) replacing LR2,LR1,L1,L2 and using 
LRC and LLC as abutment 
 
 
3 
27.5.11 
 
 
 
  Resin fissure sealant on 
  LR6,LRE,LRD, LLD,LLE,LL6 
  URD,UR1,UL1,ULD 
  Cementation of  lower RBB  
  Upper primary impression for special tray 
  Patient was satisfied and happy with the bridge 
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4 
3.06.11 
 
 
 
 
 
 
  Silicon impression using constructed special tray 
  Shade guide  
 
5 
23.6.11 
 
 
  Bite registration  
  Prosthodontic consultation with regard to upper 
over denture:  
  No need for facebow registration  
  Anterior teeth should be aligned in to class I 
 
 
6 
12.7.11 
 
 
 
  Teeth try in 
 
7 
29.7.11 
 
 
  Insertion  
  Post insertions instructions 
 
8 
9.2.12 
 
 
 
 
  Periodic review 
  No significant findings 
  PI, OHI & F 
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9 
27.9.12 
 
  Periodic review 
  No significant findings 
  PI, OHI & F 
 
 
10 
11.1.13 
Review in hypodontia clinic 
 
  Recommended to be reviewed in a year  
 
   
  11 
29-01-2013 
Emergency appointment  
 
  Pt misplaced denture  
  New impression for constructing upper denture 
which took several visits 
 
16 
13.2.14 
 
  Periodic review 
  No significant findings 
  PI 
  OHI & F 
  Clinical photographs were taken 
 
 
  Review every 6 -12months:  
o  Periodic review of restorations 
o  Review and reinforce oral hygiene measures and diet advice 
o  Review upper overdenture and how is he coping with it 
o  Monitor eruption of permanent teeth 
o  Monitor infra-occluded primary teeth and any signs of ankeylosis 276 
 
KEY STAGES IN TREATMENT PROGRESS 
Liaison with paediatrician and cardiologist  
T.D’s  physicians  were  contacted  regarding  his  condition  and  there  were  no 
concerns regarding dental treatment under local anaesthesia (LA)  
  Social worker was contacted and updated regularly with T.D 
progress   
 
Prevention 
  Plaque  score 10% and subsequently 0% 
  Oral hygiene instruction: 
o  Brush twice daily with fluoridated toothpaste that contains at least 
1,350 ppm fluoride 
o  Brush last thing at night and first thing in the morning 
o  Spit out after brushing and not to rinse 
  Diet analysis and advice: 
o  Issuing diet sheet 
o  Sweets should be consumed at mealtimes as a dessert rather than 
between meals. 
o  Sugars should not be consumed more than four times per day.  
  Fluoride varnish application (2.26% F) 
 
Behaviour management 
  Non-pharmacological behaviour management techniques including tell-
show-do and positive reinforcement were used during the provision of 
preventive care. 
  Local anaesthetic (a pharmacological behaviour management technique) 
was utilised to provide the planned comprehensive dental treatment 
(Infiltration of 2% lignocaine with 1:80,000 epinephrine) 
 
Caries management 
Treatment performed under LA and rubber dam: 277 
 
  Occlusal composite restoration for LLD and LLE 
  Resin fissure sealant of LRD,LRE,LR6,LLE,LL6, UR1 and UL1 
 
  
 
Aesthetic management  
  Construct an upper over denture  to improve: 
 
o  aesthetic  
o  correct occlusion  
o  upper lip support  
  Construct fixed fixed resin bonded bridge on lower anterior segment 
Review 
Periodic reviews every 6 months were done over 3 years, they involved monitoring 
of restorations, enhance oral hygiene, preventive and dietary advice, and fluoride 
varnish application (2.26% F). 
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POST-TREATMENT  PHOTOGRAPHS:  EXTRA  AND  INTRA  ORAL  (last  review 
13.2 2014) 
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LONG TERM TREATMENT PLAN AND FUTURE CONSIDERATIONS  
 
  Periodic review of restorations 
  Review of oral hygiene and reinforcement of oral hygiene practice  
  Monitor the development and eruption pattern of permanent dentition 
  Monitor infraoccluded primary molars 
  Referral to hypodontia clinic at appropriate timing to formulate a future plan 
to replace missing teeth. Possible treatment options include:  
o  Partial dentures 
o  Resin bonded bridge 280 
 
o  Implant         
 
 
DISCUSSION AND REFLECTION  
 
Axenfeld- Rieger’s syndrome (ARS) (# OMIM 180500) 
 
Axenfeld  Rieger’s  syndrome  (ARS)  is  a  rare  genetic  disorder  characterized  by 
malformations  of  the  anterior  chamber  of  the  eye  (goniodysgenesis)  it  may  be 
accompanied  by  a  spectrum  of  dental,  craniofacial,  and  somatic  anomalies.  Its 
frequency in the general population has been estimated to be 1 per 200,000. When 
only the eyes are affected, the condition is termed the Rieger anomaly 
1  
At present, two different genes encoding transcription factors (PITX2 and FOXC1) 
are known to cause the alterations observed in the ARS. In addition, at least two 
genetic loci involve genes that have not yet been characterized (13q14 and 16q24). 
Furthermore, two other putative genes have been implicated (PAX6 and MAF)
 1 
 
Clinical manifestation of ARS
 2 
  Ocular : Goniodysgenesis and glaucoma 
  Cranio -facial: Maxillary hypoplasia/prognathic profile, mandibular 
hypoplasia, hypertelorisim, prominent supraorbital ridges, 
telecanthus, broad nasal bridge, protrusive lower lip/recessive upper 
lip and enlarged sella turcica 
  Dental: Hypodontia, hypoplasia, taurodontia, microdontia 
  Associated systemic conditions: congenital heart defect, kidney 
malformations, retarded bone growth  
 
Congenital heart defects are common in this syndrome and are often the clinical 
manifestations leading to diagnosis. Many different defects can occur but the most 
frequently reported cardiac malformations include ventricular septal defect. 
 281 
 
Dental  problems  are  hypoplasia  or  hypomineralisation  of  enamel,  this  common 
defect can increase the risk for dental caries (as is the case with T.D). Other dental 
problems including delayed tooth eruption and aberrant tooth shape, hence close 
monitoring  of  the  development  of  the  occlusion  and  radiographic  examination 
should be undertaken at an appropriate age to exclude hypodontia
3 
   
Behaviour management   
Several non-pharmacological behaviour management techniques like tell-show-do 
and positive reinforcement were used with him during the preventive care visits with 
the aim of creating positive dental attitude and long-term interest in prevention and 
maintaining oral health. T.D’s hearing and vision impairment made communication 
challenging; however, improvement in his general behaviour toward dentistry was 
noticed  over  subsequent  visits,  his  rating  in  Frankl  scale  improved  definitely 
positive. However, T.D was shy and withdrawn at the first few visits, he refused 
photographs to be taken but subsequently agreed. 
 
Restorative treatment (hypodontia)  
Management  of  hypodontia  requires  a  multi-disciplinary  care  which  involves  the 
close  working  relationship  of  a  committed  team  contributing  their  individual 
expertise  to  achieve  an  optimum  outcome  for  the  patient  and  family.  Early 
orthodontic and restorative interception is highly recommended for the best long-
term treatment planning. After referring T.D to the hypodontia clinic, construction of 
maxillary  overdenture  was  recommended.  This  was  to  improve  aesthetics  and 
provide  better  lip  support  than  ordinary  removable  partial  denture  (RPD) 
4.  In 
addition,  resin  bonded  bridge  was  constructed  for  the  lower  anterior  segment 
instead  of  RPD  as  children  often  cope  better  with  fixed  appliances  rather  than 
removable especially in the lower arch.
 
 
Infraoccluded primary molars 
Retention  of  primary  molar  teeth  where  the  permanent  successor  is  absent  is 
important in cases of hypodontia since they retain bone in an area which may be a 
site for future transplantation or implant therapy. The prevalence of infraocclusion is 
1-9%. Altered pulp pathology will determine the most appropriate management but 282 
 
may  involve  pulp  therapy  and  restoration  with  pre-formed  metal  crowns.  Where 
restoration for  caries is not necessary, an infraoccluded tooth that is static may 
have onlays placed in order to facilitate cleaning as well as preventing food packing 
and  its  squeal.  If  seen  early  enough  it  may  be  prudent,  in  conjunction  with 
orthodontists, to remove the primary molar tooth where there is no successor to 
achieve and optimum outcome. The longevity of the primary dentition, where there 
are no permanent successors, is uncertain 
5. In this case, over the review period the 
infraoccluded  teeth  were  in  the  same  level  without  any  signs  of  ankyloses. 
Therefore, the suggested treatment was to monitor.  
 
Preventive care and Recall 
T.D had multiple carious lesions with hypomineralisation enamel defects. Therefore 
it was important to establish preventive regimen aiming to prevent the progress of 
the  disease  and  reduce  the risk  of  development  of further  caries.  An evidence-
based preventive approach was utilised for T.D 
He was placed on a 6 months recall visits, and with implementation of behaviour 
management techniques, he received diet  advice,  oral hygiene instructions, and 
fluoride therapy 
6 
 
LESSON LEARNT  
 
  I have learned that careful planning of treatment while liaising with other 
colleagues is essential for successful management of these children. This 
requires clear pre-treatment and early liaising with orthodontics and 
prosthodontics in hypodontia clinic  
   It is essential for these patients and parents to be educated about oral 
hygiene and regular recalls to maintained all remain teeth   
  It was rewarding experience, seeing this young man regaining his confident 
and self-steam and how has it implied on his attitude toward dental 
treatment.  283 
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CASE NUMBER: 3 
Patient’s age at start of treatment: 10 years, 4 month 
 
 
CASE SUMMARY 
C.L a 10 year old boy, who was referred by A&E for management following severe 
dentoalveolar  trauma,  which  resulted  in  avulsion  of  maxillary  permanent  central 
incisors.  C.L  received  emergency  treatment  at  a  General  Hospital  where 
replantation and splinting of the teeth was performed.  
Subsequently  he  presented  one  week  later  with  tenderness  to  percussion  and 
mobility. Pulp extirpation and root canal treatment were carried out, currently, 3 
years following the accident C.L has a restored dentition that is functionally and 
aesthetically acceptable. However, UR1 has a poor prognosis.     
This case will be monitored aiming to preserve the affected teeth on the medium 
term,  the  bone  and  mucogingival  structures  on  the  long  term  and  provide  a 
definitive long term treatment options.  
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PATIENT DETAILS 
 
Initials: C.L 
Gender: Male. 
Age at the start of treatment: 10 years, 4 month.  
Age at the last review: 13 years, 5 months. 
 
PRE-TREATMENT ASSESSMENT 
PATIENT COMPLAINT 
  Pain associated to upper front teeth.  
HISTORY OF PRESENTING COMPLAINTS 
  Trauma of anterior teeth on the 12/7/2011 at 04:30 pm when patient hit a 
lamp post while he was on his bicycle in front of his house 
   UR1 and UL1 were avulsed and both were fractured    
   The avulsed UR1 had half root fracture and couldn’t be found 
  Chin and lower lip were abraded  
  Teeth were immediately stored in milk and patient attended Accident and 
Emergency department at General Hospital where 
  Posteroanterior X ray view was taken to roll out any skull injuries. 
No neurological signs or symptoms were detected. 
  Amoxicillin 250 mg TDS was given  
  Tetanus booster was given  286 
 
  Around 6:20 pm teeth were replanted under local anaesthesia, 
teeth were splinted with resin composite.  Patient was referred to 
the paediatric department  
  Patient was seen in the department as emergency on  17/7/2011 
RELEVANT MEDICAL HITORY 
  Mild asthma controlled with salbutamol inhaler. 
DENTAL HISTORY 
  Regular attender at general dental practice. 
  No previous dental treatment. 
 
CLINICAL EXAMINATION 
Extra-Oral Examination: 
  Lower lip swelling 
  Upper lip and chin abrasion  
  No lymphadenopathy. 
  No muscles tender to palpation. 
  Tempromandibular joint (TMJ):  no pain, no deviation in closing.  
  Behaviour : 
o   At first visit he was complaining of sore mouth and pain in his teeth 
which subsequently increased his anxiety level (Frankl scale: 2). 
Through visits he was cooperative , well – motivated  and looking 
forward to improve the aesthetics of his teeth 
Intra-Oral Examination: 
  UR1 enamel and dentine fracture (E+D#) mesially  
  UL1  E+D# mesially  
  UR2 E+D# incisally 
  UR1 and UL1 tender to percussion, grade II mobility 287 
 
  Poor resin composite splint ( chipped interproximally btween UR2,UR1, 
UL1and UL2) 
Vitality test:   
  UR1,UL1 negative 
  UR2 positive 
  Poor oral hygiene  (Simplified plaque index ) PI : 76% 
  Mixed dentition stage. 
  Orthodontic assessment: 
o  Class I incisors  
o  Class I molars relationship both right and lift 
o  Well aligned upper and lower labial segments  
 
 
RADIOGRAPHIC EXAMINATION 
Periapical  radiographs for  UR1,  UL1  and  Upper  anterior  occlusal  radiograph,  to 
assess the dental trauma. 
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12-7-2011 
 
 
RADIOGRAPHIC FINDINGS: 
  UR1: enamel dentine fracture and missing half of the root,   
  UL1: Enamel dentine fracture, radiolucency suggesting inflammatory 
resorption, no signs of root fracture and closed apex with complete root 
development. 
  Soft tissue X-ray was taken to exclude any tooth fragment  which could be 
impeded in the lower lip  
 
PRE-TREATMENT PHOTOGRAPHS: EXTRA-ORAL AND INTRA-ORAL 
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Note: C.E was in pain and quite anxious therefore obtaining more pictures was 
difficult 
DIAGNOSIS SUMMARY 
Hard tissue 
    UR1: 
o  Avulsion 
o   E +D# 
o  Half root fracture and couldn’t be found  290 
 
  UL1: 
o  Avulsion 
o   E+D# 
  UR2:  E+D# 
  Caries free dentition. 
Soft tissue 
  Upper lip abrasion  
 
AIMS AND OBJECTIVES OF TREATMENT 
   Restore function and aesthetic of the traumatised incisors.  
   Eradicate infection and stabilise inflammatory resorption by performing pulp 
extirpation. 
   Monitor  periodontal ligament of the injured teeth for  signs of root 
resorption.  
  Preserve teeth in the medium term, aiming to maintain the bone level in the 
long term. 
  Conserve the upper permanent central incisors for as long as possible 
  Improve OH 
  Educate patient and parents about the poor long term prognosis of these 
teeth, time required for treatment and the available future treatment options. 
 
 
TREATMENT PLAN 
1-  Immediate re-splinting  of UR1 and UL1 using orthodontic wire and resin 
composite 
2-  Pulp extirpation of UR1 and UL1 
3-  Restoration of fractured teeth with composite resin restorations.  291 
 
4-  Monitor the periodontal ligament of the injured teeth for signs of root 
resorption or bone replacement 
5-  Monitor adjacent teeth  
6-  Provide preventive advice and oral hygiene instructions. 
 
KEY STAGES IN TREATMENT PROGRESS 
  First visit 12/7/2011 
o  Examination, radiographs, clinical photographs. 
o  Pulp extirpation on UR1 and UL1 under local anaesthesia 
(Infiltration of 2% lignocaine with 1:80,000 epinephrine ) and dry 
dam  
o  Estimation working length and Ca(oH)2 dressing on UR1 and UL1 
o  Pulp sensibility testing (ethyl chloride and electric pulp testing) for 
UR2 and UL2 which responded positively  
o  Splinting UR1 and UL1 for 4 weeks 
o  Flowable composite using L-Pop on UL1, UR1 and UR2 to cover the 
exposed dentine 
 
  4 weeks visit 18/7/2011 
o  Splint removal  
o  Pulp sensibility testing (ethyl chloride and electric pulp testing) for 
UR2 and UL2 gave positive responses.  
o  UR1 grade II mobility 
o  Ca(0H)2  change UR1and UL1, Sodium hypochlorite as irrigation and 
working length 292 
 
o  composite restoration on UR1,UR2 and UL1                
 
 
  3 months  visit ( 14/11/2011) 
o  Pulp sensibility testing UR2  and UL2 gave positive response 
o  No signs of bone replacement 
o  UR1 grade II mobility 
o  UR1and UL1   Ca(0H)2  change 
o  Mouth guard was constructed and advised to wear during sports 
 
  6 months  visit (6/2/2012) 
o  UL1 obturation performed  using performed with (Obtura-II system)  
o  UR1 obturation  performed using MTA  
o  post-operative periapical radiographs UL1, UR1 showed satisfactory 
root filling 
  Review visits at 6, 12 and 24 showed no signs or symptoms of infection, 
both clinically and radiographically. 
 
  Review visits at 36 months (6/8/2014) 
o  Disclouration UL1 
o  Grade II mobility UR1 
o  Poor OH which lead to moderate gingivitis  293 
 
 
  Patient now is under annual review visits. 
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Prevention and oral Hygiene improvement    
Prevention 
  Oral hygiene instruction: 
o  Brush twice daily with fluoridated toothpaste that contains at least 
1,350 ppm fluoride 
o  Brush last thing at night and first thing in the morning 
o  Spit out after brushing and not to rinse 
  Fluoride varnish application (2.26% F) 
 
 At  last  review  patient  was  referred  to  the  hygienist  clinic  for  oral  hygiene 
instructions, dietary advice, and fissure sealant and fluoride application.  
 
Long term restorative options 
  Periodic recalls to review traumatised teeth and evaluate the degree of 
mucogingival defect which may occur if bone replacement happens  
  Bleaching if any traumatised teeth developed discolouration   
  Future treatment options 
o  Partial removable denture 
o  Resin bounded bridge 
o  Auto-transplantation 
o  Implant 
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POST-TREATMENT RADIOGRAPHS 
PA 6 months post trauma (6/2/2012) 
  
  UL1: Well condensed Gutta-percha (GP).  
  Length of GP: to the root apex. 
  UR1 well condensed MTA 
  No signs of periapical lesions, pathology and bone replacement  
PA 24 months post trauma (30/8/2013) 
 
  No signs of periapical lesions or pathology or bone replacement  
  No occlusion disturbance 296 
 
Last Review 3 years post trauma (6/08/2014)  
 
  No signs of periapical lesions or pathology or bone replacement  
 
 
INTERMEDIATE PHOTOGRAPHS:  12 MONTHS POST TRAUMA  30/8/2012 
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POST-TREATMENT  PHOTOGRAPHS:  EXTRA-ORAL  AND  INTRA-ORAL  3 
YEARS POST TRAUMA (6/8/2014) 
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DISCUSSION AND REFLECTIONS 
Avulsion injuries  
Introduction  
Avulsion  represents  the  one  of  the  most  severe  displacement  injuries,  and 
comprises  0.5-3%  of  the  traumas  affecting  the  permanent  dentition.  Numerous 
studies have shown that this injury is one of the most serious dental injuries, and 
the  prognosis  is  very  much  dependent  on  the  actions  taken  promptly  after  the 
avulsion.  Replantation  is  in  most  situations  the  treatment  of  choice,  but  cannot 
always be carried out immediately. An appropriate emergency management and 
treatment plan are important for a good prognosis 
1.  
In C.L case, teeth were restored in milk for two hours. According to the IADT, this is 
considered as non-favourable outcome for mature roots, as the majority of cases 
ended  with  bone  replacement 
2.  However,  C.L  avulsed  teeth  did  not  suffer  any 
signs of bone replacement even after 3 years of follow up. 
Management in Clinic 
Choice of treatment is related to the maturity of the root (open or closed apex) and 
the  condition  of  the  periodontal  ligament  cells.  The  condition  of  the  cells  is 
depending on the storage medium and the time out of the mouth, especially the dry 
time, as this is critical for survival of the cells. After a dry time of 60 min or more, all 
periodontal ligament (PDL) cells are nonviable
1,2  
What made this case challenging are the extra-oral time, the root fracture of UR1 
and the maturity of the roots. All these will have an impact on the prognosis of these 
teeth. In this case the goal in delayed replantation was, in addition to restoring the 
tooth for aesthetic, functional and psychological reasons, to maintain alveolar bone 
contour 
3 
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Splinting  
It is considered best practice to maintain the repositioned tooth in correct position, 
provide patient comfort and improve function. Current evidence supports short-term, 
flexible splints for splinting of replanted teeth. Studies have shown that periodontal 
and pulpal healing is promoted if the replanted tooth is given a chance for slight 
motion and the splinting time is not too long 
1. In this case, 4 weeks of splinting 
using  orthodontic  wire  and  composite  resin  was  carried  out,  following  the  IADT 
recommendation for a closed apex tooth with < 60 minutes extra orally. 
Endodontic treatment  
Root canal treatment is indicated with closed apex teeth, the ideal time to begin 
treatment is 7–10 days post-replantation. Calcium hydroxide is recommended as an 
intra-canal  medication  for  up  to  1  month  followed  by  root  canal  filling  with  an 
acceptable  material  as  long  it’s  free  of  any  signs  or  symptoms  of  persisting 
infection.  C.L  started  endodontic  treatment  7  days  after  accident  and  calcium 
hydroxide  has  been  successfully  used  to  form  an  apical  calcific  barrier,  high 
success rates in the range of 79−96% have been reported 
4. Despite such success 
rates,  however,  calcium  hydroxide  has  its  limitations  associated  with  the  long 
treatment time needed. There is also an increased risk of loss of coronal seal and 
tooth fracture owing to prolonged dressing with calcium hydroxide 
4. Additionally, 
the calcific barrier formed has been found to be porous and often containing small 
amounts  of  tissue.  Therefore,  Mineral  trioxide  aggregate  (MTA)  has  recently 
emerged as a material suitable to overcome the problems associated with calcium 
hydroxide. It offers good sealing ability, biocompatibility, antibacterial properties and 
the ability to induce apical hard tissue formation. In this case, MTA was the material 
of choice for UR1 due to wide opened end, therefore it was difficult to obtain apical 
barrier using regular Ca (OH) 2. In contrast, UL1 was filled with gutta-percha after 
apical barrier formation within six months from trauma due to the root development.  
MTA provided optimum sealing for a very short root which subsequently increased 
the chance of tooth discolouration 
6.  
 
Outcomes of replanted avulsed teeth 300 
 
Despite the delay in replantation, maturity of roots and root fracture results were 
beyond expectation. The teeth remain functional and symptom free over 36 months. 
C.L was pleased with the outcome; however UR1 has a poor prognosis due to the 
short root 
 
 
 
Lessons learnt  
  It is very important to be realistic about the long term prognosis of such 
cases and to educate the patient and the parents about the different 
trauma outcomes and treatment options especially in case the tooth is 
lost in the future 
  It is very challenging managing  child behaviour immediately after 
trauma  
  Choosing final root canal restoration by weighing the benefits and the 
disadvantages of each dental material which will end in patient’s best 
interest  
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